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Abstract 
This thesis will cover aspects of functionalised dipeptide hydrogels and their 
application in energy transfer and as vehicles for drug delivery. In the first section, a 
large number of dipeptides conjugated to different aromatic groups were synthesised. 
We synthesised 35 dipeptides conjugated to different aromatic groups (naphthalene, 
anthracene, phenanthrol, anthraquinone, carbazole and pyrene). We synthesised a large 
number of dipeptides with different hydrophobicity and different aromatic groups in 
order to study their ability to form gels and study the mechanical properties of the gels. 
The second part of this thesis will investigate the formation of hydrogels based on 
dipeptides with different aromatic groups. The focus in this section was on the gelation 
as well as the effect of changing the solvent and changing the amino acids used. This 
section then explores the properties of the resulting hydrogels. A number of different 
dipeptides containing different amino acids were tested, some of which formed gels and 
others. The dipeptides also had different pKa values. This factor was shown to be 
important in driving the preferential selection of a certain amino acids. 
The thesis then describes energy transfer which can occur between two dipeptides 
(pyrene and anthracene dipeptides), or between a dipeptide and a dansyl derivative 
(phenanthrol and dansyl, or carbazole and dansyl). These results showed that energy 
transfers can occur in these specific hydrogels. In all other cases, no evidence for energy 
transfer was found. This may imply that the packing of the fibres is important for energy 
transfer and this should be the focus of future work.  
The final section of this thesis describes the controlled release of model dyes from these 
gels. We studied controlled release from FmocFF hydrogels and from one other 
functionalised dipeptide hydrogel at different gelator concentrations and at different 
pH. The release of the dye from the hydrogel can be controlled by different factors, 
including the pH, peptide concentration, the microstructure and the mesh size. 
Furthermore, choosing the right method to prepare hydrogel allows us to control the 
microstructure for hydrogel to be injectable. Therefore, by controlling these entire 
factors we can use these kinds of hydrogels for drug delivery applications. 
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1- Introduction: 
1.1- Gel: 
A gel is a material that is easier to recognise than to define1. Lloyds explained a gel as a 
material that consists of two components, liquid and solid; and it has more solid-like 
than liquid-like properties2. Others defined a gel as a material of solid- and liquid-like 
states that result from the transition of liquid state to solid state by some conditions3 
(Fig. 1.1). Most researchers describe the gels as materials that contain two components, 
a solid and a liquid component. Generally, we can define a gel as a substance that is 
formed from materials that provide a three dimensional network. Gels are important 
because they have been used for many applications, including in cosmetics and personal 
care (contact lenses, toothpaste), food stuffs (jelly and puddings) and medical 
applications such as drug delivery4 and tissue engineering1, 5 and cell culturing6, 7. 
Moreover, they have also been used in plant growth8 and in chemical sensing agents9, 10.  
 
 
Figure ‎1.1: The transition of material from liquid state to gel state by some conditions.  
 
Gels can be organogels, where the liquid component is an organic solvent or hydrogels, 
where the liquid component is water (the focus of this thesis). Hydrogels can be 
classified commonly into chemical gels and physical gels and can be used in a wide 
range of applications, due to their compatibility with water.  
 
Chemical gels are gels that are formed by covalent bonds between compounds leading 
to the formation of irreversible networks such as polymer gel3, 11 (synthetic polymers 
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such as cross-linked poly(ethylene oxide) (PEO), poly(sodium acrylate) (PSA), and 
polypeptides12 or naturally polymers such as alginate,  pectin, collagen13 and 
gelatine14,12). For example, dextran consists of α-1,6-linked-D-glucopyranoses with 
some degree of 1,3-branching can form hydrogels when cross-linked13, 15 and it also 
used for protein delivery13. Also, gelatine gels have been used as a protein delivering in 
biomedical applications13. Collagen is a protein that can be found in body tissues16. 
Polymer hydrogels can have limited uses in biomedical applications. This is because of 
the presence of radicals and initiators that are present from the polymerisation process 
used to form the gels. These can damage biological materials17.   
 
In contrast, physical gels are gels that form by non-covalent interactions leading to the 
formation of reversible networks such as gels that formed from low molecular weight 
gelators (LMWG) (small molecules) (discussed in more details below and are the focus 
of this Thesis). 
 
The difference between the LMWG hydrogels and chemical gels is that the interactions 
between gelator molecules of the LMWG consist of non-covalent interactions leading to 
self-assembly, instead of chemical (covalently-bonded) crosslinks (Scheme 1.1). 
 
 
Scheme ‎1.1: Schematic showing the differences between a chemical gels (left) and a 
molecular hydrogelator (right). 
 
 
 
LMWGs are important because a LMWG hydrogel can be used as a temporary scaffold in 
biological applications rather than using a polymer hydrogel scaffold. These LMWG 
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scaffolds could easily be released and removed when no longer needed. The difference 
between the bonds in LMWG and the chemical gel is the effect on the reversibility of the 
gel. For instance, LMWG hydrogel can melt and reform on heating and cooling. Also 
LMWG hydrogel has a wide range of different mechanical properties, where this is an 
important characteristic. For example, the LMWGs have a tendency to break at low 
strain18. Moreover, the transition of gel-sol of LMWG can be form easier than that in the 
polymers hydrogel19. Examples of the use of LMWG for biomedical applications are 
hydrogels formed from FmocFF (F= phenylalanine), which have been used as a 
temporary scaffold for cell culturing (Fig. 1.2)7 or controlled drug release4. Gazit et al. 
have previously demonstrated the self-assembly of diphenylalanine alone20. 
Furthermore, they had reported that aromatic moieties are important in the self-
assembly of these fibrils via aromatic stacking interactions20. Uljin’s group have 
reported that the when the amino acid in the molecule is changed, the compatibility of 
gel mixtures of Fmoc-dipeptide and Fmoc-peptide will be different21. 
 
 
 
Figure ‎1.2: The Fmoc-FF/RGD hydrogel promotes cell adhesion with subsequent cell spreading 
and proliferation. (A) The chemical structures of the two Fmoc peptide derivatives. (B) Cell 
adhesion and morphology in the Fmoc-FF/RGD and Fmoc FF/RGE hydrogels (C) The influence of 
cell spreading by  Fmoc-RGD concentration also influenced cell spreading (D) Integrin blocking 
experiments showed direct interaction of the cells with RGD after 20 h: Cells with unblocked 
a5b1 integrins were able to spread and directly attach to the RGD sites on the nanofibres (D1); 
Cells with blocked a5b1 integrins were unable to attach to the RGD sites and re mained rounded 
(D2). (E) Cell increase in the Fmoc-FF/RGD and Fmoc-FF/RGE hydrogels (F) Contraction of the 
cell-gel constructs7 . 
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1.2- Low molecular weight hydrogels (LMWG): 
Low molecular weight hydrogels (LMWG) or supramolecular hydrogels are hydrogels 
that are formed by the self-assembly of small molecules in water. These molecules are 
aggregated to form fibres that lead to form hydrogels22. These LMWG contain a network 
of nanofibres and water. Although the design of LMWG is not fully understood23, they 
have been widely used over the last few years. The final hydrogel properties can be 
tuned by changing the molecular structure or the method of the self-assembly24.  
 
To determine the properties and the structure of the hydrogel, different techniques can 
be used such as spectroscopy (NMR, IR, UV-vis, and fluorescence), microscopy 
(scanning electron microscopy (SEM), transmission electron microscopy (TEM)), 
diffraction (X-ray scattering (SAXS), small angle neutron scattering (SANS) and 
rheology22. SAXS and SANS can provide information about the superstructures formed 
by fibres. The crystal structure may provide insights of the stability of the interactions 
as the gel can form fibres and also it can show different molecular packing from the 
structure of the gel/fibre phase25. Rheology studies the strength of the gel, where it can 
measure and link the properties of deformation of the solid state and flow of the liquid 
state. IR can give information about the functional groups that lead to form H-bonding 
interactions. These interactions might lead to the formation of different structures 
arrangements such as parallel β-sheets or anti-parallel β-sheets (Fig. 1.3). Fluorescence 
spectroscopy can detect different aromatic groups in solution and gel state and this is 
useful for studying energy transfer. SEM and TEM can be used to study the formation of 
the fibres after the hydrogel has formed.  
 
 
Figure ‎1.3: H-bonding interactions between the functional groups in dipeptides that may lead to 
form parallel arrangement (left) or anti-parallel arrangement (right).  
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LMWG can be prepared from different molecules such as cholesterol, sugars, amino 
acids, gemini surfactants and others. The molecular structure of LMWG has been 
studied before24, 26-37. The strength of the hydrogel can be affected by several conditions. 
For example, a number of reviews have illustrated that the addition of other compounds 
such as polymers to the gel can increase the strength of the gel38. For example, addition 
of poly(acrylic acid) into a gel led to increase the strength of the gel38. Furthermore, 
Adhikari et al. showed that the strength of the gel increased after addition of a graphene 
to the gel39. 
 
Dipeptide hydrogels are now commonly demonstrated and used as a LMWG due to their 
low cost and a large number of dipeptides that form hydrogels successfully24, 26, 34, 40, 41. 
These LMWG based on dipeptides contain two amino acids coupled together and 
attached to alkyl tail (dipeptide amphiphile) or to aromatic ring (functionalised 
dipeptides)42. In general, the structure of LMWG such as dipeptides conjugated to 
aromatic groups can be divided into two regions: a hydrophilic region which is 
compatible with water via H-bonding and a hydrophobic region which make π-π 
interactions leading to the self-assembly of the LMWG and forming fibres that lead to 
the formation of the matrix of the hydrogel24, 34, 43,24, 31, 34. LMWG can be affected by 
small change in the structure leading to gel or non-gel results; and the design rules of 
the LMWG are still not clear24, 26, 29, 31, 34. Also, changing the method of preparing the 
dipeptide hydrogel can result in a significant change to the final mechanical properties 
of the hydrogel23, 24, 44. These LMWG hydrogels can be prepared using different 
approaches under the physical conditions and they have been used for different 
applications. Currently the packing of the molecules in the fibres forming the matrix is 
not clearly understood24-26. 
 
1.3- Hydrogelation approaches: 
Hydrogelation of LMWG can be achieved by using different approaches. The general 
method to prepare dipeptide hydrogels is by dissolving the hydrogelators into an 
aqueous solution and then change the temperature45, pH46, add a salt, or use an enzyme 
to start the self-assembly, leading to the formation of fibres that entrap in water 
resulting in hydrogelation (Fig. 1.4). According to other research, changing the method 
can affect the mechanical properties of the hydrogel formed24. Raeburn et al. reported 
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that FmocFF can form hydrogel with different mechanical properties using different 
methods including pH switch and solvent method.  They showed that the differences in 
the mechanical properties of the gel depend on the pH of the medium and the fraction of 
the DMSO. The gel formed in both methods has different rheological properties. 
Therefore, it can be clearly seen that the mechanical properties of the hydrogel can be 
affected by modifying the way of its preparation24. 
 
 
 
Figure ‎1.4: Self-assembly of hydrogelators to form hydrogel. 
 
 
Physical hydrogels can be formed as follow: 
 
1- Changing the pH: 
This is the most popular method to prepare hydrogels from functionalised dipeptides, 
because many LMWG are pH sensitive, therefore a pH method is simple to utilise. In this 
method, the peptide is dissolved at high pH, deprotonating the carboxylic acid (in case 
of a dipeptide); where the N-terminus protected. When the pH is lowered below the 
apparent pKa, the carboxylic acid is re-protonated allowing self-assembly starting by 
making non-covalent interactions such as H-bonding, π-π stacking and hydrophobic 
interactions26, 30, 33, 34, 41, 47. Lowering the pH can be achieved by adding HCl or by using 
glucono--lactone (GdL)24-26, 31. For example, Yang et al. synthesised naphthalene 
dipeptide derivatives, then prepared a hydrogel by dissolving the gelators at high pH. A 
small volume of 1 M HCl was added to the solution to allow the formation of the 
hydrogels after the final pH of the gels reached 248. Ulijn et al. prepared FmocFF 
hydrogels using HCl, sometimes using heating and cooling along with the addition of 
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acid45. Here, heterogeneity of the final gel resulted46. Adams et al. recently reported an 
alternative method by utilising GdL to lower a pH in the hydrogelation process33. GdL 
hydrolyses slowly in water to give gluconic acid33, 49 (Fig. 1.5) and this hydrolysis of GdL 
leads to decrease in pH. As a result, a more homogeneous hydrogel was formed. Many 
researchers have prepared hydrogels using this method33, 41, 50. 
 
 
 
 
Figure ‎1.5: The hydrolysis of glucono-δ-lactone (GdL) to gluconic acid. 
 
 
 
2- Enzyme method: 
In this method, instead of breaking a peptide bond between amino acids, an enzyme can 
be used to form a peptide bond. The newly formed peptide self-assembles, trapping the 
solvent and hence producing hydrogels. Wang et al. demonstrated that hydrogel can be 
formed using phosphatase instead of protease at low concentration of hydrogelator51. 
Xu’s group35, 52  and Uljin’s group53 have illustrated assembly methods using enzymes.  
They have used tyrosine-phosphate linked to an Fmoc group in a buffer solution. 
Xinming et al. have also used tyrosine-phosphate to prepare hydrogel based 
naphthalene-conjugated peptide. The dephosphorylation reaction that followed 
resulted in the formation of the gel54. Furthermore, Fmoc dipeptide hydrogels have 
been prepared using an enzymatic trigger55. This involves the methyl ester hydrolysis 
from the C-terminus of an Fmoc-conjugated dipeptide, to produce a hydrogel. The use of 
a two-enzyme system to trigger both the gelation and gel-sol transition has also been 
demonstrated55. 
 
3- Solvent method: 
In this method, the LMWG is dissolved in an appropriate solvent and then deionised 
water added to trigger the formation of the hydrogel. To form a hydrogel using this 
method, a balance between the hydrophobic and the hydrophilic region in the peptide is 
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needed. Here, the most popular solvent used is perhaps dimethylsulfoxide (DMSO). The 
differences between this method and the pH method are the speed of hydrogelation 
process and the mechanical properties of the hydrogel formed24,26, 45. Here, the hydrogel 
can form quickly in few minutes, while in the pH method using the GdL the formation of 
the hydrogel is slow as the change of the pH is also slow34. The popularity of using this 
method has been increased recently because it is easy to prepare the hydrogel26, 40. Also, 
hydrogels prepared in this way have been shown to be stable over a wide pH range and 
formed homogeneous gels4. It has been reported that the formation of the hydrogel can 
be affected by the solvent used56. 
 
4- Temperature method: 
Here, the hydrogel can form by changing the temperature34. At high temperature, the 
dipeptides can be soluble in water. Decreasing the solubility by then cooling allows the 
self-assembly to occur, leading to the formation of the hydrogel. Vegners et al.57 
prepared hydrogels based on Fmoc-dipeptide using the temperature method. Tang et al. 
demonstrated the formation of the hydrogel by changing the temperature (heat/cool). 
They added NaOH to the solution of peptide (FmocFF) in water to obtain a clear 
solution. Then they added diluted HCl to acidify the sample and lower the pH. The 
sample was heated to 80°C and left to cool overnight and a hydrogel was formed45. Also, 
another example of a hydrogel formed by temperature trigger was reported by Debnath 
et al. They prepared Fmoc-dipeptide hydrogels by lowering the temperature of different 
solutions that contain the hydrogelator  with a cationic C-terminus58. Many researchers 
have used a temperature trigger to form LMWG, where heat-cool cycle of a gel being a 
common way of demonstrating the healable properties of a gel40.  
 
5- Adding salt: 
In this method, the ability to form hydrogels associates with the hydrophobicity of the 
dipeptides, which determines whether worm-like micelles are formed at high pH59. It 
has been reported that the hydrogel can be formed at high pH by adding a salt, such as 
calcium chloride to the stock solution of dipeptide. Also, the hydrogel can be formed by 
adding other salts, including trivalent or polyvalent salts59. Furthermore, it has been 
reported that there is correlation between adding the salt to form gel and the 
hydrophobicity. Here, the dipeptide forms a hydrogel above the pKa when the salt was 
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added30. Roy et al. have also used enzyme trigger to form Fmoc-dipeptide hydrogel with 
addition of salts60. They have reported that the mechanical strength of the gel was 
increased after adding the salt. Other research demonstrated that when divalent cations 
were added, the charge on the C-terminus may be screened leading to non-covalent 
crosslinking between the salt cation and gelator anion,  and the formation of the 
hydrogel above of the pKa of the gelator59, 61. 
 
Many hydrogels have been prepared using different methods. It can be seen that 
changing the approaches of preparing hydrogel can lead to a specific LMWG being a 
non-gel or a gel former24. Why gels or non-gels form by changing the method is still not 
fully understood.  
 
1.4- Interaction resulting in self-assembly:  
Hydrogels can be formed by the self-assembly of dipeptides in water. The self-assembly 
is driven by non-covalent interactions such as H-bonding, and hydrophobic interactions. 
H-bonding interactions can be formed between amino acids, and aromatic groups can 
interact together via π-π stacking interactions. These interactions lead to the formation 
of one-dimensional structures that grow and entangle to form fibres, which entraps the 
water to form a hydrogel. These type of interactions are weak individually, but they can 
together lead to self-assemble and form a stable hydrogel4, 7, 26, 27, 30, 33, 34, 41, 44, 47. It has 
been reported that a change of the order may lead to significant change to the 
hydrogelation process30, 31, 41. For instance, if we compare between dipeptides that have 
similar amino acids and different substitution positions of a bromine atom, we note that 
they have different gelation results27.  
 
The relationship between sequence and structure has been further looked at by Adams 
et al. who reported that NapGA (G= Glycine, A= Alanine) formed a hydrogel but NapAG 
formed a crystal27. Also, Ulijn et al. reported that FmocFG forms gel, but FmocGF does 
not62. Therefore, it can be clearly seen that slight change in the peptide structure can 
affect and change the formation of the hydrogel. 
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1.5- The hydrogelation mechanism: 
It has been noted that when using pH method, the solution generally starts clear and 
remains clear during the hydrogelation process 26, 31, 33. In some cases, a clear solution 
starts to become turbid after gelation, and in this case the turbidity may be caused by 
the large scattering light from the fibrous structures24, 29, 33. On the other hand, using the 
solvent method, the samples usually start as turbid solutions and clarification occurs 
during the hydrogelation process24. From previous research, it can be clearly seen that 
changing the way of preparing hydrogels can lead to dramatic change of the mechanism 
and the mechanical properties of the hydrogel31, 41. Also, small changes in the molecular 
structure can affect the formation of the hydrogel24, 26, 31, 41. Furthermore, it has been 
reported that there is no correlation between the molecular structure and the formation 
of the hydrogel31. In general, it remains unclear what kind of molecules will form gel and 
what factors that may lead to form hydrogel23, 31. Moreover, it is been reported that 
there is correlation between the pKa and the pH at which the hydrogel formed41, 45. 
1.6- Dipeptide hydrogels: 
A general design of the dipeptides includes R group which is could be aromatic or alkyl 
group that attached to two coupled amino acid (dipeptide) by linker such as OCH2 or 
CH2 (Fig. 1.6). Naturally, there are 20 amino acids (Fig. 1.7). Amino acids have the same 
basic structure: a carboxylic acid end group (C-terminus); a primary amine end group 
(N-terminus) and an R-group on the central carbon connecting the termini. They are all 
chiral, except glycine, and exist in Nature as the L-form. Depending on the group of the 
amino acid, they can be classified as hydrophobic, hydrophilic, charged or “other”63. 
 
 
 
 
Figure ‎1.6: the general design of the dipeptide. 
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n
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Figure ‎1.7: Amino acid structures are shown with their common name and the one letter abbreviations 
that are commonly used in peptide sequences63. 
 
 
Currently, dipeptides with suitable functional groups have wide interest for use as a 
hydrogelators24, 26, 32, 40, 41, 45, 47, 64-66. For example, dipeptides conjugated to aromatic 
group such as naphthalene or fluorenylmethoxycarbonyl (Fmoc) were used to form 
hydrogels31. They have been utilised in many applications such as drug delivery67, 68, 
tissue engineering67-69, cell culturing70 and energy transfer71. More specifically, 
dipeptides conjugated to aromatic groups such as naphthalene34, 41, 48, Fmoc34, 72, and 
pyrene73 (Fig. 1.8) have been widely used for different applications such as cell 
culturing, energy transfer, conductivity, and drug delivery14, 34, 44. As described above, 
they can self-assemble in water forming fibres by non-covalent interactions such as H-
bonding, and π-π stacking1, 24, 31 to form the matrix of the hydrogel. After self-assembly 
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occurs, one dimensional fibril structures are formed which leads to a network which 
entraps the water to form hydrogel24, 26, 46. The water is the primary component of the 
hydrogel48. The advantage of forming hydrogel by non-covalent interactions is that the 
hydrogel tend to have rapid response to the chemical and physical stimuli such as pH 
and temperature.  
 
 
 
Figure ‎1.8: Chemical structure of functionalised dipeptides; Fmoc34, 72, , pyrene73, naphthalene41, 34, 48 and 
anthraquinone74. 
 
1.6.1- Dipeptide Hydrogels conjugated to aromatic groups: 
There are many peptide conjugates that have been used widely as an efficient 
hydrogelators, such as dipeptides conjugated to aromatic groups and dipeptide 
amphiphiles24, 26, 27, 30, 31, 37, 48. Here, the project focuses on dipeptides conjugated to 
aromatic groups. 
 
Functionalised dipeptides have been shown to be good hydrogelators31, including Fmoc, 
naphthalene, pyrene and anthraquinone dipeptides. They have been used in a wide 
range of applications such as energy transfer and drug delivery. They used for 
biomedical applications because of their biocompatibility as they contain above 97% 
water. One of the main advantages of using the aromatic rings is that they provide π-π 
stacking interaction leading to one dimensional assembly result in fibre formation31. 
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1.6.1.1- Fmoc-dipeptide hydrogels: 
The Fmoc group is a common protecting group that can also be used to form efficient 
hydrogelators26, 31. Peptides conjugated to Fmoc group has synthesised elsewhere26, 31-
34, 57, 72, 75, such as FmocFG32 (F = phenylalanine, G = Glycine), FmocVD76 (V = valine, D = 
aspartic acid)  and FmocFF26.  For example, FmocLD (L = leucine), FmocAD (A= alanine), 
and FmocID (I = isoleucine) hydrogels were prepared by cooling solutions at a 
concentration of 0.5 wt%57. Zhang et al. have prepared hydrogels based Fmoc-
dipeptides by pH control (at low pH), such as FmocAA, FmocGG, FmocGS (S = serine) 
and FmocGT (T = threonine)72. The most common Fmoc-dipeptide hydrogel is FmocFF, 
because it is a good hydrogel for biomedical applications4, 62. Gels have been prepared 
from FmocFF using different methods. One of the approaches is the solvent method (see 
section 1.3)24, 30, 31, 34. The hydrogel can be prepared by dissolving the dipeptide in 
DMSO and then adding deionised water or buffer at a concentration of 5 mg/mL. 
FmocFF forms a transparent hydrogel using this method (Fig. 1.9)46. Alternatively, Ulijn 
et al. prepared FmocFF hydrogel using HCl62. They dissolved the dipeptide in a buffer at 
pH 8 and then concentrated HCl was added to control the pH. Another method has been 
utilised to prepare FmocFF hydrogels, the GdL method33. This method depends of the 
hydrolysis of GdL to gluconic acid to lower the pH. The mechanical properties of Fmoc-
dipeptide hydrogel were studied. In DMSO method, the rheology results of FmocFF 
showed that the storage modulus (G’) was higher than the loss modulus (G’’), with a G’ 
of 104Pa, while in HCl method G’ varied, from 1,900 Pa7, 104 Pa46, and 21,000 Pa21,32. 
Recently, other research demonstrated that Fmoc-dipeptide hydrogels can be formed 
using enzymes77.  
 
 
Figure ‎1.9: The image of FmocFF hydrogel that we have prepared using the DMSO: Water method46 
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The IR spectra of Fmoc-dipeptides hydrogels were also studied. For example, in the 
solvent method, the IR of FmocFF showed peaks at 1607, 1658 and 1691 cm-1, which 
refer to the presence of -sheets and -turns4. Furthermore, IR showed peaks at 1653 
cm-1 and 1690cm-1 with subsequent results referring to -sheets conformation. On the 
other hand, using the HCl method, IR spectroscopy of Fmoc-dipeptides showed a strong 
peak at 1630 cm-1 assigned to anti-parallel -sheets31.  
Moreover, pKa measurements were carried out for Fmoc-dipeptides using HCl titration. 
For example, pKa titration with HCl showed that FmocFF hydrogel has two apparent pKa 
values, pKa 1 of 9.9 and pKa 2 of 5.8. This means that the self-assembly process results in 
two different structural transitions. The report showed that the difference of the pH 
values in the titration results in different IR spectra. As a result, it can be clearly seen 
that the formation of the hydrogel can be affected by the kinetic process31, 33. Adams et 
al. reported a new method to prepare hydrogel based on Fmoc-dipeptides. They have 
used the GdL method (see section 1.3) and they found that this method allows studying 
the hydrogelation process to give more understanding of the mechanism of 
hydrogelation34. Moreover, they studied the correlation between the molecular 
structure, gel properties and the behaviour of the gelation of Fmoc-dipeptides. They 
synthesised Fmoc-dipeptides to study their ability to form gel. They described that 
supporting hydrogel was formed at intermediate hydrophobicity (2.8˂log P ˂5.5) at pH 
432. In 2012, Raeburn et al. demonstrated the understanding of the mechanical 
properties of FmocFF hydrogel using different methods, pH method and DMSO method. 
They showed that the method of the formation of the gel affected the final pH of the gel 
and can control the rheological properties of the gel. They also reported that when using 
solvent method, the hydrogel of FmocFF formed at pH 4 which is not suitable for some 
biological applications26. 
 
1.6.1.2- Pyrene dipeptide hydrogels: 
Peptide amphiphiles conjugated to pyrene have been synthesised using different 
methods78. Dipeptides based on pyrene have also been demonstrated to form gels by 
Zhang et al73. They illustrated an increase of the mechanical properties of hydrogels that 
formed via self-assembly in water by using method based on molecular recognition. A 
weak hydrogel was formed using pyrene-D-Ala-D-Ala (Fig. 1.10) with a storage modulus 
(G’) of 120 Pa. The strength of pyrene hydrogel was increased when it bound to 
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vancomycin to result in more strong hydrogel with G’ of 160000 Pa. Furthermore, when 
L-Ala-L-Ala was used, it formed hydrogel with ten times lower in G’ over the gelator 
alone (Fig. 1.10). 
 
 
Figure ‎1.10: (A) Molecular structures of vancomycin (1), and the ligands derivatives of (2-4). (B) Linear 
viscoelastic frequency sweep responses of the hydrogels of  2 and 2+1 at strain of 1% and 0.1%,respectively. 
(C) Linear viscoelastic frequency sweep responses of the hydrogels of 3, 4, 3+1, and 4+1 at 1% strain. The 
concentrations of 1, 2, 3, and 4 are all 30 mM73. 
 
 
1.6.1.3- Anthraquinone dipeptide hydrogels: 
Peptides conjugated to an anthraquinone aromatic group have been prepared74. Five 
anthraquinone peptides were synthesised previously (Fig. 1.11)74. Hydrogels were 
prepared using two different methods, the solvent method and HCl method. They have 
used anthraquinone moiety because it is well-known as an electroactive material. They 
prepared hydrogels by self-assembly to utilise in conformal display. Anthraquinone-
dipeptides formed a successful hydrogel and were capable of redox reactions. This 
redox creates changes on the anthraquinone lead to collapse of the supramolecular 
hydrogel network. 
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Figure ‎1.11:  Five anthraquinone derivatives are shown above. An L-phenylalanine is represented by a ‘P,’ a 
glycine is shown by a ‘G’ and these units are added to the anthraquinone group, ‘Anth’74. 
 
1.6.1.4- Naphthalene dipeptide hydrogels: 
Dipeptide hydrogels based on naphthalene have received great attention. Xu et al. have 
formed naphthalene dipeptide hydrogels at concentration of 1 mg/mL and pH 4. They 
also, prepared hydrogels based on LMWG using the temperature method (i.e. a heat-
cool cycle).  They also reported that naphthalene linked with OCH2 to the amino acid 
sequence formed gels, while that linked with CH2 did not form gels48. This shows that 
the linker can affect the formation of the hydrogel48.  They also demonstrated the 
hydrogelation of naphthalene dipeptides and they showed that two hydrogelators 
formed helical nanofibres. Furthermore, they described that cell cytotoxicity assay 
indicates that naphthalene hydrogelators are biocompatible because their structure 
almost water. This gives reason for using naphthalene group commonly in medical 
applications48. In the other research, they demonstrated the use of 1-naphthalene 
diphenylalanine (naphthalene-FF) for the disruption of the dynamics of microtubules79. 
They incubated cells with naphthalene-FF at different concentrations. They found that 
naphthalene-dipeptides self-assemble to form nanofibres above 320-340 µM. These 
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nanofibres disrupt the dynamics of the microtubules and thus cause apoptosis of 
glioblastoma cells79. Furthermore, they synthesised and characterised hydrogelators 
based on the naphthalene motif that were conjugated to β-amino acids79. They 
synthesised the dipeptides with different amino acids and different linkers between the 
aromatic group and the amino acid sequences, (–OCH2, –CH2). They reported that the 
change of the structure can lead to a dramatic change of the mechanical properties of 
the hydrogel36. Moreover, they demonstrated the rheological properties and the 
molecular structure of hydrogel based on naphthalene motif. They evaluated the effect 
of phenylalanine on the mechanical properties of naphthalene hydrogels. There was a 
correlation between the molecular structure and the rheology of the naphthalene 
hydrogel37. In 2014, Xu’s group studied the synthesis and the properties of hydrogel 
based naphthalene attached to taurine80. They showed that nanostructure resulted from 
the self-assembly of naphthalene attached to taurine. The hydrogelation process 
showed that the hydrogel with taurine formed at high concentration (2 wt%) in PBS 
buffer, while without taurine the hydrogel formed at low concentration (0.4 wt%). This 
result indicated that the hydrogel can be formed at high concentration when it attached 
to taurine and this may due to the presence of sulfonic group that increase the 
hydrophilicity of the hydrogel. 
 
Chen et al. demonstrated that naphthalene dipeptides containing substituents such as 
bromine can form hydrogels using GdL method30. They have shown that after adding 
the GdL the carboxylic acid (C-terminus) was protonated to start self-assembly leading 
to the formation of the π-π stacking and β-sheets. They have provided details of self-
assembly process lead to hydrogelation and they reported that the process of self-
assembly can affect the formation of the hydrogel30, 41, 81. They also studied the 
formation of hydrogel based on naphthalene dipeptide at high pH by addition of Ca2+ to 
the solution59. Furthermore, they showed that there is correlation between the hydrogel 
formation and the hydrophobicity. They also reported that there is no correlation 
between the rheological properties and the viscosity of the solution. Chen et al. also 
applied naphthalene dipeptides for energy transfer. They reported that energy transfer 
occurred between naphthalene diphenylalanine and a dansyl derivative leading to 
emission at 485 nm. In addition there was emission at 355 nm from naphthalene 
diphenylalanine alone (Fig. 1.12). Also, a transparent self-supporting hydrogel at a 
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concentration of 2.2 mM and at pH of 4 was formed from naphthalene 
diphenylalanine71. Houton et al. synthesised and extended library of naphthalene 
dipeptides and studied their properties. They have prepared the hydrogels using the 
GdL method at concentration of 5mg/mL of the peptide. Some of these dipeptides 
crystallised from water. They studied the crystal structure of naphthalene dipeptides 
and they reported a comparison between gel/fibre phase and the crystal phase25. They 
have illustrated that minor change in the structure of the peptide lead to significant 
modification in the formation of the hydrogel and their properties. Wallace et al. have 
studied the mesh size of naphthalene diphenylalanine hydrogel using pulsed field 
gradient NMR (PFG-NMR). They prepared the hydrogel using the salt-triggered method 
by adding Ca+2 to the solution of the dipeptide. They found that worm-like micelles were 
formed at pH 12 in the solution of the dipeptide at 0.55 wt%. The addition of Ca2+ led to 
cross-linking of these micelles. They reported that studying the mesh size of the 
hydrogel can be useful because this can help for specific applications such as drug 
delivery82. Moreover, naphthalene dipeptides as LMWG have studied in the presence of 
dextran. The results showed that the addition of dextran affected the mechanical 
properties of the hydrogel. It has also been demonstrated that adding polymer to 
naphthalene dipeptides to form gel affected their mechanical properties38. 
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Figure ‎1.12: (a) Structure of naphthalene-diphenylalanine (I) and dansyl derivative (II). (b) I forms a 
transparent self-supporting hydrogel at a concentration of 2.2 mM and a pH of 4 (left). A transparent self-
supporting gel was also formed in the presence of II (0.084 mM). (c) Energy transfer occurs between I and II 
(white rectangle) hosted within the fibres that form via hydrogen-bonding between dipeptides leading to 
emission at 485 nm in addition to emission at 355 nm from I alone71. 
 
1.7- Applications of dipeptide hydrogels: 
Hydrogel based functionalised dipeptides have been used widely in different 
applications such as cell culture, energy transfer and drug delivery34. 
 
1.7.1- Cell culture: 
Hydrogels based on Fmoc-dipeptide such as FmocFF have been utilised for cell 
culturing4, 83. The solvent method and pH method were used to prepare the gel. Also, 
FmocFF gels have been used for biological applications, as a temporary scaffold for cell 
culturing7. Ulijn’s group7, 21, 83 have also reported cell growth within hydrogels prepared 
from FmocFF as well as those prepared from mixtures of FmocFF and Fmoc-amino 
acids. 
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1.7.2- Fluorescence and energy transfer: 
Energy transfer is a system that includes molecules formed fibres contains donor and 
acceptor; the donor can be used to transfer energy to the acceptor84. Hence, transfer 
energy between different aromatic groups (from donor to acceptor) has been used in 
many applications including molecular electronics71, 85, 86 and light-harvesting85, 87, 88. 
Materials such organogels (gels which contain organic solvent) were used as a 
chromophore for energy transfer89. MacPhee et al. reported that energy transfer 
occurred between donor and acceptor based peptides90. Furthermore, Chen et al. 
demonstrated that efficient energy transfer occurred between naphthalene dipeptides 
and dansyl derivatives and between naphthalene and anthracene dipeptides (Fig. 
1.12)71. Others reported that light-harvesting hydrogels have prepared using cationic 
glutamate derivatives with anionic naphthalene and anthracene-based fluorophores105. 
In addition, it has been found there can be energy transfer between a naphthalene-
based hydrogelator and a dansyl71, 91. Supratim et al. demonstrated energy transfer 
between pyrene (donor) and porphyrin (acceptor) derivatives68. Furthermore, efficient 
transfer of excitation energy during nano-structures has been evidenced in an 
anthracene light-harvesting matrix doped with less than 1 mol% of a tetracene energy 
trap by Alexandre et al.92. They have shown that anthracenes, tetracenes and 
pentacenes self-assemble into stable nano-structures due to a 2,3-bis-n-alkoxy 
substitution. The fibres forming these 3-D supramolecular networks could be aligned 
with intense magnetic fields or mechanically, creating these materials of interest for 
different applications92. Moreover, pyrene conjugated to oligopeptides has reported to 
form a fluorescent hydrogels93. 
 
1.7.3- Controlled release: 
LMWG hydrogels have been prepared using different methods26, 29-32, 34, 36, 46, 51, 64, 69, 94. 
These hydrogels have been used in some biomedical applications such as cell 
culturing83, 95 and drug delivery96-98,4, 99. Drug delivery in hydrogels has had great 
attention since the 1960s100. The concentration of the drug in a drug delivery system 
increases to reach the maximum peak and then it falls off so that another dose needs to 
maintain the effective of the drug. The toxicity from the drug may cause, if the 
concentration of the drug increases above the maximum range. Also, if the 
concentration of the drug falls below the minimum level, the drug will be ineffective101. 
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Therefore, to control and maintain the effective level of drugs, we have to study new 
controlled release systems.  
 
LMWG hydrogels based on peptides have been used for controlled release99, 102, 103 such 
as hydrogels based on FmocF, FmocY96and FmocFF33, 46, 83. Moreover, a hybrid hydrogel 
based on FmocFF and konjac glucomannan (KGM) has been demonstrated for the 
controlled release104. The hydrogel was prepared by the self-assembly of FmocFF in a 
solution of KGM. This study provides a new self-assembly of peptide-polysaccharide 
hybrid hydrogels and also provides a new sustained-release drug carrier. Docetaxel was 
used as a model of hydrophobic drugs and incorporated into hydrogel to study the 
release properties of the hydrogel. The results showed that the release rate increased 
with hydrogel prepared in KGM more than that without the KGM. Also the mechanical 
properties showed that the hybrid hydrogel (FmocFF conjugate to KGM) had a higher 
storage modulus (G’) than the FmocFF hydrogel. This means that KGM increased the 
mechanical properties of the hydrogel. The controlled release of a model dye from the 
hydrogel to a solution placed on the top of the hydrogel was studied4, 105. 
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1.8- Aim of the project: 
Dipeptides hydrogels have great attention in many applications. Previously, hydrogels 
based on functionalised dipeptides have been used in energy transfer, cell culture and 
controlled release. In this thesis, we aim to: 
 
1- Synthesise a large number of dipeptides conjugated to different aromatic 
moieties such as naphthalene, anthracene, pyrene, phenanthrol, anthraquinone 
and carbazole in order to study their ability to form hydrogels because it is still 
unclear why some dipeptides formed gel and others not when small change in 
the structure applied. 
2- Study the mechanical properties, as well as carrying out pKa and pH 
measurements of the hydrogel that formed using formed different methods, the 
solvent method (DMSO: Water) or the GdL method33 
3- Study the fluorescence and energy transfer between different aromatic groups. 
4- Demonstrate the controlled release of dyes from different gels at different 
concentrations and different pHs using the DMSO: water method. 
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2- Dipeptide synthesis: 
2.1- Introduction: 
Peptides can be synthesised by coupling the carboxylic acid (or C-terminus) of one 
amino acid to the amino group (or N-terminus) of another1-4. Functionalised dipeptides 
can be prepared by solution-phase2, 3, 5-8 and solid-phase3, 5, 9, 10 amino acid coupling 
techniques. In solid phase peptide synthesis (SPPS), the C-terminus of the first amino 
acid is coupled with a solid support and N-terminus remains free to react with C-
terminus of the second amino acid. This method is useful to synthesise peptides with 
medium sequence (up to 50 residues)3, 5, 10. The protecting group is then removed and 
the peptide sequence obtained. In the solution phase method, a chemical protecting 
group is used to protect C-terminus of the first amino acid which is then dissolved in an 
appropriate organic solvent to continue with the synthesis steps to produce the peptide 
sequence. This method is normally used to synthesise short peptide sequences (up to 10 
residues)3, 5. Different reagents including N,N-dicyclohexylcarbodimide (DCC)5, 11 and 
isobutylchloroformate (IBCF)12, 13 have been used to couple the amino acids and form 
the peptide. The DCC coupling method uses hydroxylbenzotriazole (HOBT) catalyst and 
N-methylmorpholine (NMM), whereas IBCF can be used directly as the coupling agent13, 
14. The 9-fluorenyl methyloxycarbony group (Fmoc group) has had great attention as a 
protecting group in the peptide synthesis field4, 15. Fmoc peptide derivatives have been 
synthesised using different methods15. For example, FmocLG (L = Leucine, G = Glycine) 
was synthesised using IBCF method in the solution phase strategy, followed by the 
deprotection of the t-butyl group by dissolving the Fmoc-dipeptide in chloroform in the 
presence of trifluoroacetic acid (TFA)12, 16. Other dipeptides conjugated to Fmoc have 
been synthesised elsewhere3, 4, 7, 11, 12, 16-18, such as FmocFG16 (F = Phenylalanine), 
FmocVD8 (V = Valine, D = Aspartic acid)  and FmocFF17. Furthermore naphthalene 
dipeptides have been synthesised previously19-21. In this project, we have used the IBCF 
method to synthesise functionalised dipeptide derivatives with different aromatic 
protecting groups such as naphthalene, anthracene, pyrene, phenanthrol, 
anthraquinone and carbazole in order to study their ability to form gel and their 
properties. 
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2.2-  Dipeptide synthesis: 
2.2.1- Naphthalene dipeptides: 
As stated, naphthalene dipeptides have been synthesised previously using IBCF and DCC 
methods5, 11-13. In this project, a large number of naphthalene dipeptides were 
synthesised. We have used valine methyl ester hydrochloride in the first coupling of 
naphthalene dipeptide synthesis because it is a hydrophobic amino acid expected to 
help form good hydrogels as demonstrated in previous research19. In the second 
coupling step, three different amino acids, valine methyl ester, alanine methyl ester, 
glycine methyl ester and phenylalanine ethyl ester hydrochloride were used, because 
they have different hydrophobicity, which is expected to be an important factor for 
hydrogelators according to previous literature14, 19-22. These amino acids were used to 
synthesise naphthalene dipeptides with different orders of the amino acids and 
different positions of substitution because small changes in the molecular structure can 
change the mechanical properties of the hydrogel14. We aimed to prepare a library of 
gels in order to study some applications such as energy transfer and drug delivery.  
From naphthol: 
According to Chen’s research, naphthalene was coupled to the amino acids using 
different linkers, -CH2 and –OCH2, because this can affect the formation of the 
hydrogel14. Here, we have linked the naphthalene to amino acids by –OCH2 as shown in 
the Scheme 2.1. 
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Scheme ‎2.1:  The general reaction of naphthalene dipeptide synthesis based on naphthol ring using IBCF 
method. 
 
Compound Functional group 
1 2 3 4 5 R1 R2 
a a a a a H H 
b b b b b H Br 
c c c c c Br Br 
d d d d d Br H 
Table ‎2.1:  R1 and R2 groups of the general structure of compounds 1 – 5 in the Scheme 2.1. 
 
Compound R1 R2 R3 
a b c d 
6 H H CH(CH3)2 CH3 H CH2Ph 
7 H Br CH(CH3)2 CH3 H CH2Ph 
8 Br Br CH(CH3)2 CH3 H CH2Ph 
9 Br H CH(CH3)2 CH3 H CH2Ph 
Table ‎2.2:  R1, R2 and R3 groups of the general structure of compounds 6 – 9 in the Scheme 2.1. 
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Dipeptides R1 R2 R3 Abbreviation 
10 H H CH(CH3)2 2nap-VVOH 
11 H H CH3 2nap-VAOH 
12 H H H 2nap-VGH 
13 H H CH2Ph 2nap-VFOH 
14 H Br CH(CH3)2 6Brnap-VVOH 
15 H Br CH3 6Brnap-VAOH 
16 H Br H 6Brnap-VGOH 
17 H Br CH2Ph 6Brnap-VFOH 
18 Br Br CH(CH3)2 1,6diBrnap-VVOH 
19 Br Br CH3 1,6Bdirnap-VAOH 
20 Br Br H 1,6diBrnap-VGOH 
21 Br Br CH2Ph 1,6diBrnap-VFOH 
22 Br H CH(CH3)2 1Brnap-VVOH 
23 Br H CH3 1Brnap-VAOH 
24 Br H H 1Brnap-VGOH 
25 Br H CH2Ph 1Brnap-VFOH 
Table ‎2.3: R1, R2 and R3 groups of the general structure of compounds 10 – 25 in the Scheme 2.1 and their 
abbreviation. 
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Experimental section: 
Materials: All chemicals were purchased from Sigma-Aldrich and used as received 
without purification. 
NMR: 1H NMR spectra were recorded at 400.13 MHz using a Bruker Avance 400 NMR 
spectrometer. 13C NMR spectra were recorded at 400.1 MHz. 
Mass spectroscopy: Mass spectroscopies were recorded by the University of Liverpool 
mass spectroscopy service using Micromass LCT Mass Spectrometer and Trio-1000 
Mass Spectrometer. 
Synthesis 
A general method to prepare dipeptides used by Chen et al. 8 was followed. 
To a stirred solution of 2-naphthol, 1-bromo-2-naphthol, 6-bromo-2-naphthol or 1,6-
dibromo-2-naphthol (10.0 g) and K2CO3 (3 eq.) in acetone (200 mL) was added tert-
butyl chloroacetate (1.1 eq.) and the solution was heated to reflux at 70 οC overnight. 
Chloroform (200 mL) was added to the resulting suspension in a separating funnel and 
water (100 mL) added. Then, the organic phase was washed with water (4 x 200 mL). 
The solution was dried with magnesium sulphate and the solvent was removed in vacuo 
to give compounds 2 (a – d) as shown in the Scheme 2.1 that have different R groups as 
shown in the Table 2.1. The yield was between 73 – 87% and the impurity (tert-butyl 
choloracetate) was calculated by NMR spectroscopy to be between 7 – 13%. The 
resulting product was then purified using flash column chromatography (10% ethyl 
acetate in hexane). The yield was typically 60 – 70% and the final product was between 
94 - 99% pure.  
1H, 13C NMR and mass spectroscopy of the resulting products: 
 Tert-Butyl-2-(naphthalen-2-yloxy) acetate (2a): 
1H NMR (CDCl3): 7.75 (d, ArH, 1H, 3JHH = 8.1Hz), 7.73(d, ArH, 1H, 3JHH = 8.9Hz), 7.67 (d, 
ArH, 1H, 3JHH = 8.2Hz), 7.40 (t, ArH, 1H, 3JHH = 6.9Hz), 7.31(t, ArH, 1H, 6.8Hz), 7.22 (dd, 
ArH, 1H, 3JHH = 8.9), 7.04 (d, ArH, 1H, 3JHH = 2.6Hz), 4.60 (s, OCH2C=O, 2H), 1.48 (s, 
C(CH3)3, 9H) ppm.13C NMR (CDCl3): 168.0, 155.8, 134.3, 129.6, 129.3, 127.7, 126.8, 
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126.4, 124.0, 118.6, 109.4, 107.1, 82.4, 65.8, 28.0 ppm. MS: ES+: [M+Na]+. Accurate mass 
calculated: 281.1155 Found 281.1154. 
Tert-Butyl-2-(6-bromonaphthalen-2-yloxy) acetate (2b): 
1H NMR (CDCl3): 7.91 (s, ArH, 1H,), 7.67(d, ArH, 1H, 3JHH = 9.1Hz), 7.57 (d, ArH, 1H, 3JHH = 
8.8Hz), 7.50 (d, ArH, 1H, 3JHH = 2.0Hz), 7.24(d, ArH, 1H, 3JHH = 2.6Hz), 7.02 (s, ArH, 1H, 
3JHH = 2.6Hz), 4.61 (s, OCH2C=O, 2H), 1.49 (s, OC(CH3)3, 9H) ppm. 13C NMR (CDCl3): 
167.7, 156.1, 132.7, 130.3, 129.7 (d, j = 7.2 Hz), 128.7, 128.4, 119.6, 117.4, 107.0, 82.5, 
65.7, 28.06, 27.9 ppm. MS: ES+ ([M+Na]+). Accurate mass calculated: 359.0259.  Found 
359.0262. 
Tert-Butyl-2-(1,6-dibromonaphthalen-2-yloxy)acetate (2c): 
1H NMR (CDCl3): 8.08(d, ArH, 1H, 3JHH = 9.5Hz), 7.90(d, ArH, 1H, 3JHH = 2.0Hz), 7.65 (d, 
ArH, 1H, 3JHH = 8.1Hz), 7.60 (d, ArH, 1H, 3JHH = 5.4Hz), 7.12(d, ArH, 1H, 3JHH = 8.8Hz), 4.71 
(s, OCH2C=O, 2H), 1.47 (s, OC (CH3)3, 9H)ppm. 13C NMR (CDCl3): 203.5, 167.4, 152.7, 
131.8, 131.09, 131.06, 129.8, 128.3, 127.8, 118.7, 115.6, 109.9, 82.7, 67.2, 30.7, 28.05 
ppm. MS: ES+: [M+Na]+. Accurate mass calculated: 436.9364.  Found 436.9370. 
Tert-Butyl-2-(1-bromonaphthalen-2-yloxy) acetate (2d): 
1H NMR (CDCl3): 8.10 (d, ArH, 1H, 3JHH = 11.7Hz), 7.71(d, ArH, 1H, 3JHH = 9.3Hz), 7.52 (t, 
ArH, 1H, 3JHH = 8.1Hz), 7.35 (t, ArH, 1H, 3JHH = 8.1Hz), 7.12(d, ArH, 1H, 3JHH = 9.3Hz), 4.68 
(s, OCH2C=O, 2H), 1.45 (s, OC(CH3)3, 9H) ppm. 13C NMR (CDCl3): 167.6, 152.5, 133.1, 
130.2, 128.8, 128.0, 127.8, 126.4, 124.7, 114.8, 109.8, 82.5, 67.3, 41.9, 28.0, 27.7 ppm. 
MS: ES+: [M+Na]+. Accurate mass calculated: 359.0267 Found 359.0259. 
Removal of the tert-butyl protection group:  
The tert-butyl naphthalene acetate derivatives were dissolved in chloroform (30 mL), 
and trifluoroacetic acid (10 mL) was added. The solution was stirred overnight.  Hexane 
was added to the solution, and then the resulting precipitate was collected by filtration 
to give compounds 3 (a – d) as shown in the Scheme 2.1, with different R groups as 
shown in the Table 2.1. The yield was between 87 – 90%. The resulting products of all 
derivatives were pure and used directly in the next step of the reaction. 
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2-Naphthalen-2-yloxy acetic acid (3a): 
1H NMR (d6-DMSO): 7.84 (d, ArH, 1H, 3JHH = 8.2Hz), 7.79(d, ArH, 1H, 3JHH = 8.2Hz), 7.46 (t, 
ArH, 1H, 3JHH = 6.9Hz), 7.35 (t, ArH, 1H, 3JHH = 6.9), 7.27(s, ArH, 1H,), 7.20 (dd, ArH, 1H, 
3JHH = 8.9), 7.19 (d, ArH, 1H,), 4.78 (s, OCH2C=O, 2H), 13.7 (s, OH) ppm. 13C NMR (d6-
DMSO): 170.4, 155.9, 134.4, 129.7, 129.04, 127.86, 127.09, 126.82, 124.15, 118.80, 
107.35, 64.89 ppm. MS: CI: Low resolution [NH4+] found 202.2. 
2-(6-Bromonaphthalen-2-yloxy) acetic acid (3b): 
1H NMR (d6-DMSO): 8.12 (s, ArH, 1H,), 7.84(d, ArH, 1H, 3JHH = 9.1Hz), 7.77 (d, ArH, 1H, 
3JHH = 8.8Hz), 7.56 (d, ArH, 1H, 3JHH = 2.2Hz), 7.31(d, ArH, 1H, 3JHH = 2.6Hz), 7.26 (d, ArH, 
1H, 3JHH= 2.6Hz), 4.81 (s, OCH2C=O, 2H), 13.7 (s, OH) ppm. 13C NMR (d6-DMSO): 169.8, 
156.0, 132.6, 129.8, 129.3, 129.2, 128.9, 128.6, 119.5, 116.4, 107.1, 64.5 ppm. MS: ES–: 
[M – H]–. Accurate mass calculated: 302.9633.  Found 302.9619 
2-(1,6-Dibromonaphthalen-2-yloxy) acetic acid (3c): 
1H NMR (d6-DMSO): 8.22 (d, ArH, 1H, 3JHH = 2.0Hz), 8.02(d, ArH, 1H, 3JHH = 9.1Hz), 7.95 
(d, ArH, 1H, 3JHH = 9.0Hz), 7.73 (d, ArH, 1H, 3JHH = 9.0Hz), 7.45(d, ArH, 1H, 3JHH = 9.1Hz), 
4.98 (s, OCH2C=O, 2H), 13.18 (s, OH) ppm. 13C NMR (d6-DMSO): 169.8, 152.8, 144.1, 
131.08, 129.9, 128.2, 127.6, 117.4, 115.8, 107.1, 65.5, 30.2 ppm. MS: ES–: [M – H]–. 
Accurate mass calculated: 380.8738.  Found 380.8739. 
2-(1-Bromonaphthalen-2-yloxy) acetic acid (3d): 
1H NMR (d6-DMSO):8.10 (s, ArH, 1H,), 7.96(d, ArH, 1H, 3JHH = 9.0Hz), 7.93(d, ArH, 1H, 
3JHH = 9.1Hz), 7.63 (d, ArH, 1H, 3JHH = 8.2Hz), 7.46(d, ArH, 1H, 3JHH = 9.1Hz), 7.40 (d, ArH, 
1H,), 4.97(s, OCH2C=O, 2H), 13.7 (s, OH) ppm. 13C NMR (d6-DMSO): 170.3, 152.7, 132.6, 
129.8, 129.4, 128.6, 128.5, 125.6, 124.8, 115.0, 107.6, 65.9 ppm. MS: ES–: [M – H]–. 
Accurate mass calculated: 278.9657.  Found 278.9662. 
Standard coupling methodology:                                           
N-Methylmorpholne (2 eq.) and IBCF (1.1 eq.) was added to compound 3 (a, b, c or d) 
(5.0 g) in chloroform (70 mL) at 0 oC. A solution of valine methyl ester (1.5 eq.) and 
NMM (2 eq.) in chloroform was added. The solution was stirred at room temperature 
overnight. The solution was washed with distilled water (100 mL), hydrochloric acid (2 
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x 100 mL, 0.1 M), aqueous potassium carbonate (100 mL, 0.1 M), and distilled water (4 x 
100 mL) and dried with magnesium sulfate. The solvent was removed in vacuo to give 
compounds 4(a – d) as shown in Scheme 2.1 that have different R groups as shown in 
the Table 2.1. The yield was between 77 – 85%. The impurity (an excess of valine 
methyl ester) was calculated by NMR spectroscopy to be between 15 – 29% for all 
derivatives except compounds 4a and 4b, which were pure and used as a crude product 
in the next step of the reaction. The resulting product was then purified by washing 
with methanol. The yield decreased typically between 55 – 65% and the purity was 
calculated by NMR spectroscopy between 87 – 98%. 
(S)-Methyl-2-(2-(naphthalen-2-yloxy) acetamido) butanoate (4a): 
1H NMR (CDCl3): 7.73 (d, ArH, 1H, 3JHH = 8.6Hz), 7.68 (d, ArH, 1H, 3JHH = 8.1Hz), 7.41 (t, 
ArH, 1H, 3JHH = 7.0Hz), 7.33 (t, ArH, 1H, 3JHH = 8.3Hz), 7.26(s, ArH, 1H,), 7.18 (d, ArH, 1H, 
3JHH = 10.4Hz), 7.13 (d, ArH, 1H, 3JHH = 11.0Hz), 4.65(d, NHCHCH(CH3)2, 1H, 3JHH = 4.8Hz),  
4.16 (d, OCH2C=O, 2H, 3JHH = 4.1Hz), 3.67 (s, OCH3, 3H), 2.18 (m, (CH3)2CH, 1H), 
0.92(d,(CH3)2CH, 3H, 3JHH = 7.4Hz), 0.89 (d,(CH3)2CH, 3H, 3JHH = 6.8Hz) ppm.13C NMR 
(CDCl3): 171.9, 168.09, 155.03, 134.27, 129.8, 129.5, 127.6, 126.9, 126.7, 124.3, 118.1, 
107.7, 67.3, 56.7, 52.1, 31.2, 18.9, 17.7 ppm. MS: ES+: [M+Na]+. Accurate mass calculated: 
338.1368 Found 338.1384. 
(S)-Methyl-2-(2-((6bromonaphthalen-2-yl)oxy)acetamido)-3-methylbutanoate (4b): 
1H NMR (CDCl3): 7.91 (s, ArH, 1H,), 7.68 (d, ArH, 1H, 3JHH = 8.9Hz), 7.59 (d, ArH, 1H, 3JHH = 
9.0Hz), 7.50 (d, ArH, 1H, 3JHH = 9.4Hz), 7.23(d, ArH, 1H, 3JHH = 10.1Hz), 7.12 (d, ArH, 1H, 
3JHH = 2.4Hz), 6.5(d, NH, 1H, 3JHH = 10.1Hz), 4.68 (s, OCH2C=O, 2H), 4.60 (m, 
NHCHCH(CH3)2, 1H), 3.72 (s, OCH3, 3H), 2.23 (m, (CH3)2CH, 1H) 0.93 d,(CH3)2CH, 3H, 3JHH 
= 8.7Hz), 0.88 (d,(CH3)2CH, 3H, 3JHH = 7.7Hz) ppm.13C NMR (CDCl3): 171.9, 167.8, 155.2, 
132.7, 130.5, 130.0, 129.7, 129.0, 128.6, 119.2, 117.9, 107.7, 67.3, 56.6, 52.2, 31.3, 18.9, 
17.7 ppm. MS: ES+: [M+Na]+. Accurate mass calculated: 416.0473 Found 416.0473. 
(S)-Methyl-2-(2-((1,6-dibromonaphthalen-2-yl)oxy)acetamido)-3-methylbutanoate 
(4c): 
1H NMR (CDCl3):8.08 (d, ArH, 1H, , 3JHH = 9.0Hz), 7.96 (d, ArH, 1H, , 3JHH = 2.1Hz), 7.74 (d, 
ArH, 1H, , 3JHH = 9.5Hz), 7.55 (d, NH, 1H, , 3JHH = 6.1Hz), 7.64(d, ArH, 1H, , 3JHH = 7.4Hz), 
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7.20 (d, ArH, 1H, , 3JHH = 9.0Hz), 4.70 (s, OCH2C=O, 2H), 4.66 (dd, NHCHCH(CH3)2, 1H, 3JHH 
= 5.4, 4.7Hz), 3.77 (s, OCH3, 3H), 2.29 (m, (CH3)2CH, 1H), 1.00 (d,(CH3)2CH, 3H, 3JHH = 
8.2Hz), 0.99 (d, (CH3)2CH, 3H, 3JHH = 7.1Hz)ppm. 13C NMR (CDCl3): 171.7, 167.3, 155.0, 
131.5, 131.4, 131.2, 130.0, 128.5, 128.1, 119.0, 115.3, 82.5, 68.5, 56.8, 52.2, 31.2, 19.0, 
17.6 ppm. (CDCl3): MS: ES+: [M+Na]+. Accurate mass calculated: 493.9579 Found 
493.9593. 
(S)-Methyl-2-(2-((1-bromonaphthalen-2-yl)oxy)acetamido)-3-methylbutanoate 
(4d): 
1H NMR (CDCl3): 8.22 (d, ArH, 1H, 3JHH = 8.9), 7.85 (d, ArH, 1H, 3JHH = 8.9), 7.81 (d, ArH, 
1H, 3JHH = 8.3), 7.61 (t, ArH, 1H, 3JHH = 6.4), 7.45(t, ArH, 1H, 3JHH = 7.2), 7.20 (d, ArH, 1H, 
3JHH =8.9), 4.71 (s, OCH2C=O, 2H), 4.67 (dd, NHCHCH(CH3)2, 1H, 3JHH = 5.9, 4.1), 3.76 (s, 
OCH3, 3H), 2.29 (m, (CH3)2CH, 1H), 1.01 (d, (CH3)2CH, 3H, 3JHH = 6.7Hz), 0.99 (d, 
(CH3)2CH, 3H, 3JHH = 7.3) ppm. 13C NMR (CDCl3): 171.7, 167.5, 151.4, 132.9, 130.4, 129.4, 
128.2, 128.1, 126.2, 125.0, 114.3, 109.6, 68.6, 56.8, 52.2, 31.2, 19.0, 17.7 ppm. MS: ES+: 
[M+Na]+. Accurate mass calculated: 416.0473 Found 416.0486. 
Deprotection of the C-terminus: 
A solution of THF: water (30 mL: 5 mL) was added to compounds 4 (a – d). Lithium 
hydroxide (0.5 g) was added. The solution was stirred overnight. After this time, 
distilled water (100 mL) was added, and then hydrochloric acid (1.0 M) was added 
dropwise until the pH was lowered to pH 3. The resulting precipitate was collected by 
filtration and washed with water to give compounds 5 (a – d) as shown in Scheme 2.1. 
The yield was between 61 – 91%. The impurity (excess of valine methyl ester) was 
calculated by NMR spectroscopy between 3 – 14% for all derivatives except compound 
5d, which was pure and used as crude in the next step of the reaction. Compounds 5a 
and b were then crystallised using ethanol and toluene respectively and compound 5c 
was purified by washing with methanol. The yield after purification was typically 
between 40 – 60 % and the resulting products were between 98 – 99% pure. 
(S)-3-Methyl-2-(2-(naphthalen-2-yloxy)acetamido)butanoic acid (5a): 
1H NMR (d6-DMSO): 8.20 (d, ArH, 1H, 3JHH = 8.1Hz), 7.84 (d, ArH, 1H, , 3JHH = 9.0Hz), 7.74 
(d, ArH, 1H, 3JHH = 8.1Hz), 7.46 (t, ArH, 1H, 3JHH = 7.9Hz), 7.36(t, ArH, 1H, 3JHH = 8.0Hz), 
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7.27 (t, ArH, 1H, 3JHH = 6.2Hz), 7.16(d, ArH, 1H, , 3JHH = 7.7Hz), 6.5(d, NH, 1H, , 3JHH = 
7.1Hz), 4.73 (d, OCH2C=O, 2H), 4.25 (dd, NHCHCH(CH3)2, 1H, 3JHH = 8.0, 3.0Hz), 2.13 (m, 
(CH3)2CH, 1H), 1.00 (d, (CH3)2CH, 3H, 3JHH = 6.9), 0.89 (d, CH3)2CH, 3H, 3JHH = 6.5Hz) ppm. 
13C NMR (d6-DMSO):172.7, 167.72, 155.6, 134.0, 129.3, 128.16, 127.4, 126.6, 125.2, 
123.7, 118.5, 107.1, 66.5, 56.8, 29.8, 19.1, 17.86 ppm. MS: ES–: [M – H]–. Accurate mass 
calculated: 324.1212 Found 324.1222. 
(S)-2-(2-((6-Bromonaphthalen-2-yl)oxy)acetamido)-3-methylbutanoic acid (5b): 
1H NMR (d6-DMSO): 8.43 (d, ArH, 1H, 3JHH = 8.4Hz), 8.12 (d, ArH, 1H, 3JHH = 7.4Hz), 7.85 
(d, ArH, 1H, 3JHH = 8.7Hz), 7.71 (d, ArH, 1H,3JHH = 8.7Hz), 7.57(t, ArH, 1H,3JHH = 6.2Hz), 
7.30 (t, ArH, 1H, 3JHH = 7.1Hz), 4.73 (s, OCH2C=O, 2H), 4.24 (dd, NHCHCH(CH3)2, 1H, 3JHH 
= 4.3, 2.6Hz), 2.12 (m, (CH3)2CH, 1H), 0.88 (d, (CH3)2CH, 6H, 3JHH = 6.7Hz) ppm. 13C NMR 
(d6-DMSO): 173.1, 169.9, 156.4, 132.9, 130.2, 129.7, 129.2, 129.0, 120.1, 119.9, 116.8, 
107.6, 66.9, 57.2, 30.2, 19.5, 18.3 ppm. MS: ES–: [M – H]–. Accurate mass calculated: 
402.0317 Found 402.0322. 
(S)-2-(2-((1,6-Dibromonaphthalen-2-yl)oxy)acetamido)-3-methylbutanoic acid 
(5c): 
1H NMR (d6-DMSO): 8.24 (d, ArH, 1H, 3JHH = 2.03Hz ), 8.05 (d, NH, 1H, 3JHH = 5.4Hz), 8.02 
(d, ArH, 1H, 3JHH = 5.9Hz), 7.97 (d, NH, 1H, 3JHH = 9.0Hz), 7.75(d, ArH, 1H, 3JHH = 7.0Hz), 
7.47 (d, ArH, 1H, 3JHH = 9.1Hz), 4.90 (d, OCH2C=O, 2H, 3JHH = 6.1Hz), 4.26 (dd, 
NHCHCH(CH3)2, 1H, 3JHH = 5.1, 3.1Hz), 2.14 (m, (CH3)2CH, 1H), 0.91 (d, (CH3)2CH, 6H, 
3JHH = 6.8Hz) ppm. 13C NMR (d6-DMSO): 172.9, 167.6, 153.0, 131.4, 131.2, 130.9, 130.4, 
128.8, 127.9, 118.0, 116.6, 107.7, 68.0, 57.0, 30.4, 19.4, 18.0 ppm. MS: ES–: [M – H]–. 
Accurate mass calculated: 479.9422 Found 479.9431.  
(S)-2-(2-((1-Bromonaphthalen-2-yl)oxy)acetamido)-3-methylbutanoic acid (5d): 
1H NMR (d6-DMSO): 8.10 (d, ArH, 1H, 3JHH = 8.5Hz), 8.20 (d, NH, 1H, 3JHH = 8.6Hz), 7.98 
(d, ArH, 1H, 3JHH = 9.0Hz), 7.94 (d, ArH, 1H, 3JHH = 10.1Hz), 7.65(t, ArH, 1H, 3JHH = 8.5Hz), 
7.48 (t, ArH, 1H, 3JHH = 7.7Hz), 7.44(d, ArH, H, 3JHH = 9.0Hz), 4.89 (d, OCH2C=O, 2H, 3JHH = 
5.6Hz), 4.29 (dd, NHCHCH(CH3)2, 1H, 3JHH = 5.1, 3.6Hz), 2.15 (m, (CH3)2CH, 1H), 0.91 (d, 
(CH3)2CH, 6H, 3JHH = 6.8Hz) ppm. 13C NMR (d6-DMSO): 172.9, 167.7, 152.5, 132.5, 130.0, 
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129.7, 129.6, 128.7, 125.6, 125.0, 115.5, 107.8, 68.1, 57.0, 30.4, 19.4, 18.0 ppm. MS: ES–: 
[M – H]–. Accurate mass calculated: 402.0317 Found 402.0331. 
Standard coupling methodology: 
N-Methylmorpholine (1.5 eq.) and IBCF (1.1 eq.) were added to compound 5(a – d) (1.0 
g) in chloroform (70mL) at 0 oC. A solution of L–phenylalanine ethyl ester 
hydrochloride, L–valine ethyl ester hydrochloride, L–alanine ethyl ester hydrochloride 
or glycine ethyl ester hydrochloride (1 eq.) and NMM (1.5 eq.) in chloroform was added. 
The solution was stirred at room temperature overnight. The solution was washed with 
distilled water (100 mL), hydrochloric acid (2 x 100 mL, 0.1 M), aqueous potassium 
carbonate (100 mL, 0.1 M), and distilled water again (4 x 100 mL) and dried with 
magnesium sulfate. The solvent was removed in vacuo to give compounds 6 – 9(a – d) 
as shown in the Scheme 2.1. The yield was between 33 – 76%. The impurity (an excess 
of valine methyl ester) was calculated by NMR spectroscopy between 13 – 25% for all 
derivatives except compounds 6 (a – d) and 7 (a – d), which were pure and used as 
crude in the next step of the reaction. Compounds 8(a – d) and 9(a – d) were purified 
by washing with methanol. The yield after purification was between 40 – 55% and 
compounds were 90 – 99% pure. 
(S)-Methyl-3-methyl-2-((S)-3-methyl-2-(2-(naphthalen-2-yloxy)acetamido) 
butanamido)butanoate (6a): 
1H NMR (CDCl3): 7.77 (d, ArH, 1H, 3JHH = 8.9Hz), 7.72 (d, ArH, 1H, 3JHH = 8.1Hz), 7.44 (t, 
ArH, 1H, 3JHH = 7.1Hz), 7.36 (t, ArH, 1H, 3JHH = 7.7Hz), 7.26 (d, ArH, 1H, 3JHH = 8.6Hz) , 7.22 
(d, ArH, 1H, 3JHH = 6.7Hz), 7.16 (d, ArH, 1H, 3JHH = 8.9Hz), 4.66 (d, OCH2C=O, 2H, 3JHH = 
8.0Hz), 4.51(q, OCH2CH3, 2H, 3JHH = 7.2Hz), 4.21 (m, NHCHCH(CH3)2, 1H, 3JHH = 7.4Hz), 
4.19 (dd, NHCHCH(CH3)2, 1H, 3JHH = 7.4, 3.2Hz), 2.16 (m, (CH3)2CH, 1H), 2.14 (m, 
(CH3)2CH, 1H), 1.28 (t, OCH2CH3, 3H, 3JHH = 7.1Hz), 0.97 (d, (CH3)2CH, 6H, 3JHH = 6.7Hz), 
0.98 (d, (CH3)2CH, 3H, 3JHH =7.1),  0.91 (d, (CH3)2CH, 3H, 3JHH = 6.9Hz) ppm. 13C NMR 
(CDCl3):171.9, 171.0, 168.62, 155.39, 134.64, 130.3, 129.9, 128.0, 127.3, 127.0, 124.7, 
118.6, 107.9, 67.6, 61.7, 58.5, 57.6, 31.6, 31.4, 19.5, 19.3, 18.5, 18.0, 14.6 ppm. MS: ES+: 
[M+Na]+. Accurate mass calculated: 451.2209 Found 451.2191. 
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(S)-Methyl-2-((S)-3-methyl-2-(2-(naphthalen2yloxy)acetamido)butanamido) 
propanoate (6b): 
1H NMR (CDCl3): 7.78 (d, ArH, 1H, 3JHH = 9.1Hz), 7.73 (d, ArH, 1H, 3JHH = 8.1Hz), 7.46 (t, 
ArH, 1H, 3JHH = 7.0Hz), 7.37 (t, ArH, 1H, 3JHH = 7.5Hz), 7.26 (s, ArH, 1H,), 7.22 (d, ArH, 1H, 
3JHH = 9.0Hz), 7.17 (d, NH, 1H, 3JHH = 7.4Hz), 7.10(d, ArH,1H, 3JHH = 11.6Hz), 6.5(d, NH, 1H, 
3JHH = 7.0Hz), 4.54 (dd, NHCHCH(CH3)2, 1H3JHH = 6.8, 2.8Hz), 4.66 (d, OCH2C=O, 2H, 3JHH = 
3.7Hz), 4.36 (t, NHCH(CH3), 1H, 3JHH = 7.1Hz), 4.20 (q, OCH2CH3, 2H, 3JHH = 7.0Hz), 2.15 
(m, (CH3)2CH, 1H), 1.28 (t, OCH2CH3, 3H, 3JHH = 7.1Hz), 1.38 (s, CH3, 3H), 0.95 (d, 
(CH3)2CH, 3H, 3JHH = 7.4Hz), 0.93 (d, (CH3)2CH, 3H, 3JHH = 6.4Hz)  ppm. 13C NMR (CDCl3): 
172.96, 170.4, 168.5, 155.3, 134.6, 130.3, 129.93, 128.1, 127.3, 127.1, 124.7, 118.6, 
107.9, 67.6, 62.0, 58.4, 48.5, 31.7, 19.5, 18.6, 18.4, 14.5 ppm. MS: ES+: [M+Na]+. Accurate 
mass calculated: 423.1896. Found 423.1892. 
(S)-Ethyl-2-(3-methyl-2-(2-(naphthalen-2-yloxy)acetamido)butanamido)acetate 
(6c): 
1H NMR (CDCl3): 7.79 (d, ArH, 1H, 3JHH = 3.9Hz), 7.78 (d, ArH, 1H, 3JHH = 3.1Hz), 7.73 (d, 
ArH, 1H, 3JHH = 8.1Hz), 7.46 (t, ArH, 1H, 3JHH = 8.5Hz), 7.37 (t, ArH, 1H, 3JHH = 8.0Hz), 7.22 
(d, ArH, 1H, 3JHH = 8.9Hz), 7.16 (d, ArH, 1H, 3JHH = 2.4Hz), 4.40 (dd, NHCHCH(CH3)2, 1H, 
3JHH = 6.6, 2.7Hz), 4.67 (d, OCH2C=O, 2H, 3JHH = 2.7Hz), 4.02 (q, OCH2CH3, 2H, 3JHH = 
7.1Hz), 3.97(d, NHCH2C=O, 2H, 3JHH = 5.5Hz), 2.20 (m, (CH3)2CH, 1H), 1.27 (t, OCH2CH3, 
3H, 3JHH = 7.1Hz), 0.97 (d, (CH3)2CH, 3H, 3JHH = 7.7Hz), 0.93 (d, (CH3)2CH, 3H, 3JHH = 
7.4Hz) ppm. 13C NMR (CDCl3): 171.12, 169.8, 168.8, 155.4, 134.6, 130.4, 129.9, 128.1, 
127.4, 127.2, 124.8, 118.6, 107.9, 67.7, 62.0, 58.4, 41.7, 31.3, 19.6, 18.4, 14.5 ppm. MS: 
ES+: [M+Na]+. Accurate mass calculate: 409.1739 Found 409.1743. 
(S)-Ethyl-2-((S)-3-methyl-2-(2-(naphthalen-2-yloxy)acetamido)butanamido)-3-
phenyl propanoate (6d): 
1H NMR (CDCl3): 7.80 (d, ArH, 1H, 3JHH = 5.1Hz), 7.79 (d, ArH, 1H, 3JHH = 4.1Hz), 7.73 (d, 
NH, 1H, 3JHH = 8.1Hz), 7.46 (t, ArH, 1H, 3JHH = 8.1Hz), 7.37 (t, ArH, 1H, 3JHH = 7.4Hz), 7.21 
(d, NH, 1H, , 3JHH = 8.1Hz), 7.14 (s, ArH, 1H,), 7.0 (d, ArH, 1H, 3JHH = 8.4Hz), 6.28 (d, NH, 
1H, 3JHH = 8.0Hz), 4.84(dd, NHCH(CH2Ph, 1H, 3JHH = 5.5, 3.3Hz), 1H), 4.61(d, OCH2C=O, 
2H, 3JHH = 11.8Hz), 4.33 (dd, NHCHCH(CH3)2, 1H, 3JHH = 6.6, 3.1Hz), 4.17 (q, OCH2CH3, 2H, 
3JHH = 7.1Hz), 3.07 (dd, NHCH2Ph, 2H, 3JHH = 6.4, 5.4Hz), 2.12 (m, (CH3)2CH, 1H), 1.24 (t, 
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OCH2CH3, 3H, 3JHH = 7.1Hz), 0.92 (d, (CH3)2CH, 6H, 3JHH = 7.7Hz),  0.88 (d, (CH3)2CH, 6H, 
3JHH = 6.4Hz) ppm. 13C NMR (CDCl3): 171.1, 170.1, 168.1, 154.9, 129.9, 129.5, 129.2, 
128.5, 127.7, 127.1, 126.9, 126.7, 124.3, 118.2, 107.6, 67.2, 61.6, 57.9, 53.1, 37.8, 31.0, 
19.1, 17.9, 14.1 ppm. MS: ES+: [M+Na]+. Accurate mass calculated: 499.2209 Found 
499.2216. 
 (S)-Methyl-2-((S)-2-(2-((6-bromonaphthalen-2-yl)oxy)acetamido)-3-methyl 
butanamido)butanoate (7a): 
1H NMR (CDCl3): 7.93 (s, ArH, 1H,), 7.69 (d, ArH, 1H, 3JHH = 8.9Hz), 7.60 (d, ArH, 1H, 3JHH = 
8.7Hz), 7.52 (d, ArH, 1H, 3JHH = 8.0Hz), 7.24 (d, ArH, 1H, 3JHH = 9.5Hz), 7.20(d, NH, 1H, 3JHH 
= 8.4Hz), 7.12 (s, ArH, 1H,), 6.8(d, NH, 1H, 3JHH = 9.9Hz), 4.64 (d, OCH2C=O, 2H, 3JHH = 
6.4Hz), 4.50(q, OCH2CH3, 2H, 3JHH = 8.5Hz), 4.39 (d, NHCHCH(CH3)2, 1H, 3JHH = 7.4Hz), 
4.20 (d, NHCHCH(CH3)2, 1H, 3JHH = 8.3Hz), 2.15 (m, (CH3)2CH, 1H), 1.28 (t, OCH2CH3, 3H, 
3JHH = 7.1Hz)), 0.96 (d, (CH3)2CH, 6H, 3JHH = 6.7Hz), 0.92 (d, (CH3)2CH, 3H, 3JHH = 6.4Hz), 
0.88 (d, (CH3)2CH, 3H, 3JHH = 6.9Hz) ppm. 13C NMR (CDCl3): 171.9, 170.9, 168.3, 155.6, 
133.1, 130.9, 130.4, 130.1, 129.4, 129.0, 119.7, 118.3, 107.9, 67.6, 61.7, 58.5, 57.6, 31.6, 
31.3, 19.5, 19.3, 18.5, 18.0, 14.6 ppm. MS: ES+: [M+Na]+. Accurate mass calculated: 
529.1314. Found 529.1311. 
(S)-Methyl-2-((S)-2-(2-((6-bromonaphthalen-2-yl)oxy)acetamido)-3-methyl 
butanamido) propanoate (7b): 
1H NMR (CDCl3): 7.94 (s, ArH, 1H,), 7.70 (d, ArH, 1H, 3JHH = 9.0Hz), 7.61 (d, ArH, 1H, 3JHH = 
8.7Hz), 7.52 (d, ArH, 1H, 3JHH = 6.7Hz), 7.23 (d, ArH, 1H, 3JHH = 8.2Hz), 7.17 (d, NH, 1H, 
3JHH = 8.5), 7.11 (d, ArH, 1H, 3JHH = 2.4Hz), 6.47 (d, NH, 1H, 3JHH = 6.5), 4.61 (d, OCH2C=O, 
2H, 3JHH = 3.7Hz), 4.54 (t, NHCH(CH3), 1H, 3JHH = 7.2Hz), 4.35 (dd, NHCHCH(CH3)2, 1H, 
3JHH = 7.0, 2.6Hz), 4.20 (q, OCH2CH3, 2H, 3JHH = 8.0, 7.6Hz), 2.14 (m, (CH3)2CH, 1H), 1.39 
(d, NHCH, CH3, 3H, 3JHH = 7.1Hz), 1.28 (t, OCH2CH3, 3H, 3JHH = 7.1Hz), 0.97 (d, (CH3)2CH, 
3H, 3JHH = 7.1Hz), 0.92 (d, (CH3)2CH, 3H, 3JHH = 6.6Hz) ppm. 13C NMR (CDCl3): 172.9, 
170.3, 168.2, 155.6, 133.1, 130.9, 130.4, 130.1, 129.4, 128.9, 119.7, 118.3, 107.9, 67.6, 
62.0, 58.3, 48.6, 31.5, 19.4, 18.6, 18.4, 14.5 ppm. MS: ES+: [M+Na]+. Accurate mass 
calculated: 501.1001 found 501.1004. 
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(S)-Ethyl-2-(2-(2-((6-bromonaphthalen-2-yl)oxy)acetamido)-3-methylbutanamido) 
acetate (7c): 
1H NMR (CDCl3): 7.93 (s, ArH, 1H,), 7.70 (d, ArH, 1H, 3JHH =9.0), 7.60 (d, ArH, 1H, 3JHH = 
8.7), 7.52 (d, ArH, 1H, 3JHH = 8.7), 7.24 (d, ArH, 1H, 3JHH = 9), 7.14 (d, NH, 1H, 3JHH = 8.7), 
7.11 (d, ArH, 1H, 3JHH = 2.46), 6.47 (d, NH, 1H, 3JHH = 7.15), 4.65 (d, OCH2C=O, 2H 3JHH = 
3.24), 4.41 (d, NHCHCH(CH3)2, 1H, 3JHH = 6.7), 4.20 (q, OCH2CH3, 2H 3JHH = 7.14), 4.04 (d, 
NHCH2C=O, 2H 3JHH = 5.5), 2.18 (m, (CH3)2CH, 1H), 1.28 (t, OCH2CH3, 3H, 3JHH = 7.3), 0.94 
(d, (CH3)2CH, 3H, 3JHH = 6.7Hz), 0.92 (d, (CH3)2CH, 3H, 3JHH = 7.4Hz) ppm.13C NMR 
(CDCl3): 171.1, 169.8, 168.4, 155.6, 133.1, 130.9, 130.4, 130.1, 129.4, 128.9, 119.7, 118.3, 
107.9, 67.6, 62.0, 58.4, 41.7, 31.4, 19.5, 18.4, 14.5 ppm. MS: ES+: [M+Na]+. Accurate mass 
calculated: 487.0845 Found 487.0822. 
(S)-Ethyl-2-((S)-2-(2-((6-bromonaphthalen-2-yl)oxy)acetamido)-3-methyl 
butanamido)-3-phenylpropanoate (7d): 
1H NMR (CDCl3): 7.94 (s, ArH, 1H,), 7.71 (d, ArH, 1H, 3JHH = 9.0Hz), 7.61 (d, ArH, 1H, 3JHH 
= 8.0Hz), 7.52 (d, ArH, 1H, 3JHH = 7.3Hz), 7.26 (s, ArH, 1H,), 7.20 (d, NH, 1H, 3JHH = 7.1Hz), 
7.08(t, ArH, 1H, 3JHH = 7.0Hz), 6.20 (d, NH, 1H, 3JHH = 7.5Hz), 4.84(d, NHCH(CH2Ph), 1H, 
3JHH = 7.5Hz), 4.61(d, OCH2C=O, 2H, 3JHH = 10.1Hz), 4.30 (t, NHCHCH(CH3)2, 1H, 3JHH = 
6.7Hz), 4.17 (q, OCH2CH3, 2H, 3JHH = 7.1Hz), 3.07 (dd, NHCH2Ph, 2H, 3JHH = 5.9, 4.2Hz), 
2.11 (m, (CH3)2CH, 1H), 1.24 (t, OCH2CH3, 3H, 3JHH = 7.1Hz), 0.91 (d, (CH3)2CH, 3H, 3JHH = 
6.6Hz), 0.86 (d, (CH3)2CH, 3H, 3JHH = 6.9Hz) ppm. 13C NMR (CDCl3): 207.4, 171.4, 170.4, 
168.2, 155.6, 135.9, 133.1, 130.9, 130.4, 130.1, 129.6, 129.4, 129.0, 127.6, 119.7, 118.3, 
107.9, 67.5, 62.0, 58.3, 53.5, 38.2, 31.4, 19.4, 18.3, 14.5 ppm. MS: ES+: [M+Na]+. Accurate 
mass calculated: 577.1314.  Found 577.1318.  
(S)-Methyl-2-((S)-2-(2-((1,6-dibromonaphthalen-2-yl)oxy)acetamido)-3-methyl 
butanamido)-3-methylbutanoate (8a): 
1H NMR (CDCl3): 8.08 (d, ArH, 1H, 3JHH = 9.1Hz), 7.96 (d, ArH, 1H, 3JHH = 1.9Hz), 7.73 (d, 
ArH, 1H, 3JHH = 9.0Hz), 7.64 (d, ArH, 1H, 3JHH = 6.3Hz), 7.54(d, NH, 1H, 3JHH = 8.1Hz), 7.20 
(d, ArH, 1H3JHH = 9.8Hz), 6.43(d, NH, 1H, 3JHH = 8.1Hz), 4.70 (s, OCH2C=O, 2H), 4.56 (dd, 
NHCHCH(CH3)2, 1H, 3JHH = 5.4, 3.7Hz), 4.45 (dd, NHCHCH(CH3)2, 1H, 3JHH = 6.4, 3.2Hz), 
3.74 (s, OCH3, 2H),  2.26 (m, (CH3)2CH, 1H), 2.18 (m, (CH3)2CH, 1H), 1.03 (d, (CH3)2CH, 
3H, 3JHH = 4.3Hz), 1.02 (d, (CH3)2CH, 3H, 3JHH = 2.7Hz), 0.92 (d, (CH3)2CH, 6H, 3JHH = 
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7.1Hz) ppm. 13C NMR (CDCl3): 172.1, 170.4, 167.5, 151.6, 131.5, 131.4, 131.2, 130.0, 
128.4, 128.1, 119.1, 115.4, 109.9, 68.6, 58.2, 57.1, 52.2, 31.1, 31.0, 19.2, 18.9, 17.9, 17.7 
ppm. MS: ES+: [M+Na]+. Accurate mass calculated: 593.0263 Found 593.0267. 
(S)-Methyl-2-((S)-2-(2-((1,6-dibromonaphthalen-2-yl)oxy)acetamido)-3-methyl 
butanamido)propanoate (8b): 
1H NMR (CDCl3): 8.09 (d, ArH, 1H, 3JHH = 9.0Hz), 7.96 (d, ArH, 1H, 3JHH = 2.1Hz), 7.73 (d, 
ArH, 1H, 3JHH = 8.7Hz), 7.65 (d, ArH, 1H, 3JHH = 8.1Hz), 7.61(d, NH, 1H, 3JHH = 8.1Hz), 7.20 
(d, ArH, 1H, 3JHH = 9.0Hz), 6.43(d, NH, 1H, 3JHH = 9.9Hz),  4.61 (dd, NHCHCH(CH3)2, 1H, 
3JHH = 9.0, 4.3Hz), 4.70 (s, OCH2C=O, 2H), 4.40 (dd, NHCH(CH3), 1H, 3JHH = 6.4, 2.7Hz), 
3.75 (s, OCH3, 2H), 2.25 (m, (CH3)2CH, 1H), 1.41 (d, CH3, 3H, 3JHH = 7.1Hz), 1.03 (d, 
(CH3)2CH, 3H, 3JHH = 6.3Hz), 1.02 (d, (CH3)2CH, 3H, 3JHH = 3.7Hz) ppm. 13C NMR (CDCl3): 
170.3, 167.9, 155.6, 132.0, 131.8, 131.6, 130.4, 128.8, 128.6, 119.5, 115.8, 69.0, 58.4, 
52.9, 48.4, 31.6, 19.5, 19.4, 18.7, 18.3 ppm. MS: ES+: [M+Na]+. Accurate mass calculated: 
564.9950 Found 564.9966. 
(S)-Ethyl-2-(2-(2-((1,6-dibromonaphthalen-2-yl)oxy)acetamido)-3-methyl 
butanamido)acetate (8c): 
1H NMR (CDCl3): 8.09 (d, ArH, 1H, 3JHH = 9.0Hz), 7.96 (d, ArH, 1H, 3JHH = 1.5Hz), 7.74 (d, 
ArH, 1H, 3JHH = 8.9Hz), 7.65 (d, ArH, 1H, 3JHH = 9.0Hz), 7.58 (d, NH, 1H, 3JHH = 7.1Hz),  7.20 
(d, ArH, 1H, 3JHH = 9.0Hz), 6.46 (d, NH, 1H, 3JHH = 4.5Hz), 4.70 (dd, NHCHCH(CH3)2, 1H, 
3JHH = 6.4, 3.7Hz), 4.43 (s, OCH2C=O, 2H), 4.05 (d, NHCH2C=O, 2H, 3JHH = 5.4Hz), 4.21 (q, 
OCH2CH3, 2H, 3JHH = 6.4Hz), 2.29 (m, (CH3)2CH, 1H), 1.28 (t, OCH2CH3, 3H, 3JHH = 7.1Hz), 
1.04 (d, (CH3)2CH, 3H, 3JHH = 7.3Hz), 1.03 (d, (CH3)2CH, 3H, 3JHH = 6.7Hz) ppm. 13C NMR 
(CDCl3): 171.0, 169.9, 168.0, 152.0, 131.9, 131.8, 131.6, 130.4, 128.8, 128.6, 119.5, 115.7, 
110.2, 69.0, 62.0, 58.5, 41.7, 31.2, 19.6, 18.2, 14.5 ppm. MS: ES+: [M+Na]+. Accurate mass 
calculated: 564.9950 Found 564.9941. 
(S)-Ethyl-2-((S)-2-(2-((1,6-dibromonaphthalen-2-yl)oxy)acetamido)-3-methyl 
butanamido)-3-phenylpropanoate (8d): 
1H NMR (CDCl3): 8.11 (d, ArH, 1H, 3JHH = 10.0Hz), 7.98 (d, ArH, 1H, 3JHH = 1.9Hz), 7.75 (d, 
ArH, 1H, 3JHH = 8.1Hz), 7.66 (d, ArH, 1H, 3JHH = 7.4Hz), 7.51 (d, NH, 1H, 3JHH = 9.5Hz), 7.11 
(d, ArH, 1H, 3JHH = 6.8Hz), 6.26(d, NH, 1H, 3JHH = 8.8Hz),  4.89 (dd, NHCH(CH2Ph), 1H, 3JHH 
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= 4.7, 2.6Hz), 4.66 (d, OCH2C=O, 2H, 3JHH = 5.8Hz), 4.35 (dd, NHCHCH(CH3)2, 1H, 3JHH = 
6.4, 2.6Hz), 4.17 (q, OCH2CH3, 2H, 3JHH = 7.3Hz), 3.12 (t, NHCH2Ph, 2H, 3JHH = 6.7Hz), 2.23 
(m, (CH3)2CH, 1H), 1.24 (t, OCH2CH3, 3H, 3JHH = 7.4Hz), 0.98 (d, (CH3)2CH, 3H, 3JHH = 
6.7Hz), 0.96 (d, (CH3)2CH, 3H, 3JHH = 7.3Hz) ppm. 13C NMR (CDCl3): 171.1, 169.9, 167.4, 
151.6, 135.6, 131.6, 131.4, 131.2, 130.0, 129.3, 128.6, 128.5, 128.4, 128.2, 127.1, 119.1, 
115.3, 109.9, 68.5, 61.6, 58.0, 53.0, 52.8, 37.8, 30.8, 19.2, 17.8, 14.0 ppm. MS: ES+: 
[M+Na]+. Accurate mass calculated: 655.0419 Found 655.0420. 
(S)-Methyl-2-((S)-2-(2-((1-bromonaphthalen-2-yl)oxy)acetamido)-3-methyl 
butanamido)propanoate (9a): 
1H NMR (CDCl3): 8.22 (d, ArH, 1H, 3JHH = 8.7Hz), 7.85 (d, ArH, 1H, 3JHH = 9.0Hz), 7.80 (d, 
ArH, 1H, 3JHH = 8.7Hz), 7.64 (d, NH, 1H, 3JHH = 7.0Hz), 7.59 (t, ArH, 1H, 3JHH = 6.1Hz), 7.45 
(t, ArH, 1H, 3JHH = 7.0Hz), 7.19 (d, ArH, 1H, 3JHH = 8.9Hz), 6.44 (d, NH, 1H, 3JHH = 7.9Hz), 
4.72 (s, OCH2C=O, 2H), 4.57 (dd, NHCHCH(CH3)2, 1H, 3JHH = 5.3, 3.7Hz), 4.43 (dd, 
NHCHCH(CH3)2, 1H, 3JHH = 6.4, 3.2Hz), 3.74 (s, OCH2CH3, 2H), 2.28 (m, (CH3)2CH, 1H), 
2.18 (m, (CH3)2CH, 1H), 1.02 (d, (CH3)2CH, 6H, 3JHH = 5.5Hz), 0.94 (d, (CH3)2CH, 3H, 3JHH = 
7.4Hz), 0.90 (d, (CH3)2CH, 3H, 3JHH = 6.9Hz) ppm. 13C NMR (CDCl3): 172.9, 170.4, 167.8, 
151.4, 132.9, 129.4, 128.2, 128.1, 126.3, 125.1, 114.4, 68.6, 58.3, 57.1, 52.1, 31.1, 30.8, 
19.2, 18.9, 17.9, 17.7 ppm. MS: ES+: [M+Na]+. Accurate mass calculated: 515.1158 Found 
515.1136.  
(S)-Methyl-2-((S)-2-(2-((1-bromonaphthalen-2-yl)oxy)acetamido)-3-methyl 
butanamido)propanoate (9b): 
1H NMR (CDCl3): 8.22 (d, ArH, 1H, 3JHH = 9.2Hz), 7.84 (d, ArH, 1H, 3JHH = 8.2Hz), 7.81 (d, 
ArH, 1H, 3JHH = 8.5Hz), 7.65 (d, NH, 1H, 3JHH = 7.9Hz), 7.60 (t, ArH, 1H, 3JHH = 7.9Hz), 7.45 
(t, NH, 1H, J = 7.2), 7.19 (d, ArH, 1H, 3JHH = 28.9Hz), 6.38 (d, NH, 1H, J = 8.5), 4.72 (s, 
OCH2C=O, 2H), 4.61 (t, NHCH(CH3), 1H, 3JHH = 7.2Hz), 4.39 (dd, NHCHCH(CH3)2, 1H, 3JHH 
= 6.4, 3.2Hz), 3.75 (s, OCH3, 2H), 2.26 (m, (CH3)2CH, 1H,), 1.42 (d, NHCHCH3, 3H, 3JHH = 
7.1Hz), 1.04 (d, (CH3)2CH, 3H, 3JHH = 3.2Hz), 1.02 (d, (CH3)2CH, 3H, 3JHH = 3.3Hz) ppm. 13C 
NMR (CDCl3): 1723.1, 170.1, 169.9, 167.8, 151.4, 132.9, 130.4, 129.4, 128.2, 128.1, 
126.3, 125.1, 114.5, 109.9, 68.7, 58.1, 48.0, 31.0, 19.2, 18.3, 17.9 ppm. MS: ES+: [M+Na]+. 
Accurate mass calculated: 487.0845.  Found 487.0837. 
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(S)-Ethyl-2-(2-(2-((1-bromonaphthalen-2-yl)oxy)acetamido)-3-methyl 
butanamido)acetate (9c): 
1H NMR (CDCl3): 8.23 (d, NH, 1H, 3JHH = 8.8Hz), 7.82 (dd, ArH, 2H, 3JHH = 7.8, 4.9Hz), 7.62 
(m, ArH, 2H), 7.45 (t, ArH, 1H, 3JHH = 4.6Hz), 7.20 (d, ArH, 1H, 3JHH = 8.8Hz), 6.54 (s, NH, 
1H), 4.72 (s, OCH2C=O, 2H), 4.44 (dd, NHCHCH(CH3)2, 1H, 3JHH = 6.2, 3.8Hz), 4.07 (dd, 
NHCH2C=O, 2H, 3JHH = 6.9, 5.5Hz), 3.76 (s, OCH3, 2H), 2.32 (m, (CH3)2CH, 1H), 1.05 (d, 
OCH2CH3, 3H, 3JHH = 7.1Hz), 1.05 (d, (CH3)2CH, 3H, 3JHH = 6.7Hz), 0.97 (d, (CH3)2CH, 3H, 
3JHH = 6.7Hz) ppm. 13C NMR (CDCl3): 171.2, 170.5, 168.4, 151.7, 133.3, 130.8, 129.9, 
128.6, 128.5, 126.7, 125.5, 114.8, 110.2, 69.0, 58.5, 52.9, 41.6, 31.2, 19.7, 18.3 ppm. MS: 
ES+: [M+Na]+. Accurate mass calculate: 473.0692 Found 473.0688.  
(S)-Ethyl-2-((S)-2-(2-((1-bromonaphthalen-2-yl)oxy)acetamido)-3-methyl 
butanamido)-3-phenylpropanoate (9d): 
1H NMR (CDCl3): 8.23 (d, ArH, 1H, 3JHH = 8.5Hz), 7.84 (d, ArH, 1H, 3JHH = 8.9Hz), 7.61 (d, 
ArH, 1H, 3JHH = 8.1Hz), 7.56 (t, ArH, 1H, 3JHH = 7.6Hz), 7.45 (t, ArH, 1H, 3JHH = 8.1Hz), 
7.23(d, ArH, 1H, 3JHH = 6.8Hz), 7.11(d, NH, 1H, 3JHH = 8.7Hz), 6.35 (d, NH, 1H, 3JHH = 
8.7Hz), 4.89(m, NHCH(CH2Ph), 1H), 4.61(d, OCH2C=O, 2H, 3JHH = 6.8Hz), 4.37 (dd, 
NHCHCH(CH3)2, 1H, 3JHH = 6.4, 4.3Hz), 4.17 (q, OCH2CH3, 2H, 3JHH = 8.3, 7.6Hz), 3.12 (m, 
NHCH2Ph, 2H), 2.24 (m, (CH3)2CH, 1H), 1.24 (t, OCH2CH3, 3H3JHH = 7.1Hz), 0.99 (d, 
(CH3)2CH, 3H, 3JHH = 6.3Hz), 0.96 (d, (CH3)2CH, 3H, 3JHH = 7.3Hz) ppm. 13C NMR (CDCl3): 
171.1, 170.0, 167.7, 151.3, 135.6, 132.9, 130.4, 129.4, 129.3, 128.5, 128.2, 128.1, 127.1, 
114.4, 109.8, 68.6, 61.6, 58.1, 53.0, 37.8, 30.6, 19.2, 17.7, 14.0 ppm. MS: ES+: [M+Na]+. 
Accurate mass calculated: 577.1314 Found 577.1289. 
Deprotection of the C-terminus: 
A solution of THF: water (30 mL: 5 mL) was added to the naphthalene derivative. 
Lithium hydroxide (0.3 g) was added. The solution was stirred overnight. After this 
time, distilled water (100 mL) was added, and then hydrochloric acid (1.0 M) was added 
drop-wise until the pH was lowered to pH 3. The resulting precipitate was collected by 
filtration and washed with water to give compounds (10 – 25) as shown in Scheme 2.1 
and Table 2.3. The yield was between 64 – 83%. The impurity (an excess of the amino 
acid ester) was calculated by NMR spectroscopy to be between 12 – 27% for all 
derivatives except compounds 11, 12, 13, 15, 16, 19, 22 and 24, which were pure. The 
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resulting product was purified by washing with methanol. The yield after purification 
was typically between 40 – 60% and the products was typically 90 – 99% pure. 
(S)-3-Methyl-2-((S)-3-methyl-2-(2-(naphthalen-2yloxy)acetamido)butanamido) 
butanoic acid (10): 
1H NMR (d6-DMSO): 7.89 (d, ArH, 1H, 3JHH = 8.5Hz), 7.84 (d, ArH, 1H, 3JHH = 4.3Hz), 7.77 
(s, ArH, 1H,), 7.51 (d, ArH, 1H, 3JHH = 7.9Hz), 7.49 (d, ArH, 1H, 3JHH = 8.1Hz), 7.46 (t, ArH, 
1H, 3JHH = 6.9Hz), 7.43 (t, ArH, 1H, 3JHH = 9.6Hz), 7.38 (dd, NH, 1H, 3JHH = 4.4Hz), 7.22 (d, 
NH, 1H, 3JHH = 7.9Hz), 4.81 (d, OCH2C=O, 2H, 3JHH = 6.8Hz), 4.43 (dd, NHCHCH(CH3)2, 1H, 
3JHH = 6.4, 3.2Hz), 4.12 (d, NHCHCH(CH3)2, 1H, 3JHH = 6.4, 2.7Hz), 2.05 (m, (CH3)2CH, 1H), 
1.83 (m, (CH3)2CH, 1H, 3JHH = 7.2Hz), 0.88 (d, (CH3)2CH, 6H, 3JHH = 6.5Hz), 0.82 (d, 
(CH3)2CH, 6H, 3JHH = 6.9Hz) ppm. 13C NMR (d6-DMSO): 173.1, 171.3, 167.6, 155.9, 134.3, 
129.7, 129.0, 127.8, 127.0, 126.8, 124.2, 118.8, , 107.6, 67.0, 60.6, 57.7, 57.1, 31.3, 29.9, 
19.5, 18.4, 14.4 ppm. ES+: [M+Na]+. Accurate mass calculated: 423.1896 Found 
423.1894. 
(S)-2-((S)-3-Methyl-2-(2-(naphthalen-2-yloxy)acetamido)butanamido)propanoic 
acid (11):  
1H NMR (d6-DMSO): 8.39 (d, ArH, 1H, 3JHH = 7.1Hz), 7.96 (d, ArH, 1H, 3JHH = 9.1Hz), 7.84 
(d, ArH, 1H, 3JHH = 4.0Hz), 7.79 (d, NH, 1H, 3JHH = 3.1Hz), 7.75 (d, ArH, 1H, 3JHH = 8.1Hz), 
7.46 (t, ArH, 1H, 3JHH = 7.6Hz), 7.35 (t, ArH, 1H, 3JHH = 8.1Hz), 7.27 (s, ArH, 1H,), 6.7 (d, 
NH, 1H, 3JHH = 8.6Hz), 4.71(d, OCH2C=O, 2H, 3JHH = 3.7Hz), 7.79 (d, NH, 1H, 3JHH = 7.2Hz), 
4.34(dd, NHCHCH(CH3)2, 1H, 3JHH = 7.5, 3.2Hz), 4.11 (m, NHCH(CH3), 1H), 2.02 (m, 
(CH3)2CH, 1H), 1.26 (d, CH3, 3H, 3JHH = 7.2Hz), 0.88 (d, (CH3)2CH, 3H, 3JHH = 6.6Hz), 0.83 
(d, (CH3)2CH, 3H, 3JHH = 7.4Hz) ppm.13C NMR (d6-DMSO): 173.8, 170.3, 167.2, 155.5, 
133.9, 129.3, 128.6, 127.5, 126.5, 126.4, 123.8, 118.4, 107.2, 66.6, 56.6, 47.4, 31.0, 25.0, 
19.0, 17.8 ppm. ES+: [M+Na]+. Accurate mass calculated: 395.1583 Found 395.1584. 
(S)-2-(3-Methyl-2-(2-(naphthalen-2-yloxy)acetamido)butanamido)acetic acid (12): 
1H NMR (d6-DMSO): 8.44 (t, ArH, 1H, 3JHH = 7.2Hz), 7.99 (d, ArH, 1H, 3JHH = 10.8Hz), 7.85 
(dd, ArH, 1H, 3JHH = 7.0Hz), 7.75 (d, ArH, 1H, 3JHH = 7.2Hz), 7.46 (t, ArH, 1H, 3JHH = 8.1Hz), 
7.35 (t, ArH, 1H, 3JHH = 9.0Hz), 7.25 (t, ArH, NH, 2H,), 4.71 (d, OCH2C=O, 2H, 3JHH = 7.2Hz), 
4.30 (dd, NHCHCH(CH3)2, 1H, 3JHH = 5.9, 3.3Hz), 3.78 (dd, NHCH2C=O, 2H, 3JHH = 7.2, 
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5.4Hz), 2.04 (m, (CH3)2CH, 1H), 0.87 (d, (CH3)2CH, 3H, 3JHH = 7.4Hz) 0.84 (d, (CH3)2CH, 
3H, 3JHH = 6.4Hz) ppm. 13C NMR (d6-DMSO): 170.95, 170.91, 167.3, 155.5, 134.0, 129.3, 
128.6, 127.5, 126.6, 126.4, 123.8, 118.4, 107.2, 66.6, 57.0, 40.6, 30.7, 19.1, 17.8 ppm. ES+: 
[M+Na]+. Accurate mass calculated: 381.1426 Found 381.1438. 
(S)-2-((R)-3-Methyl-2-(2-(naphthalen-2-yloxy)acetamido)butanamido)-3-phenyl 
propanoic acid (13): 
1H NMR (d6-DMSO): 8.39 (d, ArH, 1H, 3JHH = 6.9Hz), 7.89 (d, NH, 1H, 3JHH = 9.3Hz), 7.87 
(d, ArH, 1H, 3JHH = 4.4Hz), 7.84 (d, ArH, 1H, 3JHH = 4.9Hz), 7.75 (d, ArH, 1H, 3JHH = 8.3Hz), 
7.46 (t, ArH, 1H, 3JHH = 7.4Hz), 7.36 (t, ArH, 1H, 3JHH = 6.4Hz), 7.25 (d, NH, 1H, 3JHH = 
7.4Hz), 7.22 (s, NH, 1H),  4.68(d, OCH2C=O, 2H, 3JHH = 8.8Hz), 4.43(m, NHCH(CH2Ph), 
1H), 1H), 4.30 (dd, NHCHCH(CH3)2, 1H, 3JHH = 6.4, 3.3Hz), 3.04 (dd, NHCH2Ph, 1H, 3JHH = 
7.9, 5.3Hz), 2.88 (dd, NHCH2Ph, 1H, 3JHH = 7.9, 4.8Hz), 1.98 (m, (CH3)2CH, 1H), 0.83 (d, 
(CH3)2CH, 3H, 3JHH = 7.7Hz), 0.79 (d, (CH3)2CH, 3H, 3JHH = 6.4Hz) ppm. 13C NMR (d6-
DMSO): 173.1, 171.0, 167.6, 155.9, 137.8, 134.4, 129.8, 129.4, 129.1, 128.5, 127.9, 
127.0, 126.9, 126.8, 124.2, 118.8, 107.6, 67.0, 57.2, 53.8, 36.9, 31.3, 31.1, 30.8, 19.5, 
18.1 ppm. ES+: [M+Na]+. Accurate mass calculated: 471.1911 Found 471.1896. 
(S)-2-((R)-2-(2-((6-Bromonaphthalen-2-yl)oxy)acetamido)-3-methyl 
butanemido)-3-methyl butanoic acid (14): 
1H NMR (d6-DMSO): 8.27(d, NH, 1H, 3JHH = 7.2Hz),  8.12 (s, ArH, 1H,), 7.98 (d, ArH, 1H, 
3JHH = 9.0Hz), 7.85 (d, ArH, 1H, 3JHH = 9.9Hz), 7.72 (d, NH, 1H, 3JHH = 7.2Hz), 7.57 (dd, ArH, 
1H, 3JHH = 8.1Hz), 7.30 (s, ArH, 1H,), 4.72 (d, OCH2C=O, 2H, 3JHH = 7.2Hz), 4.41 (dd, 
NHCHCH(CH3)2, 1H, 3JHH = 7.2, 3.3Hz), 4.11 (d, NHCHCH(CH3)2, 1H), 1.17 (m, (CH3)2CH, 
1H), 0.84 (m, (CH3)2CH, 6H) ppm. 13C NMR (d6-DMSO): 172.7, 170.9, 167.1, 155.9, 132.6, 
129.9, 129.3, 128.8, 128.7, 119.6, 116.5, 107.4, 66.7, 57.3, 56.8, 40.1, 30.9, 29.6, 19.1, 
18.9, 18.0, 17.8 ppm. MS: ES+: [M + Na]+. Accurate mass calculated: 501.1013 Found 
501.1001. 
(S)-2-((R)-2-(2-((6-Bromonaphthalen-2-yl)oxy)acetamido)-3-methyl 
butanamido)propanoic acid (15): 
1H NMR (d6-DMSO):  8.41 (d, NH, 1H, 3JHH = 9.0Hz ), 8.13 (s, ArH, 1H,), 8.03 (d, NH, 1H, 
3JHH = 9.8Hz), 7.85 (d, ArH, 1H, 3JHH = 8.2Hz), 7.72 (d, ArH, 1H, 3JHH = 9.8Hz), 7.58 (dd, 
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ArH, 1H, 3JHH = 10.6Hz), 7.30 (s, ArH, 1H, 3JHH = 9.8Hz), 7. 92 (d, NH, 1H, 3JHH = 10.6Hz), 
4.72 (d, OCH2C=O, 2H, 3JHH = 6.5Hz), 4.31 (dd, NHCHCH(CH3)2, 1H, 3JHH = 6.7, 3.6Hz), 4.18 
(t, NHCH(CH3), 1H, 3JHH = 7.4Hz), 2.01 (m, (CH3)2CH, 1H), 1.25 (d, CH3, 3H, 3JHH = 8.2Hz), 
0.88 (d, (CH3)2CH, 3H, 3JHH = 8.0Hz), 0.83 (d, (CH3)2CH, 3H, 3JHH = 7.0Hz) ppm.13C NMR 
(d6-DMSO): 174.3, 170.8, 167.5, 156.4, 132.9, 130.2, 129.8, 129.2, 129.1, 127.4, 120.1, 
116.9, 107.8, 67.0, 57.1, 47.9, 31.4, 19.5, 18.3, 17.3 ppm. ES+: [M+Na]+. Accurate mass 
calculated: 473.0688 Found 473.0696. 
(R)-2-(2-(2-((6-Bromonaphthalen-2-yl)oxy)acetamido)-3-methylbutanamido) 
acetic acid (16): 
1H NMR (d6-DMSO): 8.42 (t, NH, 1H, 3JHH = 5.6Hz), 8.12 (s, ArH, 1H,), 8.01 (d, ArH, 1H, 
3JHH = 9.0Hz), 7.86 (d, ArH, 1H, 3JHH = 8.7Hz), 7.72 (d, ArH, 1H, 3JHH = 8.8Hz), 7.58 (dd, 
ArH, 1H, 3JHH = 6.9Hz), 7.31 (s, ArH, 1H,), 7.29 (d, NH, 1H, 3JHH = 4.6Hz), 4.72 (d, 
OCH2C=O, 2H, 3JHH = 5.3Hz), 4.30 (dd, NHCHCH(CH3)2, 1H, 3JHH = 5.5, 4.2Hz), 3.76 (dd, 
NHCH2C=O, 2H, 3JHH = 5.8Hz), 2.03 (m, (CH3)2CH, 1H), 0.86 (d, (CH3)2CH, 3H, 3JHH = 
6.9Hz), 0.84 (d, (CH3)2CH, 3H, 3JHH = 7.1Hz) ppm. 13C NMR (d6-DMSO): 171.4, 167.6, 
156.3, 133.0, 130.2, 129.7, 129.2, 129.0, 120.0, 116.9, 107.6, 67.3, 67.0, 57.4, 40.9, 31.1, 
19.4, 18.2 ppm. ES+: [M+Na]+. Accurate mass calculated: 459.0532 Found 459.0546. 
(S)-2-((R)-2-(2-((6-Bromonaphthalen-2-yl)oxy)acetamido)-3-methylbutanamido)-
3-phenylpropanoic acid (17): 
1H NMR (d6-DMSO): 8.40 (d, NH, 1H, 3JHH = 6.3Hz ), 8.38 (s, ArH, 1H,), 8.20 (d, NH, 1H, 
3JHH = 8.1Hz ),  8.12 (s, ArH, 1H, 3JHH = 8.1Hz), 7.72 (d, ArH, 1H, 3JHH = 10.8Hz), 7.57 (dd, 
ArH, 1H, 3JHH = 4.5Hz), 7.28 (d, ArH, 1H, 3JHH =9.9Hz), 7.21 (s, ArH, 1H,), 4.43(m, 
NHCH(CH2Ph), 1H), 1H), 4.68(d, OCH2C=O, 2H, 3JHH = 7.1Hz), 4.29 (dd, NHCHCH(CH3)2, 
1H, 3JHH = 6.3, 4.3Hz), 3.04 (d, NHCH2Ph, 2H, 3JHH = 6.3Hz), 1.99 (m, (CH3)2CH, 1H), 0.82 
(d, (CH3)2CH, 3H, 3JHH = 6.7Hz), 0.77 (d, (CH3)2CH, 3H, 3JHH = 7.4Hz) ppm. 13C NMR (d6-
DMSO): 172.6, 170.5, 166.9, 155.9, 137.4, 132.5, 129.8, 129.3, 128.9, 128.8, 128.1, 
126.3, 126.7, 126.3, 119.6, 116.5, 107.3, 66.6, 56.8, 53.3, 36.5, 31.31, 31.05,30.8, 19.08, 
17.71 ppm. ES+: [M+Na]+. Accurate mass calculated: 549.1001Found 549.1017. 
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(S)-2-((R)-2-(2-((1,6-Dibromonaphthalen-2-yl)oxy)acetamido)-3-methyl 
butanamido)-3-methylbutanoic acid (18): 
1H NMR (d6-DMSO): 8.26 (d, ArH, 1H, 3JHH = 3.5Hz), 8.19 (d, NH, 1H, 3JHH = 9.6Hz), 8.04 
(d, ArH, 1H, 3JHH = 9.6Hz), 7.98 (d, ArH, 1H, 3JHH = 9.6Hz), 7.89(d, NH, 1H, 3JHH = 10.5Hz), 
7.76(dd, ArH, 1H, 3JHH = 7.8Hz), 7.47(d, ArH, 1H, 3JHH = 10.5Hz), 4.87(d, OCH2C=O, 2H, 
3JHH = 7.0Hz), 4.47 (dd, NHCHCH(CH3)2, 1H, 3JHH = 5.2, 3.3Hz), 4.12 (dd, NHCHCH(CH3)2, 
1H, 3JHH = 6.3, 3.0Hz), 2.04 (m, (CH3)2CH, 1H), 0.90 (d, (CH3)2CH, 3H, 3JHH = 4.3Hz), 0.88 
(d, (CH3)2CH, 3H, 3JHH = 4.8Hz), 0.85 (d, (CH3)2CH, 6H, 3JHH = 6.8Hz), 0.79 (d, (CH3)2CH, 
6H, 3JHH = 6.8Hz) ppm. 13C NMR (d6-DMSO): 173.1, 171.1, 167.1, 152.9, 131.4, 131.2, 
130.9, 130.4, 128.8, 128.0, 118.0, 116.6, 107.7, 68.2, 57.7, 56.7, 31.6, 29.9, 19.5, 19.4, 
18.4, 17.9 ppm. ES+: [M+Na]+.  Accurate mass calculated: 579.0106 Found 579.0115. 
(S)-2-((R)-2-(2-((1,6-Dibromonaphthalen-2-yl)oxy)acetamido)-3-methyl 
butanamido) propanoic acid (19): 
1H NMR (d6-DMSO):  8.42 (d, NH, 1H, 3JHH = 6.9Hz  ), 8.25 (d, ArH, 1H, 3JHH = 1.8Hz), 8.03 
(d, ArH, 1H, 3JHH = 9.0Hz), 7.98 (d, ArH, 1H, 3JHH = 9.1Hz), 7.89 (d, NH, 1H, 3JHH = 9.1Hz), 
7.75 (dd, ArH, 1H, 3JHH = 9.0Hz), 7.67 (d, ArH, 1H, 3JHH = 9.1Hz), 4.87 (d, OCH2C=O, 2H, 3JHH 
= 5.4Hz), 4.36 (q, NHCHCH(CH3)2, 1H, 3JHH = 5.9Hz), 4.20 (t, NHCH(CH3), 1H, 3JHH = 
7.1Hz), 2.03 (m, (CH3)2CH, 1H), 1.27 (d, CH3, 3H, 3JHH = 7.3Hz), 0.88 (d, (CH3)2CH, 6H, 3JHH 
= 7.8Hz) ppm.13C NMR (d6-DMSO): 174.29, 170., 167.1, 152.9, 131.4, 131.2, 130.9, 130.4, 
128,8, 128.0, 118.0, 116.6, 107.7, 68.1, 56.7, 47.8, 31.6, 19.4, 18.0, 17.3 ppm. ES+: 
[M+Na]+. Accurate mass calculated: 550.9793 Found 550.9792. 
(R)-2-(2-(2-((1,6-Dibromonaphthalen-2-yl)oxy)acetamido)-3-methylbutanamido) 
acetic acid (20): 
1H NMR (d6-DMSO): 8.24 (d, ArH, 1H, 3JHH = 2.0Hz), 8.03 (d, ArH, 1H, 3JHH = 9.3Hz), 7.98 
(d, ArH, 1H, 3JHH = 9.4Hz), 7.86 (d, NH, 1H, 3JHH = 8.8Hz), 7.75 (dd, ArH, 1H, 3JHH = 7.7Hz), 
7.49 (d, ArH, 1H, 3JHH = 8.8Hz), 7.28 (d, NH, 1H, 3JHH = 8.8Hz), 4.87 (q, NHCHCH(CH3)2, 1H, 
3JHH = 7.4Hz), 4.51 (d, OCH2C=O, 2H, 3JHH = 6.6Hz), 4.32 (dd, NHCH2C=O, 2H, 3JHH = 6.4, 
3.6Hz), 2.05 (m, (CH3)2CH, 1H), 0.87 (d, (CH3)2CH, 3H, 3JHH = 3.8Hz), 0.86 (d, (CH3)2CH, 
3H, 3JHH = 8.2Hz) ppm. 13C NMR (d6-DMSO): 171.3, 170.8, 167.2, 153.0, 131.4, 131.2, 
130.9, 130.4, 128.8, 128.0, 117.9, 116.6, 68.1, 57.2, 41.7, 31.3, 19.5, 18.1, 17.9 ppm. ES+: 
[M+Na]+. Accurate mass calculated: 536.9637 Found 536.9658. 
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(S)-2-((R)-2-(2-((1,6-Dibromonaphthalen-2-yl)oxy)acetamido)-3-methyl 
butanamido)-3-phenylpropanoic acid (21): 
1H NMR (d6-DMSO): 8.42 (d, NH, 1H, , 3JHH = 7.5Hz), 8.25 (d, ArH, 1H, , 3JHH = 2.0Hz), 8.03 
(d, ArH, 1H, , 3JHH = 9.0Hz), 7.75 (d, ArH, 1H, , 3JHH = 9.1Hz), 7.46 (d, NH, 1H, , 3JHH = 
9.4Hz), 7.36 (dd, ArH, 1H, , 3JHH = 11.1Hz), 4.83(m, NHCH(CH2Ph), 1H), 1H), 4.93(d, 
OCH2C=O, 2H, 3JHH = 8.8Hz), 4.78 (dd, NHCHCH(CH3)2, 1H, 3JHH = 6.4, 5.4Hz), 4.34 (dd, 
NHCH2Ph, 2H, 3JHH = 6.7Hz), 2.02 (m, (CH3)2CH, 1H), 0.85 (d, (CH3)2CH, 3H, 3JHH = 8.2Hz), 
0.80 (d, (CH3)2CH, 3H, 3JHH = 5.4Hz) ppm. 13C NMR (d6-DMSO): 173.1, 170.8, 167.0, 
153.0, 137.8, 131.4, 131.2, 130.99, 130.4, 129.5, 128.8, 128.6, 128.0, 126.9, 126.7, 118.0, 
116.6, 107.7, 68.1, 56.8, 53.8, 36.9, 31.5, 19.5, 18.0, 17.8 ppm. ES+: [M+Na]+. Accurate 
mass calculated: 627.0106, Found 627.0119. 
(S)-2-((R)-2-(2-((1-Bromonaphthalen-2-yl)oxy)acetamido)-3-methylbutanamido)-
3-methylbutanoic acid (22): 
1H NMR (d6-DMSO): 8.22(d, NH, 1H, 3JHH = 8.1Hz),  8.11 (d, ArH, 1H, 3JHH = 8.1Hz), 7.96 
(d, ArH, 1H, 3JHH = 9.3Hz), 7.89 (d, ArH, 1H, 3JHH = 9.3Hz), 7.67 (d, NH, 1H, 3JHH = 8.1Hz), 
7.49 (t, ArH, 1H, 3JHH = 8.1Hz), 7.42 (d, ArH, 1H, 3JHH = 10.5Hz), 4.82 (d, OCH2C=O, 2H, 
3JHH = 6.1Hz), 4.50 (dd, NHCHCH(CH3)2, 1H, 3JHH = 5.2, 2.6Hz), 4.47 (dd, NHCHCH(CH3)2, 
1H, 3JHH = 6.4, 2.7Hz), 2.08 (m, (CH3)2CH, 1H), 0.89 (d, (CH3)2CH, 6H, 3JHH = 6.4Hz), 0.85 
(d, (CH3)2CH, 6H, 3JHH = 7.4Hz) ppm. 13C NMR (d6-DMSO): 172.7, 170.7, 166.8, 152.0, 
132.1, 129.6, 129.2, 128.3, 128.2, 125.2, 124.6, 115.1, 107.4, 67.8, 57.3, 56.3, 31.2, 29.5, 
19.1, 19.0, 18.0, 17.5 ppm. ES+: [M+Na]+. Accurate mass calculated: 501.1001.  Found 
501.1003. 
(S)-2-((R)-2-(2-((1-Bromonaphthalen-2-yl)oxy)acetamido)-3-
methylbutanamido)propanoic acid (23): 
1H NMR (d6-DMSO):  8.43 (d, NH, 1H, 3JHH = 6.9Hz ), 8.11 (d, ArH, 1H, 3JHH = 8.5Hz), 8.01 
(d, NH, 1H, 3JHH = 9.0Hz), 7.89 (d, ArH, 1H, 3JHH = 8.1Hz), 7.66 (t, ArH, 1H, 3JHH = 8.4Hz), 
7.63 (d, ArH, 1H, 3JHH = 8.0Hz), 7.50 (d, ArH, 1H, 3JHH = 9.1Hz), 7.44 (d, NH, 1H, 3JHH = 
9.1Hz), 4.83 (d, OCH2C=O, 2H, 3JHH = 6.5Hz), 4.36 (dd, NHCHCH(CH3)2, 1H, 3JHH = 6.3, 
5.3Hz), 4.19 (m, NHCH(CH3), 1H, 3JHH = 7.4Hz), 2.04 (m, (CH3)2CH, 1H), 1.28 (d, CH3, 3H, 
3JHH = 8.2Hz), 0.91 (d, (CH3)2CH, 3H, 3JHH = 8.6Hz), 0.87 (d, (CH3)2CH, 3H, 3JHH = 8.3Hz) 
ppm. 13C NMR (d6-DMSO): 171.2, 170.0, 167.8, 151.3, 135.6, 132.9, 130.4, 129.4, 129.3, 
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128.5, 128.2, 128.1, 127.1, 126.3, 125.1, 114.4, 109.8, 68.6, 61.6, 58.1, 53.0, 37.8, 30.6, 
19.2, 17.8, 14.0 ppm. ES+: [M+Na]+. Accurate mass calculated: 473.0698.  Found 
473.0688. 
(R)-2-(2-(2-((1-Bromonaphthalen-2-yl)oxy)acetamido)-3-methylbutanamido)acetic 
acid (24): 
1H NMR (d6-DMSO): 8.90 (t, NH, 1H, 3JHH = 7.3Hz), 8.53 (d, ArH, 1H, 3JHH = 8.1Hz), 8.42 (d, 
ArH, 1H, 3JHH = 8.8Hz), 8.38 (d, ArH, 1H, 3JHH = 8.6Hz), 8.32 (d, ArH, 1H, 3JHH = 8.6Hz), 8.08 
(t, NH, 1H, 3JHH = 7.8Hz), 7.90 (m, ArH, 2H), 5.29 (d, OCH2C=O, 2H, 3JHH = 8.1Hz), 4.78 (dd, 
NHCHCH(CH3)2, 1H, 3JHH = 5.6, 3.2Hz), 4.21 (dd, NHCH2C=O, 2H, 3JHH = 6.4, 4.0Hz), 2.48 
(m, (CH3)2CH, 1H), 1.33 (d, (CH3)2CH, 3H, 3JHH = 7.2Hz), 1.30 (d, (CH3)2CH, 3H, 3JHH = 
6.9Hz) ppm. 13C NMR (d6-DMSO): 171.5, 171.2, 167.4, 152.5, 132.5, 130.0, 129.7, 128.7, 
128.6, 125.6, 125.0, 115.5, 107.8, 68.2, 57.1, 31.4, 19.5, 17.9 ppm. ES+: [M+Na]+. Accurate 
mass calculated: 459.0536 Found 459.0532. 
(S)-2-((R)-2-(2-((1-Bromonaphthalen-2-yl)oxy)acetamido)-3-methylbutanamido)-
3-phenylpropanoic acid (25): 
1H NMR (d6-DMSO): 8.42(d, NH, 1H, 3JHH = 7.7Hz ), 8.11 (d, ArH, 1H, 3JHH = 8.5Hz), 7.98 
(d, NH, 1H, 3JHH = 9.0Hz ),  7.81 (d, ArH, 1H, 3JHH = 8.7Hz), 7.67 (d, ArH, 1H, 3JHH = 9.7Hz), 
7.63 (t, ArH, 1H, 3JHH = 5.5Hz), 7.48 (t, ArH, 1H, 3JHH = 8.4Hz), 7.17 (d, ArH, 1H, 3JHH = 9.0 
Hz), 4.46 (m, NHCH(CH2Ph), 1H), 1H), 4.83 (d, OCH2C=O, 2H, 3JHH = 8.9Hz), 4.35 (dd, 
NHCHCH(CH3)2, 1H, 3JHH = 6.1, 4.2Hz), 3.07 (dd, NHCH2Ph, 1H, 3JHH = 8.6, 6.5Hz), 2.93 
(dd, NHCH2Ph, 1H, 3JHH = 8.6, 4.5Hz), 2.02 (m, (CH3)2CH, 1H), 0.86 (d, (CH3)2CH, 3H, 3JHH 
= 6.5Hz), 0.81 (d, (CH3)2CH, 3H, 3JHH = 7.5Hz) ppm. 13C NMR (d6-DMSO): 171.2, 170.0, 
167.8, 151.3, 135.6, 132.9, 130.4, 129.4, 129.3, 128.5, 128.2, 128.1, 127.1, 126.3, 125.1, 
114.4, 109.8, 68.6, 61.6, 58.1, 53.0, 37.8, 30.6, 19.2, 17.8, 14.0 ppm. MS: ES–: [M – H]–. 
Accurate mass calculated: 525.1025. Found: 525.1030. 
From naphthalene acetic acid: 
According to Chen’s research, naphthalene was coupled to the amino acids using 
different linkers, -CH2 and –OCH2. Here, we have linked the naphthalene to amino acids 
by –CH2 as shown in Scheme 2.2. 
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Scheme ‎2.2: The general reaction of naphthalene dipeptide synthesis based on naphthalene acetic acid ring 
using IBCF method. 
 
Compound Substituent 
29 R 
a CH(CH3)2 
b CH3 
c H 
d CH2Ph 
Table ‎2.4: The R group of the general structure of compounds 29 (a, b, c, d) in the Scheme 2. 
 
Dipeptides R Abbreviation 
30 CH(CH3)2 1nap-VVOH 
31 CH3 1nap-VAOH 
32 H 1nap-VGOH 
33 CH2Ph 1nap-VFOH 
Table ‎2.5: The R group of the general structure of compounds 30–33 and their abbreviations in the Scheme 2. 
 
 
 
59 | P a g e  
 
Standard coupling methodology: 
N-Methylmorpholine (4 mL) and IBCF (3 mL) were added to 1-naphthalene acetic acid 
(5.0g) in chloroform (70 mL) at 0 oC. A solution of L-valine methyl ester (4.0 g, 1.5eq.) 
and NMM (4 mL) in chloroform was added. The solution was stirred at room 
temperature overnight. The solution was washed with distilled water (100 mL), 
hydrochloric acid (2 x 100 mL, 0.1 M), aqueous potassium carbonate (100 mL, 0.1 M), 
and distilled water again (4 x 100 mL) and dried with magnesium sulfate. The solvent 
was removed in vacuo to give compound 27 as shown in the Scheme 2.2. The yield was 
75%. The impurities (an excess of valine methyl ester and IBCF) were calculated by 
NMR spectroscopy to be 35%. The resulting product was purified by washing with 
methanol. The yield after purification was typically 50% and the compound was 85% 
pure and used directly in the next step.  
 (S)-Methyl-3-methyl-2-(2-napthalen-1-yl)acetamido)butanoate (27): 
1H NMR (CDCl3): 7.99 (d, ArH, 1H, 3JHH = 7.1Hz), 7.88 (d, ArH, 1H, 3JHH = 8.6Hz), 7.83 (d, 
ArH, 1H, 3JHH = 7.6Hz), 7.55 (d, ArH, 1H, 3JHH = 5.6Hz), 7.52 (d, ArH, 1H, 3JHH = 5.8Hz), 7.48 
(d, ArH, 1H, 3JHH = 6.1Hz), 7.46 (s, ArH, 1H,), 5.85 (d, NH, 1H, 3JHH = 8.1Hz), 4.50 (q, 
CH2C=O, 2H, 3JHH = 14.0Hz), 4.07 (q, NHCHCH(CH3)2, 1H, 3JHH = 6.1Hz), 1H), 3.61 ( s, 
OCH3, 3H), 1.97 (m, (CH3)2CH, 1H), 0.71 (d, (CH3)2CH, 6H, 3JHH = 6.8Hz) ppm. 13C NMR 
(CDCl3): 173.08, 170.36, 133.27, 132.93, 131.90, 128.27, 127.70, 126.93, 125.77, 125.55, 
125.42, 124.36, 102.73, 57.14, 29.19, 17.95 ppm. MS: ES+ ([M+Na]+). Accurate mass 
calculated: 322.1419 Found 322.1428. 
Deprotection of the C-terminus: 
A solution of THF: water (30 mL: 5 mL) was added to the compound 27. Lithium 
hydroxide (0.5 g) was added. The solution was stirred overnight. After this time, 
distilled water (100 mL) was added, and then hydrochloric acid (1.0 M) was added 
drop-wise until the pH was lowered to pH 3. Chloroform was added to the resulting oil 
of compound 28 in separating funnel and the organic phase was dried over magnesium 
sulfate and the solvent was removed in vacuo. The resulting precipitate was collected by 
filtration and washed with water to give compound 28 as shown in Scheme 2.2. The 
yield was 68%. The impurity (excess of valine methyl ester) was calculated by NMR 
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spectroscopy 8%. The resulting product was purified by washing with methanol to give 
yield of 45% and purity of 96%. 
 (S)-Methyl-2-(2-napthalen-1-yl)acetamido)butanoic acid (28): 
1H NMR (d6-DMSO): 8.38 (d, NH, 1H,), 8.13 (d, ArH, 1H,), 7.91 (d, ArH, 1H,), 7.80 (d, ArH, 
1H,), 7.59 (d, ArH, 1H,), 7.51 (d, ArH, 1H,), 7.45 (s, ArH, 1H,), 7.44 (d, NH, 1H,), 4.34 (d, 
CH2C=O, 2H, 3JHH = 12.8Hz), 4.13 (d, NHCHCH(CH3)2, 1H), 1.98 (m, (CH3)2CH, 1H), 0.86 
(m, (CH3)2CH, 6H) ppm. 13C NMR (d6-DMSO): 173.1, 170.4, 133.3, 132.9, 131.9, 128.3, 
127.7, 126.9, 125.8, 125.6, 125.4, 124.4, 102.7, 57.2, 29.2, 17.9 ppm. MS: ES+ ([M+Na]+). 
Accurate mass calculated: 308.1263 Found 308.1261. 
Standard coupling methodology: 
N-Methylmorpholine (0.6 mL) and IBCF (3 mL) were added to compound 26 (1.0 g) in 
chloroform (70 mL) at 0oC. A solution of L–phenylalanine ethyl ester hydrochloride, L–
valine ethyl ester hydrochloride, L–alanine ethyl ester hydrochloride or glycine ethyl 
ester hydrochloride and NMM (0.6 mL) in chloroform was added. The solution was 
stirred at room temperature overnight. The solution was washed with distilled water 
(100 mL), hydrochloric acid (2 x 100 mL, 0.1 M), aqueous potassium carbonate (100 
mL, 0.1 M), and distilled water again (4 x 100 mL) and dried with magnesium sulfate. 
The solvent was removed in vacuo to give compounds 29 (a – d) as shown in the 
Scheme 2.2 and Table 2.4. The yield was between 27 – 56%. The impurity (an excess of 
the amino acid methyl ester) was calculated by NMR spectroscopy to be between 12 – 
27% for all derivatives. The resulting product was purified by washing with methanol. 
The yield after purification was 35 – 40% and the product was typically 80 – 90% pure. 
(S)-Methyl-2-((S)-3-methyl-2-(2-naphthalen-1yl)acetamido)butanamido) 
butanoate  (29a): 
1H NMR (CDCl3): 7.96 (d, ArH, 1H, 3JHH = 8.3), 7.86 (d, ArH, 1H, 3JHH = 7.8), 7.82 (d, ArH, 
1H, 3JHH = 8.8), 7.52 (d, ArH, 1H, 3JHH = 6.9), 7.50 (d, ArH, 1H, 3JHH = 7.4), 7.45 (s, ArH, 
1H,), 7.42 (d, ArH, 1H, 3JHH = 8.9), 6.33 (d, NH, 1H, 3JHH = 8.8), 5.87 (d, NH, 1H, 3JHH = 
8.3), 4.09 (s, CH2C=O, 2H), 4.41 (dd, NHCHCH(CH3)2, 1H, 3JHH = 5.4, 4.3), 4.21 (dd, 
NHCHCH(CH3)2, 1H, 3JHH = 6.4, 2.1), 3.71 (s, OCH3, 3H), 2.08 (m, (CH3)2CH, 1H), 1.91 
(m, (CH3)2CH, 1H), 0.85 (d, (CH3)2CH, 3H, 3JHH = 7.3), 0.82 (d, (CH3)2CH, 3H, 3JHH = 
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6.3Hz), 0.75 (d, (CH3)2CH, 3H, 3JHH = 6.3), 0.54 (d, (CH3)2CH, 3H, 3JHH = 7.3Hz) ppm.13C 
NMR (CDCl3): 171.9, 171.0, 170.7, 133.9, 131.9, 130.7, 128.8, 128.3, 126.8, 126.1, 
125.6, 123.6, 58.5, 57.0, 52.1, 41.6, 30.9, 30.3, 19.0, 18.8, 17.7, 17.5, 17.3 ppm. MS: ES+ 
([M+Na]+). Accurate mass calculated: 421.2103 Found 421.2104. 
(S)-Methyl-2-((S)-3-methyl-2-(2-naphthalen-1yl)acetamido)butanamido) 
propanoate (29b):  
1H NMR (CDCl3): 7.98 (d, ArH, 1H, 3JHH = 7.8Hz), 7.86 (d, ArH, 1H, 3JHH = 4.9Hz), 7.81 (d, 
ArH, 1H, 3JHH = 5.4Hz), 7.55 (d, ArH, 1H, 3JHH = 3.4Hz), 7.50 (d, ArH, 1H, 3JHH = 4.4Hz), 7.47 
(d, ArH, 1H, 3JHH = 6.4Hz), 7.44 (d, ArH, 1H, 3JHH = 4.9Hz), 6.37 (d, NH, 1H, 3JHH = 6.9Hz), 
5.92 (d, NH, 1H, 3JHH = 7.9Hz), 4.47 (m, NHCH(CH3), 1H, 3JHH = 7.8Hz), 4.20 (dd, 
NHCHCH(CH3)2, 1H, 3JHH = 6.4,Hz), 4.08 (d, CH2C=O, 2H, 3JHH = 12.5Hz), 3.71 (s, OCH3, 
3H), 1.94 (m, (CH3)2CH, 1H), 1.31 (d, CH3, 3H, 3JHH = 7.2Hz), 0.75 (d, (CH3)2CH, 3H, 3JHH = 
6.3Hz), 0.56 (d, (CH3)2CH, 3H, 3JHH = 7.6Hz) ppm. 13C NMR (CDCl3): 172.9, 171.3, 170.6, 
134.3, 132.3, 131.2, 129.2, 128.9, 128.7, 127.1, 126.5, 126.0, 124.0, 61.8, 58.6, 48.4, 42.1, 
31.1, 19.3, 18.5, 17.9 ppm. MS: ES+: [M+Na]+. Accurate mass calculated: 393.1790.  
Found 393.1802. 
(S)-Ethyl-2-(3-methyl-2-(2-naphthalen-1yl)acetamido)butanamido)acetate(29c): 
 1H NMR (CDCl3): 7.96(d, ArH, 1H, 3JHH = 6.4Hz), 7.88 (dd, ArH, 1H, 3JHH = 6.8Hz), 7.83 (d, 
ArH, 1H, 3JHH = 7.2Hz), 7.52 (d, ArH, 1H, 3JHH = 3.1Hz), 7.49 (d, ArH, 1H, 3JHH = 3.0Hz), 
7.46 (s, ArH, 1H,), 7.44 (d, ArH, 1H, 3JHH = 2.7Hz), 6.35 (d, NH, 1H, 3JHH = 6.1Hz), 5.92 (d, 
NH, 1H, 3JHH = 5.5Hz), 4.10 (s, CH2C=O, 2H), 4.01 (d, NHCHCH(CH3)2, 1H, 3JHH = 8.0Hz), 
3.98 (q, OCH2CH3, 2H, 3JHH = 8.0Hz ), 3.90 (d, NHCH2C=O, 2H, 3JHH = 5.4Hz), 1.94 (m, 
(CH3)2CH, 1H), 1.26 (t, OCH2CH3, 3H, 3JHH = 7.1Hz) 0.73 (d, (CH3)2CH, 3H, 3JHH = 8.3Hz), 
0.54 (d, (CH3)2CH, 3H, 3JHH = 7.3Hz) ppm. 13C NMR (CDCl3): 172.1, 170.9, 169.3, 133.9, 
131.9, 130.7, 128.9, 128.6, 128.3, 126.7, 126.1, 125.7, 123.6, 61.5, 58.3, 41.7, 41.1, 30.2, 
19.0, 17.4, 14.1 ppm. MS: ES+: [M+Na]+. Accurate mass calculated: 393.1790 Found: 
393.1787.  
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(S)-Ethyl-2-((S)-3-methyl-2-(2-naphthalen-1yl)acetamido)butanamido)-3-phenyl-
propanoate(29d): 
1H NMR (CDCl3): 8.21 (d, ArH, 1H, 3JHH = 5.9Hz), 8.11 (d, ArH, 1H, 3JHH = 6.5Hz), 7.89 (d, 
ArH, 1H, 3JHH = 8.6Hz), 7.79 (d, ArH, 1H, 3JHH = 3.7Hz), 7.49 (d, ArH, 1H, 3JHH = 7.4Hz), 7.42 
(d, ArH, 1H, 3JHH = 6.5Hz), 7.14 (d, ArH, 1H, 3JHH = 7.0Hz), 6.09 (d, NH, 1H, 3JHH = 8.1Hz), 
5.72 (d, NH, 1H, 3JHH = 9.2Hz),  4.17 (m, NHCH(CH2Ph), 1H), 1H), 4.07 (s, CH2C=O, 2H), 
3.89 (dd, NHCHCH(CH3)2, 1H, 3JHH = 7.3, 6.3Hz), 3.60 ( q, OCH2CH3, 2H, 3JHH = 9.3, 6.0Hz), 
3.05 (dd, NHCH2Ph, 1H, 3JHH = 7.3, 6.3Hz), 2.93 (dd,NHCH2Ph, 1H, 3JHH = 7.0, 6.1Hz),  1.97 
(m, (CH3)2CH, 1H), 1.26 ( t, OCH2CH3, 2H, 3JHH = 7.0Hz), 0.78 (d, (CH3)2CH, 3H, 3JHH =7.6 
Hz), 0.68 (d, (CH3)2CH, 3H, 3JHH = 6.3Hz) ppm. 13C NMR (CDCl3): 171.1, 169.9, 167.4, 
151.6, 135.6, 131.6, 131.4, 131.2, 130.0, 129.3, 128.6, 128.5, 128.2, 127.1,119.1, 115.3, 
109.9, 68.5, 61.6, 58.0, 53.0, 37.8, 30.8, 19.2, 17.8, 14.0 ppm. MS: ES+ ([M+Na]+). 
Accurate mass calculated: 483.2260. Found 483.2257. 
Deprotection of the C-terminus: 
A solution of THF: water (30 mL, 5 mL) was added to the compounds 29 (a – d). 
Lithium hydroxide (0.5 g) was added and the solution was stirred overnight. After this 
time, distilled water (100 mL) was added, and then hydrochloric acid (1.0 M) was added 
drop-wise until the pH was lowered to pH 3. Chloroform was added to the resulting 
compounds 30, 31, 32 or 33 in a separating funnel and the organic phase was dried 
over magnesium sulfate and the solvent was removed in vacuo to give compounds (30 – 
32) as shown in Scheme 2.2 and Table 2.5. The yield was between 65 – 78%. The 
impurity (an excess of valine methyl ester) was calculated by NMR spectroscopy to be 
between 7 – 9% for all derivatives except compound 30, which was pure and used 
directly in the next step of the reaction. The resulting product was purified by washing 
with methanol. The yield after purification was typically between 50 – 60% and the 
resulting products were between 96 – 98% pure. 
(S)-3-Methyl-2-((S)-3-methyl-2-(2-naphthalen-1-yl)acetamido)butanamido) 
butanoic acid (30): 
1H NMR (d6-DMSO): 8.22 (d, NH, 1H, 3JHH = 9.2Hz), 8.20 (d, NH, 1H, 3JHH = 4.6Hz),  8.12 (s, 
ArH, 1H,), 8.09 (d, ArH, 1H, 3JHH = 8.5Hz), 7.91 (t, ArH, 1H, 3JHH = 3.2Hz), 7.79 (d, NH, 1H, 
3JHH = 3.1Hz), 7.80 (d, ArH, 1H, 3JHH = 5.9Hz), 7.49 (d, ArH, 1H, 3JHH = 8.1Hz), 7.43 (d, ArH, 
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1H, 3JHH = 5.3Hz), 3.96 (s, CH2C=O, 2H), 4.32 (dd, NHCHCH(CH3)2, 1H, 3JHH = 7.2, 4.3Hz), 
4.21 (dd, NHCHCH(CH3)2, 1H, 3JHH = 5.9, 3.3Hz), 2.0 (m, (CH3)2CH, 1H), 1.98 (m, 
(CH3)2CH, 1H), 0.86 (d, (CH3)2CH, 6H, 3JHH = 7.3Hz) ppm. 13C NMR (DMSO d6): 173.1, 
171.7, 170.3, 155.91, 133.6, 133.4, 132.3, 128.6, 128.1, 127.3, 126.1, 125.9, 125.8, 124.7, 
57.6, 57.5, 31.1, 31.0, 29.9, 19.5, 19.4, 18.4 ppm. MS: ES+ ([M+Na]+). Accurate mass 
calculated: 407.1947. Found 407.1943. 
(S)-2-((S)-3-Methyl-2-(2-naphthalen-1-yl)acetamido)butanamido)propanoic acid 
(31): 
 1H NMR (d6-DMSO): 8.39 (d, NH, 1H, 3JHH = 9.3Hz), 8.28 (d, ArH, 1H, 3JHH = 6.4Hz), 8.20 
(d, NH, 1H, 3JHH = 9.8Hz), 8.12 (dd, ArH, 1H, 3JHH = 5.9Hz), 7.91 (dd, ArH, 1H, 3JHH = 
5.8Hz), 7.80 (t, ArH, 1H, 3JHH = 6.9Hz), 7.51 (d, ArH, 1H, 3JHH = 4.4Hz), 7.50 (d, ArH, 1H, 
3JHH = 6.2Hz), 7.44(d, ArH, 1H, 3JHH = 5.3Hz), 4.19 (dd, NHCHCH(CH3)2, 1H, 3JHH = 5.9, 
4.0Hz), 3.95 (d, OCH2C=O, 2H, 3JHH = 10.6Hz), 4.17 (m, NHCH(CH3), 1H,), 1.98 (m, 
(CH3)2CH, 1H), 1.25 (d, CH3, 3H, 3JHH = 7.3Hz), 0.86 (d, (CH3)2CH, 3H, 3JHH = 6.3Hz), 0.84 
(d, (CH3)2CH, 3H, 3JHH = 8.6Hz) ppm. 13C NMR (d6-DMSO): 174.3, 171.1, 170.7, 170.3, 
133.6, 132.3, 128.6, 128.1, 127.3, 126.1, 126.0, 125.8, 124.7, 57.5, 47.8, 31.2, 30.2, 19.5, 
18.4, 17.3 ppm. MS: ES+ ([M+Na]+). Accurate mass calculated: 379.1634 Found 
379.1635. 
(S)-2-(3-Methyl-2-(2-naphthalen-1-yl)acetamido)butanamido)acetic acid (32): 
 1H NMR (d6-DMSO): 8.38(dd, ArH, 1H, 3JHH = 7.8Hz), 8.30 (d, NH, 1H, 3JHH = 5.9Hz), 8.43 
(d, NH, 1H, 3JHH = 7.8Hz), 8.12 (m, ArH, 1H,), 7.90 (d, ArH, 1H, 3JHH = 4.0Hz), 7.80 (t, ArH, 
1H, 3JHH = 5.2Hz), 7.50 (d, ArH, 1H, 3JHH = 4.6Hz), 7.49 (d, ArH, 1H, 3JHH = 4.6Hz), 7.44 (s, 
ArH, 1H,), 4.20 (dd, NHCHCH(CH3)2, 1H, 3JHH = 6.5, 5.3Hz), 3.95 (d, CH2C=O, 2H, 3JHH = 
12.6Hz), 3.78 (d, NHCH2C=O, 1H, 3JHH = 5.3Hz), 3.73 (d, NHCH2C=O, 1H, 3JHH = 6.3Hz),  
2.01 (m, (CH3)2CH, 1H), 0.86 (d, (CH3)2CH, 3H, 3JHH = 4.4Hz), 0.84 (d, (CH3)2CH, 3H, 3JHH = 
3.7Hz) ppm. 13C NMR (d6-DMSO): 172.8, 167.6, 153.0, 131.4, 131.2, 130.9, 130.4, 128.8, 
128.0, 118.0, 116.6, 107.7, 68.0, 57.0, 30.3, 19.4, 18.0 ppm. MS: ES+ ([M+Na]+). Accurate 
mass calculated: 365.1475. Found 365.1477. 
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(S)-2-((S)-3-Methyl-2-(2-naphthalen-1-yl)acetamido)butanamido)-3-phenyl 
propanoic acid (33): 
1H NMR (d6-DMSO): 8.21 (d, ArH, 1H, 3JHH = 9.1Hz), 8.11 (dd, ArH, 1H, 3JHH = 5.0Hz), 7.89 
(dd, ArH, 1H, 3JHH = 4.0Hz), 7.87 (t, NH, 1H, 3JHH = 4.5Hz),  7.79 (d, ArH, 1H, 3JHH = 3.4Hz), 
7.49 (d, ArH, 1H, 3JHH = 4.0Hz), 7.42 (s, ArH, 1H,), 7.20 (d, NH, 1H, 3JHH = 6.1Hz), 7.14 (d, 
ArH, 1H, 3JHH = 5.5Hz), 4.43(m, NHCH(CH2Ph), 1H, 3JHH = 8.1Hz), 1H), 4.07 (s, CH2C=O, 
2H), 4.22 (dd, NHCHCH(CH3)2, 1H,3JHH = 7.3, 4.3Hz), 2.89 (dd, NHCH2Ph, 2H, 3JHH = 9.6, 
7.3Hz), 1.97(m, (CH3)2CH, 1H), 0.84 (d, (CH3)2CH, 3H, 3JHH = 7.3Hz), 0.78 (d, (CH3)2CH, 
3H, 3JHH = 3.9Hz) ppm. 13C NMR (d6-DMSO): 173.8, 173.0, 156.6, 138.3, 133.3, 133.1, 
132.2, 129.4, 128.5, 128.3, 128.0, 127.9, 127.7, 127.6, 126.7, 126.4, 126.0, 70.1, 55.7, 
36.8, 30.2, 27.9, 19.5, 19.2, 19.1, 18.3 ppm. MS: ES+ ([M+Na]+). Accurate mass calculated: 
455.1947 Found 455.1952. 
2.2.2- Phenanthrol dipeptides: 
Phenanthrol dipeptide derivatives were synthesised previously using different 
methods, IBCF12, 13 or DCC5, 11 methods. We synthesised dipeptides conjugated to 
phenanthrol using IBCF method as shown in the Scheme 2.3. 
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Scheme ‎2.3: The general reaction of 9phenanthrene dipeptide synthesis based on 9-phenanthrol ring using 
IBCF method. 
 
 
Compound Substituent 
37, 38 R1 
a CH(CH3)2 
b CH2Ph 
Table ‎2.6: The R1 group of the general structure of compounds 37 and 38 (a, b) in the Scheme 3. 
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Compound Functional group 
39 R1 R2 
a CH(CH3)2 CH(CH3)2 
b CH2Ph  CH2Ph 
c CH(CH3)2 CH2Ph 
Table ‎2.7: The R1 and R2 groups of the general structure of compounds 39 (a, b, c) in the Scheme 3. 
 
Dipeptide R1 R2 Abreviation  
40 CH(CH3)2 CH(CH3)2 9Ph-VVOH  
41 CH2Ph CH2Ph 9Ph-FFOH  
42 CH(CH3)2 CH2Ph 9Ph-VFOH  
Table ‎2.8: The R1 and R2 groups of the general structure of compounds 40–42 and their abbreviations in the 
Scheme 3. 
 
Experimental section: 
The phenanthrol dipeptides were prepared by the general method to prepare 
dipeptides used by Chen et al14. To a stirred a solution of 9-phenanthrol (10.0 g) and 
K2CO3 (3 eq.) in acetone (200 mL), tert-butyl chloroacetate (1.1 eq.) was added and the 
solution was refluxed at 70οC overnight. Chloroform (200 mL) was added to the 
resulting suspension in a separating funnel and water (100 mL) water. The organic 
phase was washed with water (4 x 200 mL). Then, the solution was dried with 
magnesium sulphate and the solvent was removed in vacuo to give compound 35 as 
shown in Scheme 2.3. The yield was 50% and the impurity (tert-butyl choloracetate) 
was calculated by NMR spectroscopy to be around 17%. Then the resulting product was 
purified by washing with methanol and the yield was typically 30%. The resulting 
product was 93% pure. 
1H, 13C NMR and mass spectroscopy of the resulting products: 
Tert-Butyl-2-(phenanthren-9-yloxy)acetate (35): 
1H NMR (CDCl3): 8.57 (d, ArH, 1H, 3JHH = 8.3Hz), 8.51(d, ArH, 1H, 3JHH = 8.8Hz), 8.41 (d, 
ArH, 1H, 3JHH = 8.3Hz), 7.61 (m, ArH, 3H), 7.45 (m, ArH, 2H), 6.80 (s, ArH, 1H,), 4.71 (s, 
OCH2C=O, 2H), 1.45 (s, C(CH3)3, 9H) ppm. 13C NMR (CDCl3): 168.2, 152.3, 134.5, 132.9, 
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131.8, 127.8, 127.7, 127.6, 127.3, 127.2, 126.9, 126.8, 125.0, 123.3, 122.9, 122.8, 103.6, 
82.9, 66.3, 30.1, 28.5 ppm. MS: ES+: [M+Na]+. Accurate mass calculated: 331.1325 Found 
331.1334. 
Removal of the tert-butyl protection group:  
The tert-butyl 9-phenanthrol acetate derivative was dissolved in chloroform (30 mL), 
and trifluoroacetic acid (10 mL) was added, and the solution was stirred for overnight. 
Hexane was added to the solution, and then the resulting precipitate was collected by 
filtering. The resulting precipitate was collected by filtration and washed with water to 
give compound 36 as shown in Scheme 2.3. The resulting product was pure and used 
directly in the next step of the reaction. The yield was 68%. 
2-(Phenanthren-9-yloxy)acetic acid (36): 
1H NMR (d6-DMSO): 8.82 (d, ArH, 1H, 3JHH = 7.8Hz), 8.72(d, ArH, 1H, 3JHH = 7.9Hz), 8.35 
(d, ArH, 1H, 3JHH = 9.1Hz), 7.86 (d, ArH, 1H, 3JHH = 9.0), 7.72 (m, ArH, 2H,), 7.55 (m, ArH, 
2H), 7.19 (s, ArH, 1H,), 4.99 (s, OCH2C=O, 2H), 13.7 (s, OH) ppm. 13C NMR (d6-DMSO): 
170.4, 155.9, 134.4, 129.7, 129.0, 127.9, 127.1, 126.8, 124.2, 118.8, 107.4, 64.9 ppm. MS 
([M+Na]+). Accurate mass calculated: MS: CI: Low resolution [NH4+] found 270.2. 
Standard coupling methodology:                                           
N-Methylmorpholine (2 eq.) and IBCF (1.1 eq.) was added to compound 36 (5.0 g) in 
(70 mL) chloroform at 0 oC. A solution of L-valine methyl ester or L-phenylalanine ethyl 
ester (1.5 eq.) and NMM (2 eq.) in chloroform was added and the solution was stirred at 
room temperature overnight. Then, the solution was washed with distilled water (100 
mL), hydrochloric acid (2 x 100 mL, 0.1 M), aqueous potassium carbonate (100 mL, 0.1 
M), and distilled water again (4 x 100 mL) and dried with magnesium sulfate. The 
solvent was removed in vacuo to give compounds 37 (a – b) as shown in Scheme 2.3 
and Table 2.6. The yield was between 59 – 69% and the resulting product for all 
derivatives was pure and used directly in the next step of the reaction. 
(S)-Methyl-3-methyl-2-(2-(phenanthren-9-yloxy)acetamido)butanoate (37a): 
1H NMR (CDCl3): 8.69 (d, ArH, 1H, 3JHH = 8.3Hz), 8.60 (d, ArH, 1H, 3JHH = 6.1Hz), 8.36 (d, 
ArH, 1H, 3JHH = 7.2Hz), 7.73 (m, ArH, 3H), 7.55 (m, ArH, 2H,), 7.19 (d, NH, 1H,  3JHH = 
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8.9Hz), 6.99 (s, ArH, 1H), 4.83(d, OCH2C=O, 2H, 3JHH = 3.1Hz),  4.70 (dd, NHCHCH(CH3)2, 
1H, 3JHH = 4.8, 4.1Hz), 3.74 (s, OCH3, 3H), 2.24 (m, (CH3)2CH, 1H), 0.96 (d,(CH3)2CH, 3H, 
3JHH = 6.9Hz) , 0.89 (d,(CH3)2CH, 3H, 3JHH = 6.9Hz) ppm. 13C NMR (CDCl3): 198.3, 170.1, 
166.2, 149.1, 130.3, 129.6, 125.8, 125.7, 125.3, 125.1, 124.9, 123.9, 123.2, 120.9, 120.7, 
120.0, 102.4, 65.7, 54.9, 50.4, 29.5, 17.1, 15.8 ppm. MS: ES+: [M+Na]+. Accurate mass 
calculated: 388.1516 Found 388.1525. 
(S)- Ethyl-2-(2-(phenanthren-9-yloxy)acetamido)-3-phenylpropanoate (37b): 
 1H NMR (CDCl3): 8.67 (d, NH, 1H, 3JHH = 8.8Hz), 8.52 (m, ArH, 1H), 8.12 (d, ArH, 1H, 3JHH 
= 7.8Hz), 7.73 (m, ArH, 2H), 7.57 (m, ArH, 3H), 7.11 (m, ArH, 4H), 7.03 (d, ArH, 2H,  3JHH = 
7.0Hz), 6.93 (s, ArH, 1H), 5.01 (m, NHCH(CH2Ph)C=O, 1H),  4.78 (d, OCH2C=O, 2H, 3JHH = 
3.2Hz ), 4.19 (dq, OCH2CH3, 2H, 3JHH = 5.2, 4.4, 2.4Hz), 3.16 (dd, NHCH(CH2Ph)C=O, 2H, 
3JHH = 2.7, 3.3Hz), 1.23 (t, OCH2CH3, 3H, 3JHH = 7.2Hz) ppm.13C NMR (CDCl3): 171.3, 169.5, 
168.2, 151.3, 135.8, 132.6, 131.9, 129.6, 129.0, 128.1, 127.9, 127.6, 127.4, 127.1, 126.2, 
125.5, 123.2, 122.9, 122.4, 117.7, 104.3, 67.7, 62.1, 52.9, 38.3, 14.5 ppm. MS: ES+: 
[M+Na]+. Accurate mass calculated: 450.1664 Found 450.1681. 
Deprotection of the C-terminus: 
A solution of THF: water (30 mL: 5 mL) was added to compound 37a or b. Lithium 
hydroxide (0.5 g) was added and the solution was stirred overnight. After this time, 
distilled water (100 mL) was added, and then hydrochloric acid (1.0 M) was added 
drop-wise until the pH was lowered to pH 3. Then, the resulting precipitate was 
collected by filtration and washed with water to give compounds 38 (a – b) as shown in 
Scheme 2.3 and Table 2.6. The yield was between 85 – 90% and the resulting product 
for all derivatives was pure and used directly in the next step of the reaction. 
(S)-Methyl-3-methyl-2-(2-(phenanthren-9-yloxy)acetamido)butanoic acid (38a): 
1H NMR (d6-DMSO): 8.82 (d, ArH, 1H, 3JHH = 13.8Hz), 8.73 (d, NH, 1H, 3JHH = 7.9Hz), 8.36 
(t, ArH, 2H, 3JHH = 10.9Hz), 7.76 (m, ArH, 3H), 7.57 (m, ArH, 2H), 7.17 (s, ArH, 1H), 4.94 
(d, OCH2C=O, 2H, 3JHH = 6.0Hz), 4.31 (dd, NHCHCH(CH3)2, 1H, 3JHH = 5.5, 3.0Hz), 2.17 (m, 
(CH3)2CH, 1H), 0.93 (d,(CH3)2CH, 6H, 3JHH = 8.3Hz) ppm. 13C NMR (d6-DMSO): 172.8, 
167.7, 151.2, 132.2, 130.7, 127.5, 127.3, 127.2, 126.7, 125.9, 125.6, 124.7, 122.9, 122.7, 
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122.2, 103.5, 66.8, 56.8, 29.9, 19.2, 17.9 ppm. MS: ES–: [M – H]–. Accurate mass 
calculated: 350.1393 Found 350.1392. 
 (S)-2-(2-(Phenanthren-9-yloxy)acetamido)-3-phenylpropanoic acid (38b):  
1H NMR (d6-DMSO): 8.83 (d, ArH, 1H, 3JHH = 7.3Hz), 8.74 (d, NH, 1H, 3JHH = 7.3Hz), 8.39 
(d, ArH, 1H, 3JHH = 8.3Hz), 8.33 (dd, ArH, 1H, 3JHH = 8.3, 1.3Hz ), 7.76 (m, ArH, 3H), 7.57 
(m, ArH, 2H), 7.24 (m, ArH, 6H), 4.82 (d, OCH2C=O, 1H, 3JHH = 13.6Hz), 4.75 (d, OCH2C=O, 
1H, 3JHH = 13.6Hz), 4.60 (m, NHCH(CH2Ph)C=O, 1H), 3.18 (dd, NHCH(CH2Ph)C=O, 1H, 
3JHH = 8.5, 4.7Hz), 3.07 (dd, NHCH(CH2Ph)C=O, 1H, 3JHH = 9.5, 5.2Hz) ppm. 13C NMR (d6-
DMSO): 173.1, 167.9, 151.4, 137.8, 132.6, 131.1, 129.5, 128.6, 127.9, 127.8, 127.5, 126.9, 
126.8, 126.4, 125.9, 125.1, 123.3, 123.1, 122.8, 104.1, 67.4, 53.5, 36.7 ppm. MS: ES–: [M – 
H]–. Accurate mass calculated: 398.1401 Found 398.1392. 
Standard coupling methodology: 
N-Methylmorpholine (1.5 eq.) and IBCF (1.1 eq.) were added to compound 38a or 38b 
(1.0g) in chloroform (70 mL) at 0oC. A solution of L–phenylalanine ethyl ester 
hydrochloride or L–valine ethyl ester hydrochloride (1 eq.) and NMM (1.5 eq.) in 
chloroform was added and the solution was stirred at room temperature overnight. 
Then, the solution was washed with distilled water (100 mL), hydrochloric acid (2 x 100 
mL, 0.1 M), aqueous potassium carbonate (100 mL, 0.1 M), and distilled water again (4 x 
100 mL) and dried with magnesium sulphate, and the solvent was removed in vacuo to 
give compounds 39 (a – b) as shown in Scheme 2.3 and Table 2.7. The yield was 
between 38 – 50%. The resulting product for all derivatives was pure and used directly 
in the next step of the reaction, except compound 39c. This contained an impurity (an 
excess of valine methyl ester) that was calculated by NMR spectroscopy to be 3%, and 
was purified by washing with methanol to give a yield of typically 30% and purity of 
99%. 
(S)-Methyl-3-methyl-2-((S)-3-methyl-2-(2-(phenanthren-9-yloxy)acetamido) 
butanamido) butanoate (39a): 
1H NMR (CDCl3): 8.68 (d, NH, 1H, 3JHH = 8.5Hz), 8.59 (t, ArH, 1H, 3JHH = 6.3Hz), 8.34 (d, 
ArH, 1H, 3JHH = 8.1Hz), 7.72 (m, ArH, 3H), 7.55 (m, ArH, 2H,), 7.30 (d, ArH, 1H,  3JHH = 
9.5Hz), 7.00 (s, ArH, 1H), 6.39 (d, NH, 1H, 3JHH = 8.1Hz), 4.84 (s, OCH2C=O, 2H, 3JHH = 
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3.1Hz), 4.54 (dd, NHCHCH(CH3)2, 1H, 3JHH = 5.2, 3.9Hz), 4.46 (dd, NHCHCH(CH3)2, 1H, 
3JHH = 6.7, 2.4Hz), 3.74 (s, OCH3, 3H), 2.18 (m, 2x(CH3)2CH, 2H), 0.98 (d,(CH3)2CH, 3H, 
3JHH = 7.1Hz), 0.93 (d,(CH3)2CH, 3H, 3JHH = 3.4Hz), 0.91 (d,(CH3)2CH, 3H, 3JHH = 3.7Hz), 
0.88 (d,(CH3)2CH, 3H, 3JHH = 6.7Hz) ppm. 13C NMR (CDCl3): 172.5, 170.9, 168.7, 151.4, 
132.6, 131.9, 128.1, 127.9, 127.5, 127.4, 127.3, 126.2, 125.5, 123.2, 122.9, 104.5, 67.9, 
58.6, 57.6, 52.6, 31.6, 31.5, 19.6, 19.3, 18.4, 18.1 ppm. MS: ES+: [M+Na]+. Accurate mass 
calculated: 487.2212 Found 487.2209. 
(S)-Ethyl-2-((S)-2-(2-(phenanthren-9-yloxy)acetamido)-3-phenylpropanaimdo)-3-
phenylpropanoate(39b):  
1H NMR (CDCl3): 8.69 (d, NH, 1H, 3JHH = 7.8Hz), 8.60 (m, ArH, 1H), 8.16 (d, ArH, 1H, 3JHH = 
8.8Hz), 7.71 (m, ArH, 3H), 7.55 (m, ArH, 2H), 7.26 (s, ArH, 1H), 7.12 (m, ArH, 8H), 6.97 
(d, ArH, 2H, 3JHH = 7.1Hz ), 6.88 (s, ArH, 1H), 6.40 (d, NH, 1H, 3JHH = 8.3Hz), 4.79 (m, 
NHCH(CH2Ph)C=O, 2H),  4.70 (s, OCH2C=O, 2H), 4.16 (dq, OCH2CH3, 2H, 3JHH = 2.3, 4.3, 
4.8Hz), 3.05 (m, NHCH(CH2Ph)C=O, 4H), 1.23 (t, OCH2CH3, 3H, 3JHH = 7.1Hz) ppm. 13C 
NMR (CDCl3): 170.9, 169.9, 168.3, 150.9, 135.8, 135.6, 132.2, 131.5, 129.5, 129.3, 129.3, 
129.2, 128.7, 128.6, 128.5, 127.8, 127.6, 127.2, 127.1, 127.0, 126.8, 125.7, 125.1, 122.8, 
122.5, 122.1, 103.8, 67.3, 61.6, 53.7, 53.3, 53.2, 37.9, 37.7, 14.1 ppm. MS: ES+: [M+Na]+. 
Accurate mass calculated: 597.2383Found 597.2365. 
(S)-Ethyl-2-((S)-3-methyl-2-(2-(phenanthren-9-yloxy)acetamido)butanamido)-3-
phenyl propanoate(39c): 
 1H NMR (CDCl3): 8.69 (d, NH, 1H, 3JHH = 8.9Hz), 8.60 (t, ArH, 1H, 3JHH = 5.3Hz), 8.35 (dd, 
ArH, 1H, 3JHH = 5.6, 3.4Hz), 7.74 (m, ArH, 3H), 7.55 (m, ArH, 2H), 7.19 (m, ArH, 5H), 7.07 
(d, ArH, 2H, 3JHH = 7.9Hz), 6.98 (s, ArH, 1H), 6.41 (d, NH, 1H, 3JHH = 7.8Hz), 4.88 (m, 
NHCH(CH2Ph)C=O, 1H), 4.81 (d, OCH2C=O, 1H, 3JHH = 13.6Hz), 4.73 (d, OCH2C=O, 1H, 3JHH 
= 13.6Hz), 4.43 (dd, NHCHCH(CH3)2, 1H, 3JHH = 5.8, 2.6Hz ), 4.18 (q, OCH2CH3, 2H, 3JHH = 
7.3Hz), 3.12 (dd, NHCH(CH2Ph)C=O, 1H, 3JHH = 8.6, 5.0Hz), 3.01 (dd, NHCH(CH2Ph)C=O, 
1H, 3JHH = 8.6, 5.0Hz), 2.14 (m, (CH3)2CH, 1H), 1.25 (t, OCH2CH3, 3H, 3JHH = 7.3Hz), 0.94 
(d,(CH3)2CH, 3H, 3JHH = 7.5Hz), 0.84 (d, (CH3)2CH, 3H, 3JHH = 6.5Hz) ppm. 13C NMR 
(CDCl3): 171.2, 170.2, 168.2, 150.9, 135.6, 129.3, 128.6, 127.7, 127.6, 127.2, 126.9, 125.1, 
122.8, 122.6, 122.0, 104.0, 67.4, 61.7, 57.8, 53.1, 37.8, 31.1, 19.2, 17.8, 14.2 ppm. MS: 
ES+: [M+Na]+. Accurate mass calculated: 549.2363 Found 549.2365. 
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Deprotection of the C-terminus: 
A solution of THF: water (30 mL: 5 mL) was added to compound 39 (a, b or c). Lithium 
hydroxide (0.3 g) was added and the solution was stirred overnight. After this time, 
distilled water (100 mL) was added, and then hydrochloric acid (1.0 M) was added 
drop-wise until the pH was lowered to pH 3. Then, the resulting precipitate was 
collected by filtration and washed with water to give compounds (40 – 42) as shown in 
Scheme 2.3 and Table 2.8. The yield was between 71 – 75% and the impurity (and 
excess of methyl or ethyl ester) was calculated by NMR spectroscopy to be between 17 – 
20% for all derivatives except compound 40, which was pure. Then, the resulting 
product was purified by washing with methanol. The yield after purification was 
typically between 55 – 60% and the resulting products were between 89 - 95% pure. 
(S)-2-((S)-2-(2-(Phenanthren-9-yloxy)acetamido)-3-phenylpropanaimdo)-3-phenyl 
propanoic acid (40): 
1H NMR (d6- DMSO): 8.82 (d, ArH, 1H, 3JHH = 8.0Hz), 8.72 (d, ArH, 1H, 3JHH = 8.2Hz), 8.50 
(d, NH, 1H, 3JHH = 8.1Hz), 8.25 (d, ArH, 1H, 3JHH = 8.3Hz), 8.15 (d, NH, 1H, 3JHH = 8.3Hz), 
7.74 (m, ArH, 3H), 7.56 (m, ArH, 2H), 7.21 (m, ArH, 10H), 7.10 (s, ArH, 1H), 4.72 (m, 
NHCH(CH2Ph)C=O,OCH2=O, 3H), 4.51 (dd, NHCH(CH2Ph)C=O, 1H, , 3JHH = 8.2, 5.4Hz ), 
3.19 (m, NHCH(CH2Ph)C=O, 2H), 2.93 (m, NHCH(CH2Ph)C=O, 2H) ppm. 13C NMR (d6- 
DMSO): 172.7, 170.8, 167.0, 150.9, 137.4, 137.3, 132.2, 130.7, 129.3, 129.1, 128.2, 127.9, 
127.5, 127.4, 127.1, 126.6, 126.4, 126.3, 126.0, 125.5, 124.7, 122.9, 122.7, 122.3, 103.6, 
66.9, 53.5, 53.2, 37.4, 36.7 ppm. MS: ES–: [M – H]–. Accurate mass was not measured 
because the product could not be dissolved in any solvent suitable for mass 
spectroscopy.  
(S)-3-Methyl-2-((S)-3-methyl-2-(2-(phenanthren-9-yloxy)acetamido)butanamido) 
butanoic acid(41): 
 1H NMR (d6- DMSO): 8.84 (d, NH, 1H, 3JHH = 8.6Hz), 8.72 (d, NH, 1H, 3JHH = 8.0Hz), 8.34 
(d, ArH, 1H, 3JHH = 6.6Hz), 8.18 (d, ArH, 1H, 3JHH = 8.1Hz ), ), 8.10 (d, ArH, 1H, 3JHH = 9.0Hz 
), 7.76 (m, ArH, 3H), 7.56 (m, ArH, 2H) 7.17 (s, ArH, 1H), 4.84 (d, OCH2C=O, 2H, 3JHH = 
4.7Hz),  4.49 (dd, NHCHCH(CH3)2, 1H, 3JHH = 6.2, 3.3Hz), 4.15 (dd, NHCHCH(CH3)2, 1H, 
3JHH = 5.6, 2.6Hz), 2.06 (m, 2x(CH3)2CH, 2H), 0.87 (d, (CH3)2CH, 12H) ppm. 13C NMR (d6- 
DMSO): 172.7, 170.9, 167.1, 151.1, 132.2, 130.8, 127.5, 127.3, 127.1, 126.7, 125.9, 125.6, 
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124.7, 122.9, 122.7, 122.0, 103.6, 66.9, 57.3, 56.7, 31.1, 29.6, 25.1, 19.2, 19.0, 18.0, 17.8 
ppm. MS: ES–: [M – H]–. Accurate mass calculated: 449.2076 Found 449.2076. 
(S)-2-((S)-3-Methyl-2-(2-(phenanthren-9-yloxy)acetamido)butanamido)-3-
phenylpropanoic acid(42): 
 1H NMR (d6-DMSO): 8.82 (d, ArH, 1H, 3JHH = 8.6Hz), 8.72 (d, NH, 1H, 3JHH = 8.0Hz), 8.43 
(d, ArH, 1H, 3JHH = 7.8Hz), 8.33 (d, ArH, 1H, 3JHH = 8.1Hz), 8.02 (d, NH, 1H, 3JHH = 9.1Hz), 
7.76 (m, ArH, 3H), 7.56 (m, ArH, 2H), 7.24 (m, ArH, 6H), 4.93(d, OCH2=O, 2H, 3JHH = 9.7Hz 
), 4.50 (m, NHCH(CH2Ph)C=O, 1H), 4.38 (dd, NHCHCH(CH3)2, 1H, 3JHH = 6.4, 4.3Hz), 3.06 
(dd, NHCH(CH2Ph)C=O, 2H, 3JHH = 7.7, 5.1Hz), 2.92 (dd, NHCH(CH2Ph)C=O, 2H, 3JHH = 8.5, 
6.4Hz), 2.06 (m, (CH3)2CH, 1H), 0.86 (d, (CH3)2CH, 3H, 3JHH = 6.9Hz), 0.81 (d, (CH3)2CH, 
3H, 3JHH = 7.4Hz) ppm. 13C NMR (d6-DMSO): 171.7, 170.6, 167.1, 151.0, 137.5, 132.2, 
129.0, 128.1, 127.5, 127.3, 127.2, 126.3, 125.9, 124.7, 122.9, 103.6, 66.9, 53.5, 36.5, 30.9, 
19.2, 17.6 ppm. MS: ES–: [M – H]–. Accurate mass calculated: 521.2058 Found 521.2052. 
2.2.3- Anthraquinone dipeptide: 
Peptides conjugated to anthraquinone were prepared elsewhere23. Here, we have 
attempted to synthesise similar peptides using the IBCF method as shown in the 
Scheme 2.4 in order to study the hydrogelation properties and compare with other 
aromatic groups in Chapter 3. 
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Scheme ‎2.4: The general reaction of 2-anthraquinone dipeptide synthesis based on 2-anthraquinone ring 
using IBCF method. 
 
 
 
Dipeptide      Abreviation  
47 2AQ-FFOH  
Table ‎2.9: The abbreviation of compounds 47 in the Scheme 4. 
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Experimental section: 
Standard coupling methodology: 
N-Methylmorpholine (4 mL) and IBCF (3 mL) was added to anthraquinone acetic acid 
(5.0 g) in chloroform (70mL) at 0oC. A solution of phenylalanine ethyl ester 
hydrochloride (4.0 g, 1.5 eq.) and NMM (4 mL) in chloroform was added and the 
solution was stirred at room temperature overnight. After this time, the solution was 
washed with distilled water (100 mL), hydrochloric acid (2 x 100 mL, 0.1 M), aqueous 
potassium carbonate (100 mL, 0.1 M), and distilled water again (4 x 100 mL) and dried 
with magnesium sulfate. Then, the solvent was removed in vacuo to give compound 44 
as shown in Scheme 2.4. The yield was 40% and the impurity (an excess of phenyl 
alanine ethyl ester and IBCF) was calculated by NMR spectroscopy to be 28%. The 
resulting product was purified by washing with methanol. The yield after purification 
was typically 25% and the purity was 81%. 
(2S)-2-(9,10-dioxo-4a,9,9a,10-tetrahydroanthracene-2-carboxamido)-3-phenyl 
propanoate (44): 
1H NMR (CDCl3): 8.58 (d, ArH, 1H, , 3JHH = 2.0Hz), 8.36 (m, ArH, 3H), 8.21 (dd, ArH, 1H, 
3JHH = 6.2, 2.0Hz), 7.85 (dd, ArH, 2H, 3JHH = 2.5, 3.0Hz), 7.31 (m, ArH, 3H), 7.20 (d, ArH, 
2H, 3JHH = 6.7Hz), 6.85 (d, NH, 1H, 3JHH = 7.8Hz), 5.12 (dd, NHCH(CH2Ph)C=O, 1H, 3JHH = 
7.6, 5.6Hz), 4.27 (q, OCH2CH3, 2H, 3JHH = 7.1, 7.1Hz), 3.33 (dd, NHCH(CH2Ph)C=O, 2H, 3JHH 
= 7.8, 6.0Hz), 1.32 (t, OCH2CH3, 3H, 3JHH = 7.2Hz) ppm. 13C NMR (CDCl3): 182.4, 182.3, 
171.3, 165.1, 138.9, 135.7, 135.3, 134.5, 133.6, 133.4, 133.3, 132.8, 129.4, 128.7, 128.5, 
1227.9, 127.4, 127.3, 125.4, 61.9, 61.4, 53.9, 37.9 18.9, 14.2, 14.1 ppm. MS: (ES+): 
[M+Na]+. Accurate mass calculated: 450.1329 Found: 450.1317. 
Deprotection of the C-terminus: 
A solution of THF: water (30 mL: 5 mL) was added to anthraquinone derivative. Lithium 
hydroxide (0.3 g) was added. The solution was stirred overnight. After this time, 
distilled water (100 mL) was added, and then hydrochloric acid (1.0 M) was added 
drop-wise until the pH was lowered to pH 3. The resulting precipitate was collected by 
filtration and washed with water. The resulting precipitate was collected by filtration 
and washed with water to give compound 45 as shown in Scheme 2.4. The yield was 75 
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%. The impurity (an excess of phenylalanine ethyl ester) was calculated by 1HNMR 
spectroscopy to be 12%. The resulting product was purified by washing with methanol. 
The yield after purification was typically 50% and the purity was 90%. 
(2S)-2-(9,10-Dioxo-4a,9,9a,10-tetrahydroanthracene-2-carboxamido)-3-
phenylpropanoic acid (45): 
1H NMR (d6-DMSO): 9.30 (d, NH, 1H, 3JHH = 7.8Hz), 8.62 (s, ArH, 1H), 8.25 (m, ArH, 4H), 
7.96 (m, ArH, 2H), 7.34 (d, ArH, 2H, 3JHH = 7.3Hz ), 7.28 (t, ArH, 2H, 3JHH = 7.3Hz), 7.19 (t, 
ArH, 1H, 3JHH = 6.3Hz), 4.70 (m, NHCH(CH2Ph)C=O, 1H), 3.25 (dd, NHCH(CH2Ph)C=O, 2H, 
3JHH = 8.8, 6.3Hz), 1.32 (t, OCH2CH3, 3H, 3JHH = 7.2Hz) ppm. 13C NMR (d6-DMSO): 182.5, 
173.3, 165.3, 139.1, 138.4, 135.1, 135.0, 133.5, 133.4, 133.3, 129.4, 128.6, 128.5, 127.5, 
127.2, 127.1, 126.8, 126.0, 67.4, 54.7, 36.5 25.5, 19.2 ppm. MS: ES–: [M – H]–. Accurate 
mass calculated: 398.1043 Found: 398.1028.  
Standard coupling methodology: 
N-Methylmorpholine (4 mL) and IBCF (3 mL) was added to anthraquinone 
phenylalanine derivative (3.0 g) in chloroform (70 mL) at 0 oC. A solution of 
phenylalanine ethyl ester hydrochloride (4.0 g, 1.5 eq.) and NMM (4 mL) in chloroform 
was added and the solution was stirred at room temperature overnight. After this time, 
the solution was washed with distilled water (100 mL), hydrochloric acid (2 x 100 mL, 
0.1 M), aqueous potassium carbonate (100 mL, 0.1 M), and distilled water again (4 x 
100 mL) and dried with magnesium sulfate. Then, the solvent was removed in vacuo to 
give compound 46 as shown in Scheme 2.4. The yield was 35% and the impurity of IBCF 
was calculated by 1H NMR spectroscopy to be 13%. The resulting product was purified 
by washing with methanol. The yield after purification was typically 20% and the purity 
was 92%. 
2S-2-((2S)-2-(9,10-Dioxo-4a,9,9a,10-tetrahydroanthracene-2-carboxamido)-3-
phenyl propanamido)-3-phenylpropanoate (46): 
1H NMR (CDCl3): 8.56 (s, ArH, 1H), 8.34 (m, ArH, 3H), 8.16 (d, NH, 1H, 3JHH = 7.8Hz), 7.84 
(m, ArH, 2H), 7.28 (m, ArH, 10H), 7.01 (d, ArH, 2H, 3JHH = 8.3Hz), 6.18 (d, NH, 1H, 3JHH = 
7.8Hz), 4.81(m, NHCH(CH2Ph)C=O, 2H), 4.16 (m, OCH2CH3, 2H), 3.12 (m,2x 
NHCH(CH2Ph)C=O, 4H), 1.24 (t, OCH2CH3, 3H, 3JHH = 7.1Hz) ppm.13C NMR (CDCl3): 182.3, 
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165.2, 138.7, 135.5, 134.5, 133.4, 132.8, 129.4, 129.2, 128.9, 128.6, 128.5, 127.9, 127.5, 
127.4, 127.3, 127.2, 125.8, 61.7, 54.9, 53.6, 37.9, 14.1 ppm. MS: ES+: [M+Na] +. Accurate 
mass calculated: 597.1989 Found: 597.2002.  
Deprotection of the C-terminus: 
A solution of THF: water (30 mL: 5 mL) was added to compound 46. Lithium hydroxide 
(0.3 g) was added. The solution was stirred overnight. After this time, distilled water 
(100 mL) was added, and then hydrochloric acid (1.0 M) was added drop-wise until the 
pH was lowered to pH 3. The resulting precipitate was collected by filtration and 
washed with water. The resulting precipitate was collected by filtration and washed 
with water to give compound 47 as shown in the Scheme 2.4. The yield was 75%. The 
resulting product was purified by washing with methanol. The yield after purification 
was typically 50% and the purity was 92%. 
2S-2-((2S)-2-(9,10-Dioxo-4a,9,9a,10-tetrahydroanthracene-2-carboxamido)-3-
phenyl propanamido)-3-phenylpropanoic acid (47): 
1H NMR (d6-DMSO): 9.13 (d, NH, 1H, 3JHH = 8.9Hz), 8.59 (s, ArH, 1H), 8.46 (d, NH, 1H, 3JHH 
= 7.9Hz), 8.25 (m, ArH, 4H), 7.96 (m, ArH, 2H), 7.26 (m, ArH, 10H), 4.83 (m, 
NHCH(CH2Ph)C=O, 1H), 4.48 (m, NHCH(CH2Ph)C=O, 1H), 3.11 (m, NHCH(CH2Ph)C=O, 
2H), 2.99 (m, NHCH(CH2Ph)C=O, 2H) ppm. 13C NMR (d6-DMSO): 182.2, 172.7, 171.1, 
164.7, 138.9, 138.2, 137.4, 134.7, 133.1, 133.1, 133.0, 1332.9, 129.1, 128.2, 128.0, 126.9, 
126.8, 126.8, 126.4, 126.2, 125.8, 54.7, 53.6, 38.9, 36.8, 36.5, 27.5 ppm. MS: ES–: [M – H]–. 
Accurate mass calculated: 545.1723 Found: 545.1713. 
2.2.4- Carbazole dipeptides: 
Carbazole dipeptide derivatives were synthesised previously using different methods, 
IBCF12, 13 or DCC5, 11 methods. Previous research has described the synthesis of 
carbazole linked with cyclic and acyclic peptoids24. Also, a carbazole based organogel 
has been prepared previously25, but there is no literature reporting dipeptides 
conjugated to carbazole. Therefore we have synthesised dipeptides conjugated to 
carbazole using the method26 described in Scheme 2.5. 
 
77 | P a g e  
 
 
Scheme ‎2.5: The general reaction of dipeptide synthesis based on carbazole ring using IBCF method. 
 
Compound  Substituent  
50, 51 R1 
a CH3 
b CH2Ph 
c CH(CH3)2 
Table ‎2.10: The R1group of the general structure of compounds 50 and 51 (a, b, c, d) in the Scheme 5. 
 
Compound Functional group 
52 R1 R2 
a CH3 CH(CH3)2 
b CH2Ph  CH2Ph 
c CH(CH3)2 CH(CH3)2 
d CH(CH3)2 CH2Ph  
Table ‎2.11: The R1 and R2 group of the general structure of compound 52 (a ,b, c, d) in the Scheme 5. 
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Dipeptide R1 R2 Abreviation  
53 CH3 CH(CH3)2 Carb-AVOH  
54 CH2Ph CH2Ph Carb-FFOH  
55 CH(CH3)2 CH(CH3)2 Carb-VVOH  
56 CH(CH3)2 CH2Ph Carb-VFOH  
Table ‎2.12: The R1 and R2 group of the general structure of compounds 53–56 and their abbreviations in the 
Scheme 5. 
 
Experimental section: 
Carbazole acetic acid synthesis: 
Carbazole (8.35 g, 0.05 moles) was dissolved in dimethyl sulfoxide (30 mL) and ground 
NaOH (6.0 g, 0.15 moles) was added to the solution. The mixture was heated to 85°C for 
30 minutes to give a dark brown solution. Bromoacetic acid (8.34 g, 0.06 moles) was 
added to the solution in portions for 30 minutes. The resulting solution was stirred 
overnight, and then poured into 200 mL of cold distilled water. The precipitate was 
filtered under vacuum. HCl (1.0 M) was added drop-wise to the filtrate to reach pH 3 – 4. 
Then, the resulting precipitate was collected by filtration and washed with water to give 
compound 49 as shown in the Scheme 2.527. The yield was 75 % and the resulting 
product was pure and used directly in the next step of the reaction. 
Carbazole acetic acid (49): 
1H NMR (d6-DMSO): 8.16 (d, ArH, 2H3JHH = 7.7Hz), 7.56(d, ArH, 2H3JHH = 8.2Hz), 7.45 (t, 
ArH, 2H3JHH = 7.1Hz), 7.22 (t, ArH, 2H3JHH = 7.8Hz), 5.24 (s, NCH2C=O, 2H), 13.70 (s, OH) 
ppm.  13C NMR (d6-DMSO): 170.6, 140.8, 126.1, 122.6, 120.5, 119.5, 109.6, 44.3 ppm. MS 
(CI): [NH4]+ 243.24. 
Standard coupling methodology:                                           
N-Methylmorpholine (1.5 eq.) and IBCF (1 eq.) was added to carbazole acetic acid (4.0 g, 
0.017 mole) in chloroform (150 mL) at 0 oC. A solution of alanine methyl ester (1 eq.) 
and NMM (1.5 eq.) in chloroform was added and the solution was stirred at room 
temperature overnight. Then, the solution was washed with distilled water (2 x 100 
mL), hydrochloric acid (100 mL, 0.1 M), aqueous potassium carbonate (100 mL, 0.1 M), 
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and distilled water again (2 x 100 mL) and dried with magnesium sulfate, and the 
solvent was removed in vacuo to give compounds 50 (a – c) as shown in Scheme 2.5 and 
Table 2.10. The yield was between 51 – 67% and the impurity (an excess of valine 
methyl ester) was calculated by 1H NMR spectroscopy to be between 8 – 15% of all 
derivatives, except compound 50a, which was pure and used directly in the next step of 
the reaction. Then, the resulting product was purified by washing with methanol to give 
yield between 40 – 50% and the purity was typically between 93 – 97%. 
(R)-Methyl-2-(2-(9H-carbazol-9-yl)acetamido)propanoate (50a): 
1H NMR (CDCl3): 8.11 (d, ArH, 2H, 3JHH = 6.7Hz), 7.49 (t, ArH, 2H, 3JHH = 7.7Hz), 7.37 (d, 
ArH, 2H, 3JHH = 9.2Hz), 7.31 (t, ArH, 2H, 3JHH = 8.7Hz), 7.25(s, CDCl3), 6.08 (d, NH, 1H, 3JHH 
= 7.5Hz), 4.92 (s, NCH2C=O, 2H), 4.59 (m, NHCH(CH3)C=O, 1H), 3.60 (s, OCH3, 3H), 1.21  
(d, NHCH(CH3)C=O, 3H, 3JHH = 7.2Hz) ppm. 13C NMR (CDCl3): 172.4, 167.9, 140.5, 126.3, 
123.6, 120.2, 118.8, 108.7, 52.4, 47.9, 47.2, 17.9 ppm. MS: ES+: ([M+Na]+). Accurate mass 
calculated: 333.1215 Found: 333.1222. 
(R)-Ethyl-2-(2-(2-(9H-carbazole-9-yl)acetamido)-3-phenylpropanoate (50b): 
1H NMR (CDCl3): 8.11 (d, ArH, 2H, , 3JHH = 7.7Hz), 7.46 (t, ArH, 2H, , 3JHH = 7.8Hz), 7.31 (d, 
ArH, 2H, , 3JHH = 6.9Hz), 7.26 (d, ArH, 3H, 3JHH = 8.1Hz), 7.06 (t, ArH, 1H, 3JHH = 7.7Hz), 
6.94 (t, ArH, 2H, 3JHH = 7.2Hz), 6.62 (d, ArH, 2H, 3JHH = 8.7Hz),  5.87 (d, NH, 1H, 3JHH = 
5.6Hz), 4.89 (s, NCH2C=O, 2H), 4.80 (d, NHCH(CH2Ph)C=O, 1H, 3JHH = 6.5Hz), 4.01 (q, 
OCH2CH3, 2H, 3JHH = 7.1Hz), 2.94 (dd, NHCH(CH2Ph)C=O, 1H, 3JHH = 8.2, 5.1Hz), 2.82 (dd, 
NHCH(CH2Ph)C=O, 1H, 3JHH = 7.2, 6.1Hz), 1.07 (t, OCH2CH3, 3H, 3JHH = 7.1Hz) ppm. 13C 
NMR (CDCl3): 170.8, 168.1, 140.5, 135.38, 129.2, 128.8, 127.3, 126.8, 123.8, 120.9, 
120.7, 108.9, 61.8, 53.1, 47.3, 37.8, 14.3 ppm. MS: ES+: ([M+Na]+). Accurate mass 
calculated: 423.1685 Found: 423.1700. 
(R)-Methyl-2-(2-(9H-carbazol-9-yl)acetamido)-3-methylbutanoate (50c): 
1H NMR (CDCl3): 8.13 (d, ArH, 2H, 3JHH = 7.8Hz), 7.51 (t, ArH, 2H, 3JHH = 8.1Hz), 7.39 (d, 
ArH, 2H, 3JHH = 8.5Hz), 7.32 (t, ArH, 2H, 3JHH = 8.1Hz), 7.26 (s, NH, 1H), 4.97 (d, NCH2C=O, 
2H, 3JHH = 2.8Hz), 4.49 (dd, NHCH(CH3)2C=O, 1H, 3JHH = 5.6, 4.0Hz), 3.55 (s, OCH3, 3H), 
1.96 (m, CH(CH3)2, 1H), 0.72 (d, CH(CH3)2, 3H, 3JHH = 7.1Hz).  0.46 (d, CH(CH3)2, 3H, 3JHH = 
7.3Hz) ppm. 13C NMR (CDCl3): 171.8, 169.5, 168.5, 140.7, 126.9, 123.9, 121.1, 109.2, 
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57.3, 52.5, 47.5, 31.1, 19.4, 19.3, 17.6 ppm. MS: ES+: ([M+Na]+). Accurate mass 
calculated: 361.1542 Found: 361.1528. 
Deprotection of the C-terminus: 
A solution of THF: water (30 mL: 5 mL) was added to compound 50 (a, b or c). Lithium 
hydroxide (0.3 g) was added and the solution was stirred overnight. After this time, 
distilled water (100 mL) was added, and then hydrochloric acid (1.0 M) was added 
drop-wise until the pH was lowered to pH 3. The resulting precipitate was collected by 
filtration and washed with water to give compounds 51 (a – c) as shown in Scheme 2.5 
and Table 2.10. The yield was between 84 – 87% and the resulting products for all 
derivatives were pure and used directly in the next step of the reaction. 
(R)-2-(2-(9H-Carbazol-9-yl)acetamido)propanoic acid (51a): 
1H NMR (d6-DMSO): 8.74 (d, NH, 1H, 3JHH = 7.4Hz), 8.15 (d, ArH, 2H, 3JHH = 7.5Hz), 7.54 
(d, ArH, 2H, 3JHH = 8.2Hz), 7.42 (t, ArH, 2H, 3JHH = 8.2Hz), 7.21(t, ArH, 2H, 3JHH = 7.8Hz), 
5.08(d, NCH2C=O, 2H, 3JHH = 16.8Hz), 4.26 (m, NHCH(CH3)C=O, 1H), 1.30 (d, 
NHCH(CH3)C=O, 3H, 3JHH = 7.2Hz) ppm. 13C NMR (d6-DMSO): 173.9, 167.3, 140.5, 125.6, 
122.2, 120.1, 118.9, 109.4, 47.6, 45.2, 17.3 ppm. MS: ES–: [M – H]–. Accurate mass 
calculated: 319.1059 Found: 319.1063.  
(R)-Ethyl-2-(2-(2-(9H-Carbazole-9-yl)acetamido)-3-phenylpropanoate (51b): 
 1H NMR (d6-DMSO): 8.71 (d, ArH, 1H, 3JHH = 11.8Hz), 8.12 (d, ArH, 2H, 3JHH = 7.7Hz), 7.37 
(d, ArH, 4H, 3JHH = 3.67Hz), 7.28 (m, ArH, 5H), 7.18 (m, ArH, 2H), 5.01(q, NCH2C=O, 2H, 
3JHH = 17.0Hz), 4.49(m, NHCH(CH2Ph)C=O, 1H), 3.11 (dd, NHCH(CH2Ph)C=O, 1H, 3JHH = 
9.2, 5.2Hz), 2.91 (dd, NHCH(CH2Ph)C=O, 1H, 3JHH = 8.2, 4.0Hz) ppm. 13C NMR (d6-DMSO): 
172.7, 167.4, 140.5, 137.4, 129.2, 128.2, 126.5, 125.6, 122.1, 120.0, 118.9, 109.3, 53.5, 
45.2, 36.8 ppm. MS: ES–: [M – H]–. Accurate mass calculated: 371.1396 Found: 371.1398.  
(R)-2-(2-(9H-Carbazol-9-yl)acetamido)-3-methylbutanoic acid (51c): 
1H NMR (d6-DMSO): 8.60 (d, NH, 1H, 3JHH = 8.8Hz), 8.15 (d, ArH, 2H, 3JHH = 7.8Hz), 7.56 
(d, ArH, 2H, 3JHH = 8.8Hz), 7.43 (t, ArH, 2H, 3JHH = 7.1Hz), 7.21 (t, ArH, 2H, 3JHH = 7.8Hz), 
5.17 (q, NCH2C=O, 2H, 3JHH = 16.6, 13.7Hz), 4.20 (dd, NHCH(CH3)2C=O, 1H, 3JHH = 5.6, 
3.7Hz), 2.11 (m, CH(CH3)2, 1H), 0.92 (d, CH(CH3)2, 3H, 3JHH = 7.0Hz), 0.90 (d, (CH3)2CH, 
81 | P a g e  
 
3H, 3JHH = 7.3Hz) ppm. 13C NMR (d6-DMSO): 172.8, 167.7, 168.5, 140.5, 125.6, 122.1, 
120.1, 118.9, 109.3, 57.1, 45.1, 29.9, 19.1, 17.9 ppm. MS: ES–: [M – H]–.  Accurate mass 
calculated: 323.1406 Found: 323.1396.  
Standard coupling methodology: 
N-Methylmorpholine (1.5 eq.) and IBCF (1 eq.) were added to compound 51 (a, b, or c) 
(1.0 g) in chloroform (100 mL) at 0 oC. A solution of L-valine methyl ester 
hydrochloride, L–phenylalanine ethyl ester hydrochloride or L–alanine methyl ester 
hydrochloride (1eq.) and NMM (1.5eq.) in chloroform was added and the solution was 
stirred at room temperature overnight. Then, the solution was washed with distilled 
water (2 x 100 mL), hydrochloric acid (100 mL, 0.1 M), aqueous potassium carbonate 
(100 mL, 0.1 M), and distilled water again (2 x 100 mL) and dried with magnesium 
sulfate, and the solvent was removed in vacuo to give compounds 52 (a – d) as shown in 
Scheme 2.5 and Table 2.11. The yield was between 50 – 75% and the impurity (an 
excess of valine methyl ester) was calculated by 1H NMR spectroscopy to be between 5 – 
6% for all derivatives except compounds 52a and 52b, which were pure and used 
directly in the next step of the reaction. Then, the resulting product was purified by 
washing with methanol. The yield after purification was between 25 – 40% and the 
resulting product was between 98 – 99% pure. 
(R)-Methyl-2-((R)-2-(2-(9H-carbazole-9-yl)acetamido)propanamido)-3-methyl 
butanoate (52a): 
1H NMR (CDCl3): 8.11 (d, ArH, 2H, 3JHH = 6.9Hz), 7.48 (t, ArH, 2H, 3JHH = 7.1Hz), 7.32 (m, 
ArH, 4H), 7.25(s, CDCl3), 6.47 (d, NH, 1H, 3JHH = 8.2Hz), 6.06 (d, NH, 1H, 3JHH = 6.2Hz), 
4.94(s, NCH2C=O, 2H),  4.52 (m, NHCH(CH3)C=O, 1H), 4.41 (dd, NHCHCH(CH3)2, 1H, 3JHH 
= 5.5Hz ), 3.72 (s, OCH3, 3H), 2.10 (m, (CH3)2CH, 1H), 1.17 (d, NHCH(CH3)C=O, 3H, 3JHH = 
7.0Hz), 0.85 (d, NHCHCH(CH3)2, 3H, 3JHH = 6.9Hz ), 0.84 (d, (CH3)2CH, 3H, 3JHH = 7.4Hz) 
ppm. 13C NMR (CDCl3): 172.1, 171.1, 168.6, 168.3, 140.5, 126.5, 123.6, 120.7, 120.5, 
108.4, 57.1, 52.2, 48.7, 47.1, 31.1, 18.9, 17.6 ppm. MS: ES+: ([M+Na]+). Accurate mass 
calculated: 432.1899 Found: 432.1908.  
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(R)-Ethyl-2-((R)-2-(2-(9H-carbazole-9-yl)acetamido)-3-phenylpropanamido)-3-
phenyl propanoate (52b): 
1H NMR (CDCl3): 8.13 (d, ArH, 2H, 3JHH = 6.2Hz), 7.42 (t, ArH, 2H, 3JHH = 8.8Hz), 7.31 (t, 
ArH, 2H, 3JHH = 8.8Hz), 7.26 (CDCl3), 7.16 (m, ArH, 5H), 7.05 (t, ArH, 1H, 3JHH = 8.8Hz), 
6.94 (t, ArH, 2H, 3JHH = 8.8Hz), 6.83 (d, ArH, 2H, 3JHH = 9.7Hz), 6.63 (d, ArH, 2H, 3JHH = 
7.1Hz),   6.21 (d, NH, 1H, 3JHH = 7.9Hz), 5.84 (d, NH, 1H, 3JHH = 8.8Hz), 4.84 (d, NCH2C=O, 
2H, 3JHH = 6.2Hz), 4.64 (m, NHCH(CH2Ph)C=O, 1H), 4.14 (q, OCH2CH3, 2H, 3JHH = 9.7Hz), 
2.99 (dd, NHCH(CH2Ph)C=O, 1H, 3JHH = 7.2, 6.2Hz), 2.80 (m, NHCH(CH2Ph)C=O, 2H), 2.69 
(dd, NHCH(CH2Ph)C=O, 1H, 3JHH = 8.2, 6.2Hz), 1.22 (t, OCH2CH3, 3H, 3JHH = 7.1Hz) ppm. 
13C NMR (CDCl3): 170.9, 169.5, 168.3, 140.1, 135.7, 135.3, 129.2, 128.9, 128.6, 128.4, 
127.1, 126.9, 126.7, 123.5, 120.7, 120.5, 108.4, 61.6, 53.8, 53.3, 46.9, 37.9, 37.1, 14.1 
ppm. MS: ES+: [M+Na]+. Accurate mass calculated: 570.2369 Found: 570.2363.  
(R)-Methyl-2-((R)-2-(2-(9H-carbazol-9-yl)acetamido)-3-methylbutanamido)-3-
methyl butanoate (52c): 
1H NMR (d6-DMSO): 8.09 (d, ArH, 2H, 3JHH = 8.8Hz), 7.46(t, ArH, 2H, 3JHH = 8.6Hz), 7.34(d, 
NH, 1H, 3JHH = 8.6Hz), 7.28 (t, ArH, 2H, 3JHH = 7.5Hz), 6.54 (d, NH, 1H, 3JHH = 8.2Hz), 
6.12(d, NH, 1H, 3JHH = 8.7Hz), 4.94 (d, NCH2C=O, 2H, 3JHH = 8.5Hz),  4.41(dd, 
NHCH(CH3)C=O, 1H, 3JHH = 5.4, 4.4Hz), 4.29 (dd, NHCHCH(CH3)2, 1H, 3JHH = 6.4, 3.3Hz ), 
3.70 (s, OCH3, 3H), 2.07 (m, (CH3)2CH, 1H), 1.93 (m, (CH3)2CH, 1H), 0.84 (d, CH(CH3)2, 
3H, 3JHH = 7.4Hz), 0.80 (d, CH(CH3)2, 3H, 3JHH = 6.4Hz), 0.76 (d, CH(CH3)2, 3H, 3JHH = 
7.7Hz), 0.53 (d, CH(CH3)2, 3H, 3JHH = 7.4Hz) ppm. 13C NMR (CDCl3): 172.1, 170.3, 168.5, 
140.3, 126.5, 126.3, 125.8, 123.5, 120.8, 120.4, 119.3, 110.6, 108.5, 94.0, 58.6, 57.0, 52.2, 
46.9, 31.0, 30.2, 19.1, 18.9, 17.7, 17.5 ppm. MS (ES+): ([M+Na]+). Accurate mass 
calculated: 460.2223 Found: 460.2212.  
(R)-Ethyl-2-((R)-2-(2-(9H-carbazol-9-yl)acetamido)-3-methylbutanamido)-3-phenyl 
propanoate (52d): 
1H NMR (CDCl3): 8.14 (d, ArH, 2H, 3JHH = 8.5Hz), 7.49 (t, ArH, 2H, 3JHH = 8.8Hz), 7.34 (dd, 
ArH, 4H, 3JHH = 8.8, 8.8Hz), 7.22 (t, ArH, 3H, 3JHH = 2.8Hz), 6.96(m, ArH, 2H), 6.04(d, NH, 
1H, 3JHH = 8.8Hz), 5.82 (d, NH, 1H, 3JHH = 8.1Hz), 4.97 (d, NCH2C=O, 2H, 3JHH = 2.4Hz), 4.70 
(m, NHCH(CH2Ph)C=O, 1H), 4.16 (m, NHCH(CH2Ph)C=O, OCH2CH3, 3H), 3.05 (dd, 
NHCH(CH2Ph)C=O, 1H, 3JHH = 6.3, 7.1Hz), 2.83 (dd, NHCH(CH2Ph)C=O, 1H, 3JHH = 7.8, 
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7.3Hz), 1.87 (m, (CH3)2CH, 1H),  1.23 (t, OCH2CH3, 3H, 3JHH = 8.1Hz), 0.69 (d, CH(CH3)2, 
3H, 3JHH = 8.1Hz), 0.31(d, CH(CH3)2, 3H, 3JHH = 6.3Hz) ppm. 13C NMR (CDCl3): 171.1, 
169.6, 168.3, 140.2, 135.7, 129.2, 127.1, 126.6, 123.5, 120.8, 120.5, 108.5, 99.9, 61.6, 
58.2, 52.9, 47.0, 37.9, 30.0, 19.0, 17.1, 14.1 ppm. MS ES+: [M+Na]+. Accurate mass 
calculated: 522.2372 Found: 522.2369.  
Deprotection of the C-terminus: 
A solution of THF: water (30 mL: 5 mL) was added to the carbazole derivative. Lithium 
hydroxide (0.3 g) was added and the solution was stirred overnight. After this time, 
distilled water (100 mL) was added, and then hydrochloric acid (1.0 M) was added 
drop-wise until the pH was lowered to pH 3. The resulting precipitate was collected by 
filtration and washed with water to give compounds (53 – 56) as shown in Scheme 2.5 
and Table 2.12. The yield was between 69 – 80% and the impurity (an excess of valine 
methyl ester) was calculated by 1H NMR spectroscopy to be between 4 – 5% for all 
derivatives except compounds 53 and 55, which were pure and used directly in the next 
step of the reaction. Then, the resulting product was purified by washing with methanol. 
The yield after purification was between 50 – 55% and the resulting product was 
between 97 – 98% pure. 
 (R)-2-((R)-2-(2-(9H-Carbazole-9-yl)acetamido)propanamido)-3-methylbutanoic 
acid  (53): 
1H NMR (d6-DMSO): 8.63 (d, NH, 1H, 3JHH = 7.7Hz), 8.14(d, ArH, 2H, 3JHH = 7.7Hz), 8.01(d, 
NH, 1H, 3JHH = 8.4Hz), 7.53 (d, ArH, 2H, 3JHH = 8.2Hz), 7.42(t, ArH, 2H, 3JHH = 7.1Hz), 
7.20(t, ArH, 2H, 3JHH = 7.8Hz), 5.10(d, NCH2C=O, 2H, 3JHH = 13.8Hz), 4.47(m, 
NHCH(CH3)C=O, 1H), 4.14(dd, NHCHCH(CH3)2, 1H, 3JHH = 6.4, 5.6Hz ), 2.03 (m, (CH3)2CH, 
1H)  1.27 (d, NHCH(CH3)C=O, 3H, 3JHH = 7.0Hz), 0.85 (d, CH(CH3)2, 3H, 3JHH = 7.5Hz), 0.83 
(d, CH(CH3)2, 3H, 3JHH = 6.4Hz) ppm. 13C NMR (d6-DMSO): 172.8, 172.2, 167.0, 140.6, 
125.6, 122.1, 120.1, 118.9, 109.4, 57.1, 47.9, 45.2, 30.0, 19.0, 18.5, 17.8 ppm. MS: ES–: [M 
– H]–.  Accurate mass calculated: 418.1743 Found 418.1749.  
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(R)-2-((R)-2-(2-(9H-Carbazole-9-yl)acetamido)-3-phenylpropanamido)-3-phenyl 
propanoic acid (54): 
1H NMR (d6-DMSO): 8.58 (d, NH, 1H, 3JHH = 8.7Hz), 8.51 (d, NH, 1H, 3JHH = 7.7Hz),  8.10 (d, 
ArH, 2H, 3JHH = 7.6Hz), 7.35 (t, ArH, 2H, 3JHH = 6.0Hz), 7.22 (m, ArH, 14H), 4.94 (q, 
NCH2C=O, 2H, 3JHH = 16.8Hz), 4.63 (m, NHCH(CH2Ph)C=O, 1H), 4.47 (m, 
NHCH(CH2Ph)C=O, 1H), 3.07 (m, NHCH(CH2Ph)C=O, 2H), 2.92 (dd, NHCH(CH2Ph)C=O, 
1H, 3JHH = 7.9, 6.2Hz), 2.77 (dd, NHCH(CH2Ph)C=O, 1H, 3JHH = 8.2, 3.2Hz) ppm. 13C NMR 
(d6-DMSO): 172.7, 171.1, 166.9, 140.4, 137.5, 137.4, 129.3, 129.1, 128.2, 128.0, 126.4, 
126.3, 125.5, 122.0, 119.9, 118.8, 109.3, 53.5, 53.4, 45.1, 37.9, 36.6 ppm. MS: ES–: [M – 
H]–. Accurate mass calculated: 518.2080 Found: 518.2095.   
(R)-2-((R)-2-(2-(9H-Carbazol-9-yl)acetamido)-3-methylbutanamido)-3-methyl 
butanoic acid (55): 
1H NMR (d6-DMSO): 8.44 (d, NH, 1H, 3JHH = 9.6Hz), 8.14(d, ArH, 3H, 3JHH = 7.7Hz), 8.01(d, 
NH, 1H, 3JHH = 8.4Hz), 7.55 (d, ArH, 2H, 3JHH = 8.3Hz), 7.43 (t, ArH, 2H, 3JHH = 7.1Hz), 
7.21(t, ArH, 2H, 3JHH = 7.7Hz), 5.22 (q, NCH2C=O, 2H, 3JHH = 16.6, 18.9Hz),  4.41(dd, 
NHCH(CH3)C=O, 1H, 3JHH = 6.2, 3.7Hz), 4.14 (dd, NHCHCH(CH3)2, 1H, 3JHH = 5.8, 2.5Hz ), 
2.03 (m, (CH3)2CH, 2H)  0.87 (d, CH(CH3)2, 12H, 3JHH = 6.8Hz) ppm. 13C NMR (d6-DMSO): 
172.8, 171.1, 167.3, 161.6, 151.3, 140.5, 125.6, 122.1, 120.1, 118.9, 109.4, 78.8, 57.3, 
45.2, 31.1, 29.5, 19.2, 19.1, 18.1, 17.9 ppm. MS: ES–: [M – H]–. Accurate mass calculated: 
446.5620 Found: 446.5620. 
(R)-2-((R)-2-(2-(9H-Carbazol-9-yl)acetamido)-3-methylbutanamido)-3-phenyl 
propanoic acid (56): 
1H NMR (d6-DMSO): 8.42 (d, NH, 1H, 3JHH = 7.7Hz), 8.36 (d, NH, 1H, 3JHH = 9.2Hz), 8.15 (d, 
ArH, 2H, 3JHH = 7.7Hz), 7.53 (d, ArH, 2H, 3JHH = 8.2Hz), 7.43 (t, ArH, 2H, 3JHH = 7.1Hz ), 7.23 
(m, ArH, 7H), 5.13 (q, NCH2C=O, 2H, 3JHH = 22.9, 16.2Hz),  4.46 (m, NHCH(CH2Ph)C=O, 
1H), 4.29 (dd, NHCHCH(CH3)2, 1H, 3JHH = 6.0, 3.5Hz), 3.06 (dd, NHCH(CH2Ph)C=O, 1H, 
3JHH = 8.9, 5.2Hz), 2.90(dd, NHCH(CH2Ph)C=O, 1H, 3JHH = 9.5, 4.6Hz), 2.01 (m, (CH3)2CH, 
1H), 0.85 (d, CH(CH3)2, 3H, 3JHH = 3.8Hz), 0.84 (d, CH(CH3)2, 3H, 3JHH = 4.0Hz) ppm. 13C 
NMR (d6-DMSO): 203.0, 172.8, 170.8, 167.2, 140.5, 137.5, 129.0, 128.2, 126.4, 125.6, 
122.1, 120.1, 118.9, 109.3, 78.8, 56.9, 53.4, 45.2, 31.1, 19.2, 17.8 ppm. MS: ES–: [M – H]–
.Accurate mass calculated: 470.2075 Found: 470.2080.  
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2.2.5- Anthracene dipeptides:  
Dipeptides conjugated to anthracene by a C=O linker have not been synthesised 
previously. The method26 of the synthesis is described in Scheme 2.6. 
  
 Scheme ‎2.6: The general reaction of dipeptide synthesis based on 9-anthracene ring using IBCF method. 
 
Compound Substituent 
59, 60 R1 
a CH(CH3)2 
b CH3 
c H 
Table ‎2.13: The R1 group of the general structure of compounds 59 and 60 (a, b, c, d) in the Scheme 2.6. 
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Compound Functional group 
61 R1 R2 
a CH(CH3)2 CH(CH3)2 
b CH(CH3)2 H 
c CH(CH3)2 CH2Ph 
d CH3 CH3 
e CH3 CH(CH3)2 
f H CH2Ph 
Table ‎2.14: The R1 and R2  group of the general structure of compound 61 (a - f) in the Scheme 2.6. 
 
Dipeptide R1 R2 Abreviation  
62 CH(CH3)2 CH(CH3)2 9anth-VVOH  
63 CH(CH3)2 H 9anth-VGOH  
64 CH(CH3)2 CH2Ph 9anth-VFOH  
65 CH3 CH3 9anth-AAOH  
66 CH3 CH(CH3)2 9anth-AVOH  
67 H CH2Ph 9anth-GFOH  
Table ‎2.15: The R1 and R2 group of the general structure of compounds 62–67 and their abbreviations in the 
Scheme 2.6. 
 
Experimental section: 
Preparation of anthracene acid chloride (58):  
Anthracene acetic acid (2.22g, 0.01mol) was refluxed in thionyl chloride (30mL) for 1.5 
hours. An excess of thionyl chloride was evaporated in vacuo and completely removed 
by washing the result product with toluene (10 mL) three times26. Then, the resulting 
precipitate was collected by filtration and washed with water to give compound 58 as 
shown in Scheme 2.6. The yield was 83 % and the resulting product was pure and used 
directly in the next step of the reaction. 
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First coupling step: 
Anthracene acid chloride was dissolved in THF (80 mL). A solution of L-valine methyl 
ester hydrochloride, L-alanine methyl ester hydrochloride or glycine methyl ester 
hydrochloride, THF and NMM was added drop-wise to a solution of anthracene at room 
temperature and the mixture was stirred at room temperature overnight. The solution 
was washed with distilled water (100 mL), hydrochloric acid (2 x 100 mL, 0.1 M), 
aqueous potassium carbonate (100 mL, 0.1 M), and distilled water again (4 x 100 mL) 
and dried with magnesium sulfate, and the solvent was removed in vacuo to give 
compounds 59 (a – c) as shown in Scheme 2.6 and Table 2.13. The yield was between 
60 – 72% and the impurity (an excess of valine methyl ester, IBCF) was calculated by 
NMR spectroscopy to be between 8 – 13% for all derivatives except compound 59b, 
which was pure and used directly in the next step of the reaction. Then, the resulting 
product was purified by washing with methanol. The yield after purification was 
between 45 – 50% and the resulting product was between 88 – 95% pure. 
(S)-Methyl-2-(anthracene-9-carboxamido)-3-methylbutanoate (59a): 
1H NMR (CDCl3): 8.44 (s, ArH, 1H), 8.08 (s, ArH, 2H), 7.96 (d, ArH, 2H, 3JHH = 8.1Hz), 7.45 
(m, ArH, 4H), 6.38 (d, NH, 1H, 3JHH = 9.3Hz), 5.02 (dd, NHCH(CH3)2C=O, 1H, 3JHH = 5.2, 
4.8Hz), 3.78 (s, OCH3, 3H), 2.38 (m, CH(CH3)2, 1H), 1.10 (d, CH(CH3)2, 3H, 3JHH = 7.6Hz), 
0.91 (d, CH(CH3)2, 3H, 3JHH = 6.7Hz) ppm. 13C NMR (CDCl3): 172.6, 170.0, 131.8, 131.5, 
129.4, 128.9, 128.6, 127.2, 125.9, 125.7, 125.5, 68.4, 58.2, 52.7, 45.3, 31.3, 26.0, 21.8, 
19.8, 18.3, 17.6 ppm. MS: ES+: [M+Na]+. Accurate mass calculated: 358.1420 Found 
358.1419. 
(S)-Methyl-2-(anthracene-9-carboxamido)propanoate (59b): 
1H NMR (CDCl3): 8.43 (s, ArH, 1H), 8.08 (s, ArH, 2H), 7.94 (d, ArH, 2H, 3JHH = 8.8Hz), 7.44 
(m, ArH, 4H), 6.47 (d, NH, 1H, 3JHH = 7.3Hz), 5.02 (m, NHCHCH3C=O, 1H), 3.78 (s, OCH3, 
3H), 1.59 (d, NHCHCH3C=O, 3H, 3JHH = 7.4Hz) ppm. 13C NMR (CDCl3): 173.5, 169.5, 131.5, 
131.4, 128.9, 128.8, 128.6, 128.1, 127.2, 125.9, 125.4, 53.0, 49.1, 30.7, 18.7 ppm. MS: 
ES+[M+Na]+. Accurate mass calculated: 330.1107 Found 330.110. 
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Methyl-2-(anthracene-9-carboxamido)acetate (59c): 
1H NMR (CDCl3): 8.44 (s, ArH, 1H), 8.11 (d, ArH, 2H, 3JHH = 8.8Hz), 7.95 (d, ArH, 2H, 3JHH = 
8.8Hz), 7.45 (m, ArH, 4H), 6.44 (s, NH, 1H), 4.42 (d, NHCH2C=O, 2H, 3JHH = 6.2Hz), 3.79 (s, 
OCH3, 3H) ppm. 13C NMR (CDCl3): 183.2, 169.3, 142.4, 134.1, 133.9, 133.5, 130.8, 129.6, 
129.2, 128.6, 127.6, 127.3, 126.2, 122.4, 121.6, 120.7, 119.8, 117.1, 52.4, 42.1, 41.6, 40.7 
ppm. MS: ES+: [M+Na]+. Accurate mass calculated: 316.0955 Found 316.0950 
Deprotection of the C-terminus: 
A solution of THF: water (30 mL: 5 mL) was added to compound 59 (a, b or c). Lithium 
hydroxide (0.3 g) was added and the solution was stirred overnight. After this time, 
distilled water (100 mL) was added, and then hydrochloric acid (100 mL, 1.0 M) was 
added drop wise until the pH was lowered to pH 3. Then, the resulting precipitate was 
collected by filtration and washed with water to give compounds 60 (a – c) as shown in 
Scheme 2.6 and Table 2.13. The yield was between 52 – 73% and the impurity (an 
excess of valine methyl ester) was calculated by 1H NMR spectroscopy to be between 4 – 
12% for all derivatives except compound 60b, which was pure and used directly in the 
next step of the reaction. Then, the resulting product was purified by washing with 
methanol. The yield after purification was between 30 – 55% and the resulting product 
was typically between 89 – 97% pure. 
(S)-2-(anthracene-9-carboxamido)-3-methylbutanoic acid (60a): 
1H NMR (d6-DMSO): 9.08 (d, ArH, 1H, 3JHH = 7.8Hz), 8.66 (s, ArH, 1H), 8.24 (m, ArH, 1H), 
8.13 (m, ArH, 2H), 7.96 (d, NH, 1H, 3JHH = 7.8Hz), 7.55 (d, ArH, 4H, 3JHH = 5.6Hz), 4.59 (t, 
NHCH(CH3)2C=O, 1H, 3JHH = 7.3Hz), 2.24 (m, CH(CH3)2, 1H), 1.08 (d, CH(CH3)2, 3H, 3JHH = 
8.1Hz), 1.00 (d, CH(CH3)2, 3H, 3JHH = 6.3Hz) ppm. 13C NMR (d6-DMSO): 173.0, 168.9, 
133.1, 130.7, 128.6, 128.3, 128.1, 127.7, 127.4, 127.0, 126.3, 126.0, 125.8, 125.5, 125.2, 
66.9, 58.4, 29.1, 25.1, 19.4, 18.3 ppm. MS: ES–: [M – H]–.Accurate mass calculated: 
344.1261 Found 344.1263. 
(S)-2-(anthracene-9-carboxamido)propanoic acid (60b): 
 1H NMR (d6-DMSO): 9.18 (d, NH, 1H, 3JHH = 6.6Hz), 8.67 (s, ArH, 1H), 8.37 (d, ArH, 1H, 
3JHH = 6.6Hz), 8.13 (d, ArH, 2H, 3JHH = 6.8Hz),   7.98 (d, ArH, 1H, 3JHH = 8.0Hz), 7.56 (dd, 
ArH, 4H, 3JHH = 4.5, 3.3Hz), 4.66 (m, NHCHCH3C=O, 1H), 1.45 (d, NHCHCH3C=O, 3H, 3JHH = 
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7.4Hz) ppm. 13C NMR (d6-DMSO): 174.5, 168.6, 133.2, 131.0, 128.7, 128.5, 128.1, 127.6, 
126.7, 126.5, 126.2, 125.9, 125.7, 79.5, 67.4, 48.7, 25.5, 17.1 ppm. MS: ES–: [M – H]–
.Accurate mass calculated: 292.0964 Found 292.0974. 
2-(anthracene-9-carboxamido)acetatic acid (60c):  
1H NMR (d6-DMSO): 9.19 (t, NH, 1H, 3JHH = 6.0Hz), 8.67 (s, ArH, 1H), 8.22 (m, ArH, 2H), 
8.13 (m, ArH, 2H), 7.56 (m, ArH, 4H), 4.13 (d, NHCH2C=O, 2H, 3JHH = 6.0Hz) ppm. 13C 
NMR (d6-DMSO): 171.3, 168.8, 134.5, 133.0, 132.7, 130.6, 130.5, 128.6, 128.2, 127.5, 
127.3, 127.0, 126.7, 126.3, 125.6, 124.8, 41.2 ppm. MS: ES–: [M – H]–.Accurate mass 
calculated: 278.0818 Found 278.0817. 
Standard coupling methodology: 
N-Methylmorpholine (1.5 eq.) and IBCF (1 eq.) were added to compound 60 (a, b or c) 
(1.0 g) in chloroform (100 mL) at 0 oC. A solution of L–phenylalanine ethyl ester 
hydrochloride, L–alanine methyl ester hydrochloride, L–valine methyl ester 
hydrochloride or glycine methyl ester hydrochloride (1.0 eq.) and NMM (1.5 eq.) in 
chloroform was added and the solution was stirred at room temperature overnight. 
Then, the solution was washed with distilled water (2 x 100 mL), hydrochloric acid (100 
mL, 0.1 M), aqueous potassium carbonate (100 mL, 0.1 M), and distilled water again (2 x 
100 mL) and dried with magnesium sulfate, and the solvent was removed in vacuo to 
give compounds 61 (a – f) as shown in Scheme 2.6 and Table 2.14. The yield was 
between 33 – 78% and the impurity (an excess of valine methyl ester and IBCF) was 
calculated by 1H NMR spectroscopy to be between 18 – 25% for all derivatives except 
compound 61a, which was pure and used directly in the next step of the reaction. Then, 
the resulting product was purified by washing with methanol. The yield after 
purification was between 20 – 60% and the resulting product was between 85 – 94% 
pure. 
(S)-Methyl-2-((S)-2-(anthracene-9-carboxamido)-3-methylbutanamido)-3-methyl 
butanoate (61a): 
1H NMR (CDCl3): 8.52 (s, ArH, 1H), 8.08 (d, ArH, 2H, 3JHH = 10.0Hz), 8.03 (d, ArH, 2H, 3JHH 
= 7.4Hz), 7.52 (m, ArH, 4H), 6.59 (dd, NH, 2H, 3JHH = 7.1, 8.6Hz), 4.79 (dd, 
NHCH(CH3)2C=O, 1H, 3JHH = 7.1, 2.1Hz), 4.70 (dd, NHCH(CH3)2C=O, 1H, 3JHH = 5.0, 4.4Hz),  
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3.80 (s, OCH3, 3H), 2.31(m, 2x CH(CH3)2, 2H), 1.66 (d, CH(CH3)2, 6H, 3JHH = 7.6, 8.2Hz), 
1.08 (d, CH(CH3)2, 3H, 3JHH = 6.8Hz), 1.03 (d, CH(CH3)2, 3H, 3JHH = 6.8Hz) ppm. 13C NMR 
(CDCl3): 172.1, 170.9, 131.2, 131.0, 128.5, 128.4, 128.1, 126.9, 125.5, 124.9, 59.7, 57.3, 
52.2, 31.1, 30.9, 19.5, 19.0, 18.7, 17.7 ppm. MS: ES+([M+Na]+). Accurate mass calculated: 
457.2112 Found 457.2103. 
(S)-Methyl-2-(2-(anthracene-9-carboxamido)-3-methylbutanamido)acetate (61b): 
 1H NMR (CDCl3): 8.93 (d, NH, 1H, 3JHH = 8.6Hz), 8.65(s, ArH, 1H), 8.60 (t, ArH, 1H, 3JHH = 
6.5Hz), 8.13 (d, ArH, 3H, 3JHH = 7.5Hz),   7.94 (d, NH, 2H, 3JHH = 8.8Hz), 7.54 (d, ArH, 4H, 
3JHH = 7.5Hz), 4.73 (dd, NHCH(CH3)2C=O, 1H, 3JHH = 6.3, 3.3Hz), 4.10 (d, NHCH2C=O, 1H, 
3JHH = 6.3Hz), 4.03 (d, NHCH2C=O, 1H, 3JHH = 5.3Hz), 3.69 (s, OCH3, 3H), 2.13 (m, 
CH(CH3)2, 1H), 1.08 (d, CH(CH3)2, 3H, 3JHH = 7.3Hz), 1.01 (d, CH(CH3)2, 3H, 3JHH = 6.3Hz) 
ppm. 13C NMR (CDCl3): 171.4, 170.3, 169.5.2, 131.5, 131.4, 128.9, 128.5, 127.3, 125.9, 
125.4, 59.6, 52.8, 45.3, 31.3, 19.9, 18.8 ppm. MS: ES+: [M+Na]+. Accurate mass calculated: 
415.1644. Found 415.1634. 
(S)-Ethyl-2-((S)-2-(anthracene-9-carboxamido)-3-methylbutanamido)-3-
phenylpropanoate (61c): 
1H NMR (CDCl3): 8.51 (s, ArH, 1H), 8.03 (d, ArH, 2H, 3JHH = 9.0Hz), 7.51 (m, ArH, 4H), 
7.28 (m, ArH, 6H), 6.64 (d, NH, 1H, 3JHH = 9.5Hz), 6.50 (d, NH, 1H, 3JHH = 8.6Hz), 5.00 (d, 
NHCH(CH2Ph)C=O, 1H, 3JHH = 8.8Hz), 4.78 (dd, NHCH(CH3)2C=O, 1H, 3JHH = 8.6, 2.6Hz), 
4.20 (q, OCH2CH3, 2H, 3JHH = 7.1, 7.1Hz ), 3.23 (d, NHCH(CH2Ph)C=O, 2H, 3JHH = 6.0Hz), 
2.29(m, CH(CH3)2, 1H), 1.29 (t, OCH2CH3)2, 3H, 3JHH = 7.1Hz), 1.15 (d, CH(CH3)2, 3H, 3JHH = 
6.7Hz) 1.07 (d, CH(CH3)2, 3H, 3JHH = 6.8Hz) ppm. 13C NMR (CDCl3): 171.6, 170.7, 170.1, 
136.0, 131.6, 131.5, 129.7, 129.1, 129.0, 128.9, 128.5, 127.7, 127.3, 125.9, 125.4, 66.2, 
62.0, 59.7, 53.8, 38.5, 31.6, 19.8, 18.8, 15.7, 14.5 ppm. MS: ES+: [M+Na]+. Accurate mass 
calculated: 519.2263 Found 519.2260. 
(S)-Methyl-2-((S)-2-(anthracene-9-carboxamido)propanamido)propanoate (61d): 
1H NMR (CDCl3): 8.51 (s, ArH, 1H), 8.10 (d, ArH, 2H, 3JHH = 8.2Hz), 8.04 (d, ArH, 2H, 3JHH = 
7.6Hz), 7.53 (m, ArH, 4H), 6.87 (d, NH, 1H, 3JHH = 7.8Hz), 6.63 (d, NH, 1H, 3JHH = 7.3Hz), 
5.01 (m, NHCHCH3C=O, 1H), 4.70 (m, NHCHCH3C=O, 1H), 3.81 (s, OCH3, 3H), 1.63 (d, 
NHCHCH3C=O, 3H, 3JHH = 7.3Hz), 1.53 (d, NHCHCH3C=O, 3H, 3JHH = 7.1Hz) ppm. 13C NMR 
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(CDCl3): 170.9, 169.2, 167.5, 128.9, 128.6, 126.6, 126.2, 124.8, 123.5, 122.7, 50.5, 47.4, 
46.2, 16.3, 15.9 ppm. MS: ES+: [M+Na]+. Accurate mass calculated: 401.1483 Found 
401.1477. 
(S)-Methyl-2-((S)-2-(anthracene-9-carboxamido)propanamido)-3-
methylbutanoate (61e): 
1H NMR (CDCl3): 8.50 (s, ArH, 1H), 8.09 (d, ArH, 2H, 3JHH = 8.1Hz), 8.03 (d, ArH, 2H, 
3JHH = 7.8Hz), 7.50 (m, ArH, 4H), 6.85 (d, NH, 1H, 3JHH = 8.8Hz), 6.65 (d, NH, 1H, 3JHH = 
7.1Hz), 5.02 (m, NHCHCH3C=O, 1H), 4.64 (dd, NHCH(CH3)2C=O, 1H, 3JHH = 5.1, 4.0Hz 
), 3.80 (s, OCH3, 3H), 2.29 (m, NHCH(CH3)2C=O, 1H), 1.63 (d, NHCHCH3C=O, 3H, 3JHH 
= 7.6Hz), 1.05 (d, NHCH(CH3)2C=O, 3H, 3JHH = 7.3Hz), 1.01 (d,(CH3)2CH, 3H, 3JHH = 
6.9Hz) ppm. 13C NMR (CDCl3): 172.6, 172.1, 170.0, 134.5, 131.4, 129.1, 128.9, 128.5, 
127.6, 127.3, 125.9, 125.2, 123.2, 57.9, 52.7, 50.2, 31.8, 31.7, 19.4, 19.3, 18.4, 18.2 
ppm. MS: ES+: [M+Na]+. Accurate mass calculated: 429.1801 Found 429.1790. 
(S)-Ethyl-2-(2-(anthracene-9-carboxamido)acetamido)-3-phenylpropanoate (61f): 
 1H NMR (CDCl3): 8.48 (s, ArH, 1H), 8.03 (m, ArH, 3H), 7.49 (m, ArH, 3H), 7.28 (m, ArH, 
5H), 7.18 (d, ArH, 2H, 3JHH = 7.5Hz), 6.87 (s, NH, 1H), 6.71 (d, NH, 1H, 3JHH = 8.4Hz), 4.87 
(dd, NHCH(CH2Ph)C=O, 1H, 3JHH = 8.2, 6.9Hz), 4.37 (dd, NHCH2C=O, 2H, 3JHH = 7.3, 7.1Hz), 
4.20 (q, OCH2CH3, 2H, 3JHH = 7.1, 7.1Hz ), 3.20 (d, NHCH(CH2Ph)C=O, 1H, 3JHH = 6.9Hz), 
3.13 (d, NHCH(CH2Ph)C=O, 1H, 3JHH = 8.3Hz), 1.26 (t, OCH2CH3)2, 3H, 3JHH = 7.1Hz) ppm. 
13C NMR (CDCl3): 171.6, 170.5, 168.5, 136.0, 131.4, 131.2, 129.8, 129.0, 128.9, 128.8, 
128.5, 128.1, 127.6, 127.3, 125.9, 125.4, 62.1, 53.9, 43.9, 38.3, 19.4, 14.5 ppm. MS: ES+: 
[M+Na]+. Accurate mass calculated: 477.1802 Found 477.1709. 
Deprotection of the C-terminus: 
A solution of THF: water (30 mL: 5 mL) was added to the compounds 61 (a, b, c, d, e or 
f). Lithium hydroxide (0.3 g) was added and the solution was stirred overnight. After 
this time, distilled water (100 mL) was added, and then hydrochloric acid (1.0 M) was 
added drop-wise until the pH was lowered to pH 3. The resulting precipitate was 
collected by filtration and washed with water to give compounds (62 – 67) as shown in 
Scheme 2.6 and Table 2.15. The yield was between 60 – 77% and the impurity (excess of 
valine methyl ester) was calculated by NMR spectroscopy to be between 3 – 12% of all 
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derivatives. Then, the resulting product was purified by washing with methanol. The 
yield after purification was between 30 – 35% and the resulting product was typically 
between 90 – 99% pure. 
(S)-2-((S)-2-(Anthracene-9-carboxamido)-3-methylbutanamido)-3-methylbutanoic 
acid (62): 
1H NMR (d6-DMSO): 8.93 (d, NH, 1H, 3JHH = 9.1Hz), 8.66 (s, ArH, 1H), 8.11 (m, ArH, NH, 
4H), 7.95 (m, ArH, 1H), 7.54 (m, ArH, 4H), 4.69 (t, NHCH(CH3)2C=O, 1H, 3JHH = 8.2Hz), 
4.32 (dd, NHCH(CH3)2C=O, 1H, 3JHH = 5.9, 2.5Hz), 2.14(m, 2x CH(CH3)2, 2H), 1.05 (d, 
NHCH(CH3)2, 3H, 3JHH = 7.4Hz), 0.99 (d, NHCH(CH3)2, 6H, 3JHH = 6.2Hz), 1.03 (d, 
NHCH(CH3)2, 3H, 3JHH = 6.8Hz) ppm. 13C NMR (d6-DMSO): 171.4, 170.3, 169.5.2, 131.5, 
131.4, 128.9, 128.5, 127.3, 125.9, 125.4, 59.6, 52.8, 45.3, 31.3, 19.9, 18.8 ppm. MS: ES–: 
[M – H]–. Accurate mass calculated: 419.1961 Found 419.1971. 
(S)-2-(2-Anthracene-9-carboxamido)-3-methylbutanamido)acetic acid (63): 
1H NMR (d6-DMSO): 8.90 (d, NH, 1H, 3JHH = 8.8Hz), 8.65 (s, ArH, 1H), 8.43 (t, NH, 1H, 3JHH 
= 7.1Hz), 8.13 (d, ArH, 3H, 3JHH = 6.3Hz), 7.96 (m, ArH, 1H), 7.54 (d, ArH, 4H, 3JHH = 
6.3Hz), 4.62 (t, NHCH(CH3)2C=O, 1H, 3JHH = 7.8Hz), 4.06 (dd, NHCH2C=O, 1H, 3JHH = 5.6, 
3.6Hz), 3.90 (dd, NHCH2C=O, 1H, 3JHH = 5.8, 11.6Hz), 2.14 (m, CH(CH3)2, 1H), 1.03 (d, 
NHCH(CH3)2, 3H, 3JHH = 8.1Hz), 0.97 (d, NHCH(CH3)2, 3H, 3JHH = 4.1Hz) ppm. 13C NMR (d6-
DMSO): 171.4, 171.2, 168.3.2, 134.6, 133.2, 133.0, 130.6, 128.3, 128.1, 127.6, 127.3, 
126.9, 126.7, 126.2, 125.9, 125.4, 125.2, 58.9, 40.7, 29.8, 19.4, 18.6 ppm. MS: ES–: [M – 
H]–. Accurate mass calculated: 377.1512 Found 377.1501. 
(S)-2-((S)-2-(Anthracene-9-carboxamido)-3-methylbutanamido)-3-
phenylpropanoic acid (64): 
1H NMR (d6-DMSO): 8.80 (d, NH, 1H, 3JHH = 8.6Hz), 8.64 (s, ArH, 1H), 8.32 (s, ArH, 3H), 
8.12 (d, ArH, 2H, 3JHH = 6.0Hz), 7.95 (d, NH, 1H, 3JHH = 9.2Hz), 7.53 (m, ArH, 3H), 7.34 (d, 
ArH, 2H, 3JHH = 7.6Hz), 7.28 (t, ArH, 2H, 3JHH = 6.8Hz), 7.22 (t, ArH, 1H, 3JHH = 8.6Hz), 4.62 
(m, NHCH(CH2Ph)C=O, NHCH(CH3)2C=O, 2H), 3.17 (dd, NHCH(CH2Ph)C=O, 1H, 3JHH = 8.7, 
4.8Hz), 2.99 (dd, NHCH(CH2Ph)C=O, 1H, 3JHH = 9.2, 4.8Hz), 2.08 (m, CH(CH3)2, 1H), 0.99 
(d, NHCH(CH3)2, 3H, 3JHH = 6.8Hz), 0.96 (d, CH(CH3)2, 3H, 3JHH = 7.4Hz) ppm. 13C NMR (d6-
DMSO): 172.9, 170.9, 168.2, 137.5, 134.5, 133.2, 130.6, 129.1, 128.4, 128.2, 127.5, 127.3, 
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127.0, 126.7, 126.4, 126.2, 125.8, 125.1, 64.9, 58.9, 53.4, 38.9, 36.8, 30.1, 25.1, 19.3, 18.6, 
15.1 ppm. MS: ES–: [M – H]–. Accurate mass calculated: 467.1964 Found 467.1971. 
(S)-2-((S)-2-(Anthracene-9-carboxamido)propanamido)propanoic acid (65): 
1H NMR (d6-DMSO): 9.00 (d, NH, 1H, 3JHH = 6.5Hz), 8.65 (s, ArH, 1H), 8.39 (s, ArH, 1H), 
8.33 (d, NH, 1H, 3JHH = 7.3Hz), 8.12 (d, ArH, 2H, 3JHH = 8.1Hz), 7.96 (m, ArH, 1H), 7.55 (m, 
ArH, 4H), 7.76 (m, NHCHCH3C=O, 1H), 4.38 (m, NHCHCH3C=O, 1H), 1.40 (d, 
2xNHCHCH3C=O, 6H, 3JHH = 4.9Hz) ppm. 13C NMR (d6-DMSO): 174.6, 172.7, 168.4, 133.3, 
130.9, 128.7, 128.4, 128.1, 127.5, 127.1, 126.7, 126.5, 125.9, 125.6, 49.2, 47.9, 17.9, 17.6 
ppm. MS: ES–: [M – H]–. Accurate mass calculated: 387.1317 Found 387.1321. 
(S)-2-((S)-2-(Anthracene-9-carboxamido)propanamido)-3-methylbutanoic acid 
(66): 
1H NMR (d6-DMSO): 9.01 (d, NH, 1H, 3JHH = 8.5Hz), 8.65 (s, ArH, 1H), 8.28 (m, ArH, 1H), 
8.12 (m, ArH, 2H), 8.08 (d, NH, 1H, 3JHH = 8.7Hz), 7.95 (m, ArH, 2H), 7.55 (m, ArH, 3H), 
4.82 (t, NHCHCH3C=O, 1H, 3JHH = 7.8Hz), 4.31 (dd, NHCH(CH3)2C=O, 1H, 3JHH = 5.3, 3.2Hz 
), 2.15 (m, NHCH(CH3)2C=O, 1H), 1.37 (d, NHCHCH3C=O, 3H, 3JHH = 7.4Hz), 0.99 (d, 
NHCH(CH3)2C=O, 3H, 3JHH = 4.3Hz), 0.97 (d, CH(CH3)2, 3H, 3JHH = 4.2Hz) ppm. 13C NMR 
(d6-DMSO): 182.5, 173.0, 172.7, 168.0, 134.6, 133.0, 132.9, 130.6, 127.1, 126.7, 125.5, 
57.2, 48.9, 30.0, 29.2, 19.1, 17.9, 17.7 ppm. MS: ES–: [M – H]–. Accurate mass calculated: 
391.1643 Found 391.1658. 
(S)-2-(2-(Anthracene-9-carboxamido)acetamido)-3-phenylpropanoic acid (67): 
1H NMR (d6-DMSO): 8.97 (t, NH, 1H, 3JHH = 5.5Hz), 8.65 (s, ArH, 1H), 8.41 (d, NH, 1H, 3JHH 
= 7.9Hz), 8.22 (m, ArH, 2H), 8.12 (m, ArH, 2H), 7.54 (m, ArH, 4H), 7.31 (d, ArH, 4H,  3JHH = 
4.4Hz), 7.23 (m, ArH, 1H), 4.59 (m, NHCH(CH2Ph)C=O, 1H), 4.13 (dd, NHCH2C=O, 2H, 
3JHH = 9.8, 6.1Hz), 3.16 (dd, NHCH(CH2Ph)C=O, 1H, 3JHH = 8.5, 5.7Hz) ppm. 13C NMR (d6-
DMSO): 172.9, 168.8, 168.6, 137.4, 134.6, 132.9, 130.6, 129.2, 128.2, 128.1, 127.4, 127.2, 
126.7, 126.5, 126.2, 125.8, 125.5, 64.9, 53.7, 41.9, 38.9, 36.9, 15.1 ppm. MS: ES–: [M – H]–. 
Accurate mass calculated: 425.1512 Found 425.1501. 
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2.2.6- Pyrene dipeptides: 
Peptides amphiphile conjugated to pyrene have been synthesised using different 
methods elsewhere28. Also, Zhang et al. have synthesised dipeptide based pyrene29 
Here, we have synthesised 1-pyrene dipeptide using the IBCF method as shown in 
Scheme 2.7. 
 
 
Scheme ‎2.7: The general reaction of dipeptide synthesis based on 1-pyrene ring using IBCF method. 
 
Dipeptide Abreviation  
72 Py-VVOH  
Table ‎2.16: The abbreviation of compounds 72 in the Scheme 2.7. 
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Experimental section: 
Standard coupling methodology: 
N-Methylmorpholine (4 mL) and IBCF (3 mL) was added to pyrene carboxylic acid (5.0 
g) in chloroform (70 mL) chloroform at 0 0C. A solution of L-valine methyl ester 
hydrochloride (4.0 g, 1.5 eq.) and NMM (4 mL) in chloroform was added and the 
solution was stirred at room temperature overnight. Then, the solution was washed 
with distilled water (100 mL), hydrochloric acid (2 x 100 mL, 0.1 M), aqueous 
potassium carbonate (100 mL, 0.1 M), and distilled water again (4 x 100 mL) and dried 
with magnesium sulfate, and the solvent was removed in vacuo to give compound 69 as 
shown in Scheme 2.7. The yield was 50% and the impurity (an excess of valine methyl 
ester) was calculated by 1H NMR spectroscopy to be 10%. Then, the resulting product 
was purified by washing with methanol. The yield after purification was typically 25% 
and the resulting product was 95% pure. 
(S)-Methyl-3-methyl-2-(pyrene-1-carboxamido)butanoate (69): 
1H NMR (CDCl3): 8.63 (d, ArH, 1H, 3JHH = 8.8Hz), 8.24 (d, ArH, 2H, 3JHH = 8.1Hz), 8.18 (m, 
ArH, 6H), 6.63 (d, NH, 1H, 3JHH = 8.8Hz ), 5.01 (dd, NHCH(CH3)2C=O, 1H, 3JHH = 5.1, 
4.3Hz), 3.84 (s, OCH3, 3H), 2.41 (m, CH(CH3)2, 1H), 1.15 (d, CH(CH3)2, 3H, 3JHH = 6.3Hz), 
1.04 ppm (d, CH(CH3)2, 3H, 3JHH = 7.1Hz) ppm. 13C NMR (CDCl3): 173.0, 170.2, 133.2, 
131.7, 131.1, 130.9, 129.3, 129.2, 129.1, 127.6, 126.8, 126.3, 126.2, 125.2, 125.1, 124.8, 
58.1, 52.8, 32.0, 19.7, 18.4 ppm. MS: ES+: [M+Na]+. Accurate mass calculated: 382.1428 
Found 382.1419. 
Deprotection of the C-terminus: 
A solution of THF: water (30 mL: 5 mL) was added to the compound 69. Lithium 
hydroxide (0.3 g) was added and the solution was stirred overnight. After this time, 
distilled water (100 mL) was added, and then hydrochloric acid (1.0 M) was added 
dropwise until the pH was lowered to pH 3. Then, the resulting precipitate was collected 
by filtration and washed with water to give compound 70 as shown in Scheme 2.7. The 
yield was 77% and the impurity (an excess of valine methyl ester) was calculated by 1H 
NMR spectroscopy to be 20%. Then, the resulting product was purified by washing with 
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methanol. The yield after purification was typically 35% and the resulting product was 
87% pure. 
(S)-3-Methyl-2-(pyrene-1-carboxamido)butanoic acid (70): 
1H NMR (d6- DMSO): 8.87 (d, NH, 1H, 3JHH = 8.8Hz), 8.49 (d, ArH, 1H, 3JHH = 9.5Hz), 8.36 
(m, ArH, 3H), 8.25(m, ArH, 3H), 8.13 (m, ArH, 2H), 4.51 (dd, NHCH(CH3)2C=O, 1H, 3JHH = 
6.3, 2.3Hz), 2.26 (m, CH(CH3)2, 1H), 1.06 (d, CH(CH3)2, 3H, 3JHH = 6.9Hz), 1.05 (d, 
CH(CH3)2, 3H, 3JHH = 7.3Hz) ppm. 13C NMR (d6- DMSO): 173.6, 169.8, 132.2, 131.9, 131.1, 
130.6, 128.6, 128.4, 128.2, 127.6, 126.9, 126.2, 126.0, 125.8, 125.1, 124.7, 124.1, 124.0, 
58.8, 29.8, 19.8, 18.9 ppm. MS: ES–: [M – H]–. Accurate mass calculated: 344.1288 Found 
344.1287. 
Standard coupling methodology: 
N-Methylmorpholine (4 mL) and IBCF (3 mL) was added to compound 70 (3.0 g) in 
chloroform (70 mL) at 0 oC. A solution of L-valine methyl ester hydrochloride (4.0 g, 1.5 
eq.) and NMM (4 mL) in chloroform was added and the solution was stirred at room 
temperature overnight. Then, the solution was washed with distilled water (100 mL), 
hydrochloric acid (2 x 100 mL, 0.1 M), aqueous potassium carbonate (100 mL, 0.1 M), 
and distilled water again (4 x 100 mL) and dried with magnesium sulfate, and the 
solvent was removed in vacuo to give compound 71 as shown in Scheme 2.7. The yield 
was 53% and the impurity (an excess of valine methyl ester) was calculated by 1H NMR 
spectroscopy to be 10%. Then, the resulting product was purified by washing with 
diethyl ether. The yield after purification was typically 20% and the resulting product 
was 92% pure. 
 (S)-Methyl-3-methyl-2-((S)-3-methyl-2-(pyrene-1-carboxamido)butanamido) 
butanoate (71): 
1H NMR (CDCl3): 8.61 (d, ArH, 1H, 3JHH = 9.3Hz), 8.25 (d, ArH, 2H, 3JHH = 7.4Hz), 8.16 (m, 
ArH, 4H), 8.07 (m, ArH, 2H), 6.85 (d, NH, 1H, 3JHH = 9.1Hz ), 6.60 (d, NH, 1H, 3JHH = 8.5Hz 
), 4.75 (dd, NHCH(CH3)2C=O, 1H, 3JHH = 6.0, 2.7Hz), 4.65 (dd, NHCH(CH3)2C=O, 1H, 3JHH = 
4.8, 3.9Hz),  3.79 (s, OCH3, 3H), 2.35 (m, CH(CH3)2, 1H), 2.28 (m, CH(CH3)2, 1H), 1.17 (d, 
CH(CH3)2, 3H, 3JHH = 7.2Hz), 1.16 (d, CH(CH3)2, 3H, 3JHH = 8.2Hz),  1.00 (d, CH(CH3)2, 3H, 
3JHH = 6.2Hz), 0.96 (d, CH(CH3)2, 3H, 3JHH = 7.2Hz) ppm. 13C NMR (CDCl3): 172.5, 171.6, 
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170.4, 133.1, 131.5, 131.1, 130.7, 129.2, 129.2, 129.2, 129.1, 127.5, 126.8, 126.3, 126.2, 
125.2, 125.1, 124.7, 124.6, 59.8, 57.8, 52.6, 31.8, 31.5, 19.8, 19.4, 18.9, 18.2 ppm. MS: 
ES+: [M+Na]+. Accurate mass calculated: 481.2108 Found 481.2103. 
Deprotection of the C-terminus: 
A solution of THF: water (30 mL: 5 mL) was added to the compound 71. Lithium 
hydroxide (0.3 g) was added and the solution was stirred overnight. After this time, 
distilled water (100 mL) was added, and then hydrochloric acid (1.0 M) was added 
drop-wise until the pH was lowered to pH 3. Then, the resulting precipitate was 
collected by filtration and washed with water to give compound 72 as shown in Scheme 
2.7. The yield was 73% and the impurity was THF. The resulting product was purified 
by washing with methanol. The yield after purification was typically 45% and the 
resulting product was 85% pure. 
(S)-3-methyl-2-((S)-3-methyl-2-(pyrene-1-carboxamido)butanamido)butanoic acid 
(72): 
1H NMR (d6-DMSO): 8.76 (d, NH, 1H, 3JHH = 8.6Hz), 8.46 (d, NH, 1H, 3JHH = 9.2Hz), 8.35 (t, 
ArH, 3H, 3JHH = 7.8Hz ), 8.26 (m, ArH, 3H), 8.13 (m, ArH, 3H), 4.60 (t, NHCH(CH3)2C=O, 
1H, 3JHH = 7.6Hz), 4.28 (dd, NHCH(CH3)2C=O, 1H, 3JHH = 6.7, 4.2Hz), 2.16 (m, 2xCH(CH3)2, 
2H), 1.05 (d, CH(CH3)2, 3H, 3JHH = 7.1Hz), 1.03 (d, CH(CH3)2, 3H, 3JHH = 7.7Hz), 0.97 (d, 
CH(CH3)2, 6H, 3JHH = 6.8Hz) ppm. 13C NMR (d6-DMSO): 172.5, 171.6, 170.4, 133.1, 131.5, 
131.1, 130.7, 129.2, 129.2, 129.2, 129.1, 127.5, 126.8, 126.3, 126.2, 125.2, 125.1, 124.7, 
124.6, 59.8, 57.8, 52.6, 31.8, 31.5, 19.8, 19.4, 18.9, 18.2 ppm. MS: ES–: [M – H]–. Accurate 
mass calculated: 443.1969 Found 443.1971. 
DCC coupling method: 
We have attempted to synthesise some peptide derivatives such as compounds 75 and 
77 using a different coupling method (using DCC) in an effort to increase the yield or 
decrease the amount of impurity, but this method was not successful. The yield was low 
(typically 18%) and there was lots of impurity. The experimental of the DCC method 
was similar to IBCF method, but we used DCC as coupling agent and dimethyl amino 
pyridine (DMAP) as a catalyst. The reaction was carried out in dichloromethane instead 
of chloroform. An example synthesis is described below:  
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A DMAP (0.1 g) was added to a solution of the anthraquinone or pyrene derivative (1.0 
g) in DCM (70 mL). Then, a DCC (1 eq.) was added. A solution of valine methyl ester 
hydrochloride (1 eq.) and NMM (1 eq.) in DCM (30 mL) was added in ice bath. The 
solution was stirred overnight at room temperature. After this time, the solution was 
washed with distilled water (100 mL), hydrochloric acid (2 x 100 mL, 0.1 M), aqueous 
potassium carbonate (100 mL, 0.1 M), and distilled water again (4 x 100 mL) and dried 
with magnesium sulfate, and the solvent was removed in vacuo. 
2.3- Result and Discussion: 
Peptides can be synthesised by coupling the carboxyl group (C-terminus) of one amino 
acid to the amino group (N-terminus) of another1-3. Here, we have synthesised 35 
dipeptides conjugated to different aromatic rings. 20 Dipeptides were linked to a 
naphthalene ring with different linkers and different substituents, 6 dipeptides linked to 
anthracene, 4 dipeptides linked to carbazole, 1 dipeptide linked to anthraquinone and 1 
dipeptide linked to pyrene. We have used different methods in the first step of the 
reaction to prepare different linkers such as reacting with tert-butyl chloroacetate, 
thionyl chloride or bromoacetic acid and we have used the IBCF method to couple the 
carboxyl group of the aromatic ring to the N-terminus of the first amino acid. We have 
synthesised this large library of dipeptides in order to study their ability to form 
hydrogels and study their properties for some applications which is discussed in more 
detail in Chapter 3. 
2.3.1- Dipeptides synthesis: 
Naphthalene dipeptide synthesis 
Naphthalene dipeptides derivatives were synthesised by using two methods. A first 
method was the method of Chen et al.14 This starts from naphthol derivatives. The 
second method started from naphthalene acetic acid derivatives. The difference 
between the methods is that the first method used tert-butyl chloroacetate to react with 
naphthol derivatives and then the tert-butyl group was removed using trifluoroacetic 
acid. In the first coupling step, the resulting product was reacted with valine methyl 
ester hydrochloride. In the second method, naphthalene acetic acid derivatives were 
coupled with the first amino ester (valine methyl ester hydrochloride) without using 
tert-butyl chloroacetate. The results showed that the dipeptides conjugated to the 
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aromatic ring with different linker groups have different ability to form gels. These 
results agreed with Chen’s research30, where they reported that using different linkers, 
–CH2 and –OCH2 to couple naphthalene ring to the amino acid can affect the ability of a 
dipeptide to form a hydrogel. 
The reaction mechanism of dipeptides conjugated to naphthol was as following: 
Deprotonation of the naphthol derivatives: 
Naphthol derivatives were deprotonated by potassium carbonate, followed by 
nucleophilic attack of the deprotonated naphthalene derivative on chloro-tert-
butylacetate to give compounds 2(a, b, c, d) (Fig. 2.1). The tert-butyl group was 
removed using trifluoroacetic acid (TFA) in chloroform. 
 
Figure ‎2.1:  The general structure of compound 2 (a, b, c, d).  
 
Coupling step reaction mechanism for two methods: 
Compounds 3 (a, b, c, d) were synthesised by coupling with the first amino acid (valine 
methyl ester hydrochloride) using IBCF and N-methylmorpholine (NMM) in chloroform. 
NMM was used to free the amino group from the corresponding hydrochloride salt. 
IBCF was used as the coupling agent. The reaction proceeded by the nucleophilic attack 
of the amino acid on to the activated carboxylic acid as shown in Scheme 2.8. 
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Scheme ‎2.8: The reaction mechanism of the coupling step of the amino acid conjugated to naphthalene ring. 
 
Deprotection reaction mechanism: 
Lithium hydroxide was used to deprotect the resulting products of the first coupling 
step at room temperature overnight. The product was isolated using 1.0M HCl to lower 
the pH to pH 3 and so precipitate the carboxylic acid as shown in Scheme 2.9. 
 
Scheme ‎2.9: The deprotection reaction mechanism between the resulting product of the first amino acid and 
the base (lithium hydroxide). 
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According to Chen et al. the naphthalene dipeptides can be used as a hydrogelators14, 18. 
Chen et al. synthesised naphthalene dipeptides from 6-bromonaphthol using different 
amino acids in the first coupling step. Here, twenty naphthalene dipeptide derivatives 
were synthesised from 1-bromo-2-naphthol, 6-bromo-2-naphthol, 1,6-dibromo-2-
naphthol, 2-naphthol and 1-naphthalene acetic acid (Fig. 2.2). In general, the yields of 
the deprotection step were good (65 – 73%), whereas in the first and the second 
coupling steps the yield was low (between 35 to 40% for all derivatives). We tried to 
increase the yield by using a different coupling method (DCC5, 19 instead of IBCF5, 13, 14). 
The result showed that the yield of the coupling step using DCC method was lower 
(20%) than when using the IBCF method. Therefore, we instead attempted to change 
the equivalents of the reactants in the IBCF method, the equivalents of the amino acid 
and of IBCF. The yields increased for the first coupling step when the equivalents of 
valine methyl ester hydrochloride and IBCF were increased from one equivalent to 1.5 
and the equivalents of IBCF changed from one to 1.1. By this optimisation, the yield in 
the first coupling step was raised to between 73 to 76%. This modification in protocol 
was also used for the second coupling step, but the yield was not found to increase.  The 
lack of improvement for this second coupling could be due to the steric hindrance of the 
dipeptide.  
 
 
Figure ‎2.2: The general structure of twenty dipeptides that synthesised. Structure of compounds 
10 - 24 refer to dipeptides based on 2-naphthol, 1-bromonaphthol, 6-bromonapthol and 
1,6dibromonaphthol. Structure of compounds 29 – 32 refer to dipeptides based on 1-napthalene 
acetic acid. 
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9-Phenanthrol dipeptide synthesis: 
We have used the same procedure that we used to prepare naphthalene dipeptide 
derivatives to prepare dipeptides linked to phenanthrol, with the same linker between 
the aromatic group and the amino acid. 9-Phenanthrol was reacted with tert-butyl 
chloroacetate in acetone in the presence of K2CO3 to give tert-butyl phenanthrol 
derivative, followed by a deprotecting step using trifluoroacetic acid in chloroform, and 
then the resulting product was coupled with the first amino acid.  
The yields of the coupling steps and the deprotection steps were between 71 – 75 %. 
We obtained a white or off-white solid product in all steps. We synthesised three 
dipeptide derivatives, 40, 41 and 42. 1H, 13C NMR and mass spectroscopic analysis 
produced evidence of the success the reaction. Almost all compounds in the coupling 
and deprotection steps were pure, so we used the product directly for the second step 
of the next reaction. Exceptions were 35, 39c, 41 and 42 where we removed impurities 
by washing with methanol. The yield however decreased after purification to typically 
40 – 60%.  
2-Anthraquinone dipeptide synthesis: 
The protocol of the synthesis of naphthalene dipeptide derivatives was used again to 
prepare anthraquinone dipeptides, but we directly coupled the first amino acid, rather 
than using an –OCH2 linker. Here, unlike for the naphthalene examples, we carried out 
the coupling reaction using phenylalanine because it has been used in much research 
previously17 and reported as a good hydrophobic amino acid to form a strong hydrogels. 
We repeated the coupling and deprotection steps and we synthesised one dipeptide 
from anthraquinone, compound 47. The yield of the last step of the reaction to obtain 
the dipeptide 47 was 75%. We attempted to synthesise other peptides with a different 
amino acid, glycine methyl ester. The reaction was successful as shown by the 1H NMR 
spectroscopy result after purification with methanol (Fig. 2.3). However, the yield of 
compound 75 in this step was very low (27%) (Scheme 2.10) and the impurities (IBCF, 
starting material) were very difficult to remove in this stage of the synthesis. We tried 
changing the equivalents of some reactants, such as the amount of glycine methyl ester 
from 1 equivalent to 1.5 equivalents, but this modification of the method did not 
increase the yield and did not remove the impurity. Moreover, we attempted changing 
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the method by using DCC coupling method, but the impurities increased and the yield 
decreased to 18%. 
 
Scheme ‎2.10: Reaction of anthraquinone to obtain compounds 75 and 76.  
 
 
Figure ‎2.3: An example of 1H NMR spectroscopy of compound 75.  
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When we attempted the deprotection step to obtain compound 76 (Scheme 2.10), there 
were impurities as shown in the 1H NMR data (Fig. 2.4). We noted some impurity in the 
aromatic area (7 – 9ppm). We noted that there were 2 extra protons in the aromatic 
area, but the identity of the impurity is not clear. We tried to purify the product by 
washing with organic solvents (methanol, hexane, ethyl acetate or diethyl ether) that 
have different polarity, but they did not remove the impurity. Furthermore, we tried to 
purify the product by using crystallisation from toluene, ethanol or ethyl acetate, but 
also this did not purify the compound 76. We have repeated the coupling and 
deprotection step with glycine four times, but we obtained the same result and we failed 
to synthesise more peptides from these aromatic groups. 
 
 
Figure ‎2.4: An example of 1H NMR spectroscopy of compound 76. Circles are the impurities (excess of 
aromatic protons at 8 – 8.5ppm) 
 
 
 
 
105 | P a g e  
 
1-Pyrene dipeptide synthesis: 
We have synthesised pyrene dipeptide derivatives using the same protocol as for the 
synthesis of naphthalene dipeptide derivatives. Again, we directly coupled the amino 
acids to the ring without a –OCH2 linker. We synthesised one pyrene dipeptide, 
compound 72. The yield of the last step to obtain compound 72 was 73%. We have tried 
to synthesise other peptides using different amino acid sequences such as 
phenylalanine ethyl ester or alanine methyl ester to obtain compounds 77a or 77b 
(Scheme 2.11), but the yield was very low in the first coupling step (25 and 27% 
respectively) and the impurities (excess of phenylalanine ethyl ester, alanine methyl 
ester, IBCF) were again very difficult to remove from the first coupling of the synthesis. 
Figure 2.5 shows an example of a 1H NMR spectrum of 77a. We attempted to change the 
synthesis method by using DCC coupling method, but the impurity increased and there 
were impurities that it has not removed. The yield was lower (18%) than for the IBCF 
method. Again, we tried varying the reaction conditions; the equivalents of some 
reactants such as phenylalanine ethyl ester, alanine methyl ester, or IBCF to try and 
lower the amounts of impurity, but changing these conditions did not decrease the 
impurity or increase the yield.  
 
 
Scheme ‎2.11:  The reaction of pyrene carboxylic acid to obtain compounds 77a and 77b.  
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Figure ‎2.5: The 1H NMR spectrum of 77a with some impurities. Circled are the impurities (excess of ethyl 
ester at 1.4ppm and 4.3ppm, IBCF at 0.9, 3ppm, NH at 5.3ppm and aromatic protons at 8 – 8.5ppm). 
 
Furthermore, we tried to synthesise compound 74, but the last step of the reaction (the 
second deprotection step) was not successful (Scheme 2.12). There was a lot of impurity 
such as excess of phenylalanine and some pyrene carboxylic acid either had not reacted 
or was formed during the deprotection step. Figure 2.6 shows the 1H NMR spectrum of 
73. We tried different purification methods, for example washing with organic solvents 
(methanol or diethyl ether) and crystallisation with hexane or toluene, but these 
methods were not successful. Also the yield was low (25%). Although we tried to 
synthesise 73 many times by changing reaction conditions such as the equivalent of 
IBCF and phenylalanine ethyl ester as we did for the naphthalene derivatives, no 
improvement was found. 
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Scheme ‎2.12: The successful synthesis reaction of compound 72 and unsuccessful synthesis reaction of 
compound 74. 
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Figure ‎2.6: The 1H NMR spectrum of compound 73 showing some impurities. This NMR is after purification by 
washing with some solvents. Circled are the impurities (excess of valine at 0.5 – 1ppm, NH at 6.5ppm and 
aromatic protons at 7.5 – 8ppm). 
 
9-Anthracene dipeptide synthesis: 
We attempted to synthesise 9-anthracene dipeptide derivatives using the IBCF method 
by coupling 9-anthracene carboxylic acid with the first amino acid. However, unlike for 
the pyrene and anthraquinone examples described above, the reaction was not 
successful (Scheme 2.13). This may be a result of the steric clash between the 
anthracene ring and the amino acid. To the best of our knowledge, there are no 
literature examples of a successful coupling reaction between 9-anthracene carboxylic 
acid and an amino acid. For this reason we examined another strategy. Kim et al. have 
used thionyl chloride to react with 9-anthracene carboxylic acid to prepare 9-
anthracene acid chloride26. We have used this reaction to convert the carboxylic acid to 
the acid chloride and tried to reacts the acid chloride with the first amino acid. The 
reaction was successful as determined by NMR spectroscopy.  
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Scheme ‎2.13: The unsuccessful coupling reaction between 9-anthracene and valine methyl ester 
hydrochloride. 
 
After the second coupling and deprotection steps, the dipeptide derivatives were 
formed in good yield (60 – 70%). Scheme 2.14 shows an example of the successful 
reaction of 9-anthracene with thionyl chloride followed by coupling with the first amino 
acid. We have synthesised 6 dipeptide derivatives with different sequences: compounds 
62, 63, 64, 65, 66 and 67. 
 
 
Scheme ‎2.14: An example of a successful reaction of anthracene dipeptide synthesis after react the 
anthracence carboxylic acid with thionyl chloride to give anthracene acid chloride. 
 
We have tried to synthesise 9-anthracene dipeptide derivatives using phenylalanine in 
the first coupling of the reaction again because it has been reported before as a good 
hydrophobic amino acid likely lead to hydrogelation17. The reaction was successful for 
the first coupling and deprotection steps, but in both steps the yield was very low (less 
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than 20%) and we found that there were significant impurities such as anthracene 
chloride, phenylalanine ethyl ester and unknown impurities. We attempted purification 
of the resulting product in three steps and using different methods, by crystallization 
with ethanol, toluene or ethyl acetate and washing with organic solvents (diethyl ether, 
hexane or methanol that have different polarity). The most effective solvent was found 
to be methanol. We washed the product three times with methanol, but even then we 
could not remove all impurities. This purification method by washing with methanol 
was successful with 9-anthracene peptide conjugated to different amino acid such as 
compound 63. Figures 2.7 and 2.8 show the 1H NMR spectra before and after 
purification of 63 with methanol respectively.  
 
Figure ‎2.7: The 1H NMR spectrum of compound 63 before purification. Circled are the impurities (excess of 
valine at 1 – 1.5ppm, THF at 0.7ppm and 3.6ppm and aromatic protons at approximately 8.3ppm). 
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Figure ‎2.8: The 1H NMR spectrum of compound 63 after purification with MeOH. 
 
Carbazole dipeptide synthesis: 
We have used two different starting materials to synthesise carbazole dipeptide 
derivatives, 9-carbazole methanol and carbazole. 9-Carbazole methanol was reacted 
with tert-butyl chloroacetate in acetone in the presence of K2CO3 at 70oC overnight 
(Scheme 2.15). However, this reaction was not successful. Instead, we recovered the 
starting material as determined by 1H NMR and 13C NMR spectroscopy. The failure of the 
reaction may result from the instability between N and O. We therefore tried to find 
another carbazole derivative from which to synthesise dipeptides. 
 
 
Scheme ‎2.15: The unsuccessful reaction between 9-carbazole methanol and tert-butylchloroformate. 
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Following a literature procedure, carbazole was reacted with bromoacetic acid in DMSO 
in the presence of NaOH11 to give carbazole acetic acid derivative in a good yield (83%) 
as shown in the Scheme 2.16. The resulting product was coupled with the first amino 
acid using the IBCF method13, 14 followed by deprotection, a second coupling and second 
deprotection step to give four carbazole dipeptide derivatives, 53, 54, 55, and 56.  
 
 
Scheme ‎2.16: A successful reaction between carbazole and bromoacetic acid. 
 
From the results we noted that the yield was good (between 67 – 80 %), where the 
highest yield obtained was for compound 54 (80%) and the lowest yield was for 
compound 56 (67%). The products contained few impurities, which were purified using 
washes with diethyl ether and methanol. We obtained white or off-white solid products 
in all steps.  
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2.4- Conclusion: 
Peptides can be synthesised by coupling the carboxylic group of the C-terminus of one 
amino acid to the N-terminus of another. Here, we have synthesised a range of new 
dipeptides conjugated to various aromatic groups such as naphthalene, anthracene, 
anthraquinone, pyrene, carbazole and phenanthrol. We have used different methods for 
the first step of the reaction before the coupling step. We have synthesised 35 
dipeptides conjugated to different aromatic groups. 20 dipeptides were synthesized 
from naphthalene ring with different substituents and different linker between the 
aromatic ring and amino acid sequence, 6 dipeptides from 9-anthracene ring, 4 
dipeptides from 9-carbazole ring, 3 dipeptides from 9-phenanthrol, 1 dipeptide from 1-
pyrene ring and 1 dipeptide from 2-anthraquinone ring. The yields were good (between 
51 – 83%) for all dipeptides. We failed to synthesise some dipeptides because we had 
difficulty to purify them and their yields were very low (such as compounds 74 and 76). 
We have synthesised a large number of dipeptides with different hydrophobicity and 
different aromatic group in order to study their ability to form gel and study their 
mechanical properties which we will discuss that in details in Chapter 3. 
 
Table 2.17 shows the summary of the yield and the purities of all conjugated dipeptides 
that synthesised. From the table 2.17, we noted that the purity was excellent for almost 
dipeptide derivatives except compound 72; where it has more impurities which may 
affect its hydrogelation properties.  
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Dipeptide Yield % Purity % 
10 40 90 
11 60 95 
12 57 97 
13 55 98 
14 59 94 
15 60 98 
16 50 99 
17 48 97 
18 60 99 
19 57 96 
20 58 95 
21 49 98 
22 60 99 
23 56 99 
24 59 98 
25 60 99 
30 50 96 
31 54 97 
32 60 99 
33 60 98 
40 55 89 
41 59 94 
42 60 95 
47 50 92 
53 50 97 
54 66 98 
55 56 98 
56 67 97 
62 30 90 
63 34 96 
64 35 99 
65 33 98 
66 35 97 
67 35 99 
72 45 85 
Table ‎2.17: the yield and the purity of the all dipeptide synthesised.  
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3-  Hydrogel formation and their properties  
3.1- Introduction: 
Supramolecular hydrogels are formed by the self-assembly of hydrogelators1. These 
supramolecular hydrogels contain a network of nanofibres and water (Fig. 3.1)2. 
Hydrogels were defined by Flory in 1974 as “a coherent colloidal system of at least two 
components, exhibiting mechanical properties characteristic of a solid, where both the 
dispersed component and the dispersion medium extend themselves continuously 
throughout the system”3. The amount of water in hydrogels is often more than 97%4. 
Nowadays, supramolecular hydrogels have been used in many applications such as drug 
delivery5, 6, tissue engineering5-7, cell culturing8 and energy transfer9. They have also 
been used in chemical sensing agents10. Currently, dipeptides with suitable functional 
groups have a wide interest for use as hydrogelators. For example, dipeptides 
conjugated to aromatic group such as naphthalene or Fmoc have been used to form 
hydrogels11.  
 
 
 
Figure ‎3.1: Self-assembly of hydrogelators to form hydrogel.  
 
 
Hydrogel preparation: 
Supramolecular hydrogels are an emerging class of soft materials which are usually 
formed by the self-assembly of some small organic molecules. Supramolecular dipeptide 
hydrogels can be prepared by several different approaches. The main method used to 
prepare hydrogels is to dissolve the hydrogelators into an aqueous solution and then 
change the temperature12, pH13, or add an enzyme to start molecular self-assembly in 
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water, resulting in hydrogelation. For example, Zhao et al. have shown hydrogelation by 
chemical or enzymatic conversion14, 15 such as phosphorylation of tyrosine1. In this 
Chapter, we discuss the hydrogelation of a range of dipeptides. 
3.2- Experimental Section: 
 
3.2.1- Gel formation (Hydrogels based on dipeptide derivatives): 
Hydrogels based on naphthalene, phenanthrol, anthraquinone, pyrene and carbazole 
dipeptide derivatives were prepared using different methods, solvent method (DMSO: 
water) or the pH switch method (GdL method)16, which are described below.  
1- pH switch method (GdL method): 
10 mg of dipeptide derivative were suspended in deionized water (2 mL) and an 
equimolar amount of NaOH (0.1 M) was added to the solution to dissolve the dipeptide. 
The solution was stirred for about 30 minutes or until a clear solution was formed. The 
pH of the solution was measured to be about 10 to 12. Measured quantities of glucono-
-lactone (GdL) were added to the solutions to control the pH to form gels. The samples 
were left to stand overnight to form hydrogels before measurement. 
2- Solvent switch (DMSO: water): 
The dipeptide derivatives (10 mg) were dissolved in 100 µL DMSO and then deionized 
water (1.9 mL) was added to give a final concentration of dipeptide of 5 mg/mL. The 
samples were left to stand overnight. 
We have used a variation on the DMSO: water method where we used water of different 
pH to study their effect on the hydrogelation. Previous research illustrated that 
hydrogels using this method cannot be formed at high pH17-20, while other research 
reported that hydrogels can be formed at high pH using a different method in the 
presence of salts21. 
Dipeptide derivatives (10 mg) were dissolved in 100 µL DMSO and then made up to 2 
mL with acetate buffer solutions of pH 3, 4, 5, 6 (1.9 mL), which were prepared as 
shown below (Table 1), were added to give a final concentration of dipeptide of 5 
mg/mL. The samples were left overnight to form gels. 
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Buffer solution preparation: 
Acetate buffer solutions of pH 3, 4, 5 and 6 were prepared by mixing 0.1 M acetic acid 
with 0.1 M sodium acetate in different ratios22 as shown in Table 3.1. 
pH Vol. of 0.1 M acetic 
acid 
Vol. of 0.1 M sodium 
acetate 
3 982.3 mL 17.7 mL 
4 847.0 mL 153.0 mL 
5 357.0 mL 643.0 mL 
6 52.2 mL 947.8 mL 
Table ‎3.1: The proportions of 0.1M of acetic acid and 0.1 M of sodium acetate that were used to 
prepare acetate buffer solutions of pH 3, 4, 5 and 6 22. 
 
3.2.2- pH and pKa measurements: 
An FC200pH probe (HANNA instruments) with a 6 mm x 10 mm conical tip was used to 
measure pH of the dipeptide derivatives. We utilised the GdL method to prepare the 
samples, whilst constantly measuring the pH (at a concentration of 5mg/ mL of 
dipeptide). We recorded the changes in the pH every 60 s overnight at room 
temperature. 
To determine the pKa, water (5 mL) was added to the dipeptide derivatives (25 mg), and 
then an equimolar amount of NaOH (0.1 M) was added to the solutions. The pKa was 
determined using titration by adding a 0.1 M HCl (10 – 40 µL) every 5 minutes. The 
solution was stirred during the titration to prevent the formation of  hydrogels23. 
3.2.3- Rheology studies: 
Rheology is a method that was developed to characterise materials that possess both 
classical liquid-like and solid-like properties24. Rheology can measure and link the 
properties of deformation of the solid state and flow of the liquid state. Rheology 
measures Gʹ and Gʹʹ. Gʹ refers to the storage modulus, which is a material’s ability to 
store energy, giving it solid-like properties. Gʹʹ refers to the loss modulus, which 
demonstrates the material’s ability to dissipate energy, giving it liquid-like properties. 
G’ is an order of magnitude larger than Gʹʹ when a material is considered to be a rigid 
hydrogel25. 
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The rheology was studied for dipeptides that formed hydrogels using different methods 
for the preparation of hydrogels. 2 mL of the peptide solution as described above to 
prepare hydrogel was placed in a sample tube. The samples left to stand overnight to 
form hydrogel. After forming hydrogels, the rheology was studied using an Anton Paar 
Physica MCR101 rheometer. All tests were performed at room temperature. Frequency 
sweeps at constant strain (0.5 %) were measured between 1 rad s-1 and 100 rad s-1 
using a cup and vane geometry. The measurements of Gʹ and Gʹʹ with gelation were 
carried out at constant frequency (10 rad/s) at 25οC. Rheological data was acquired for 
each of the successful hydrogelators and compared.  
3.2.4- Fourier-transform Infra-Red Spectroscopy (FT-IR): 
FT-IR spectroscopy is a technique that studies the absorption of infra-red light. It 
measures the absorbed light by the sample to produce peaks at specific wavelength. The 
absorption peaks correspond to the frequencies of vibration between specific bonds in 
the material. This result identifies important functional groups that should be present in 
the product such as carbonyl groups, carboxylic acids and amide bonds26. Infra-red 
spectra of hydrogels were collected using a TENSOR series Bruker FT-IR spectrometer, 
at 2cm-1 resolution averaging 64 scans. Samples were prepared in D2O, adding 1.9 mL of 
D2O to dipeptide dissolved in 100 µL DMSO. Samples were left for a minimum of twelve 
hours to form hydrogels. The hydrogels were transferred onto the IR plates without 
damaging the supramolecular structure. We also prepared samples using the GdL 
method in D2O, H2O in both the wet and dry gel states as well as the as-synthesised 
dipeptide.  The FT-IR was carried out by Lin Chen, University of Liverpool. 
 
3.2.5-  Scanning electron microscopy (SEM): 
SEM images were recorded using a Hitachi S-4800 FE-SEM at 3 KeV. Diced silicon 
wafers (Agar) were used to deposit a portion of the hydrogels, prepared as described 
previously (the hydrogel of compound 40 was prepared in GdL method). The hydrogel 
was allowed to stand on the silicon wafer while it was air-dried for 1 hour. The silicon 
wafers were placed on aluminium stubs with an Agar adhesive tape. A 5 nm gold layer 
was used deposited with a sputter coating machine for 1 minute at 5 mA current. To 
avoid charging, a low voltage SEM was used (0.5 to 1 keV) at a 1.5 to 3 mm working 
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distance with the deceleration mode. The SEM was carried out by Andre Zamith 
Cardoso, University of Liverpool. 
 
3.3- Result and discussion: 
 
3.3.1- Hydrogel and Rheology: 
 
3.3.1.1- Hydrogelation of naphthalene dipeptides: 
The ability of naphthalene dipeptides to form hydrogels was studied previously using 
different methods2, 23, 27, 28. Here, we have used a solvent switch method (DMSO: water) 
and the GdL method because they have been used previously as effective methods to 
form hydrogels with combinations of different aromatic groups and amino acids, 
naphthalene and Fmoc dipeptides 23, 29. Here, we attempted to use these methods with 
dipeptides containing different aromatic groups and different hydrophobicity to study 
the formation of hydrogels and compared the data with that previous collected. The first 
method used was a solvent method (DMSO: water). In this method, 100 µL of DMSO was 
added to 10 mg of dipeptide derivative. Then, 1.9 mL H2O was added to the solution. We 
have also used this method with buffered water (pH 3, 4, 5 or 6) in order to study the 
formation of hydrogels at different pH. The other method we used to form the gels is the 
GdL (glucono--lactone) method16. Here, the self-catalysed hydrolysis of GdL in water 
lowers the pH of the solution slowly30. The hydrolysis mechanism opens the lactone 
ring, producing gluconic acid which donates protons to the dipeptides, allowing non-
covalent interactions to dominate and self-assembly to occur.  
We are interested in the different methods of forming gels as these can be used to 
change the properties of the final material11. In the solvent switch method, the self-
assembly starts quickly after adding the water to the solution of peptide in DMSO and 
the hydrogel can form in a few minutes. This method might be useful for drug delivery 
application because it can be used to form an injectable hydrogel.31 On the other hand, 
in the GdL method, the formation of a hydrogel occurs after few hours. This method is 
useful to study and understand the self-assembly process and the mechanical properties 
of the hydrogel.19 The solvent switch method at different pH was used for compounds 
10 – 25 (Fig. 3.2). Some dipeptides formed hydrogels and others did not using the 
solvent switch method with different acetate buffers. The results of these methods are 
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shown in Table 3.2, which shows the rheological data, i.e. storage modulus (Gʹ) and loss 
modulus (Gʹʹ) for the samples that formed a gel. According to the rheology, some of 
dipeptide derivatives have high Gʹ at low pH such as compound 12, 13, 16 and 17. This 
means these dipeptides are good hydrogelators. Others, which have low Gʹ, are poor 
hydrogelators. These results agreed with previous research17-20. For instance, Chen et al. 
reported that dipeptides conjugated to aromatic groups can form hydrogels at low pH, 
whereas at high pH no gels are formed. Moreover, some peptides did not form hydrogel 
at all pH such as compound 10 and 11.  
There are other factors that are known to affect hydrogel formation such as 
hydrophobicity and pKa17, 19, 20. Here, it can be clearly seen that an increase in 
hydrophobicity and pKa can lead to the formation of hydrogels17-20. For example, 16 and 
17 formed gels at all pH (pH 3, 4, 5, 6). In contrast, 15 formed hydrogel at pH 3 and pH 
4, which agrees with other research that reported hydrogels formed at low pH using the 
DMSO method11. Similarly, two naphthalene dipeptide derivatives based on 2-naphthol 
formed gels. One of them formed hydrogels at all pH, compound 13, whereas compound 
12 was only able to form hydrogels at pH 3 and pH 4. These results show that the 
hydrophobicity cannot be used as a simple guide to whether a gel is formed, as we can 
see that compound 15 which contains a bromine group and is more hydrophobic than 
compound 13.  
 
 
Figure ‎3.2: General structure of naphthalene dipeptides. 
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Sample name pH 3 pH 4 pH 5 pH 6 
Gʹ  
(Pa) 
Gʹʹ 
(Pa) 
Gʹ  
(Pa) 
Gʹʹ 
(Pa) 
Gʹ  
(Pa) 
Gʹʹ 
(Pa) 
Gʹ 
 (Pa) 
Gʹʹ  
(Pa) 
Compound (11) - - - - - - - - 
Compound (10) - - - - - - - - 
Compound (12) 22100 5100 14200 3000 - - - - 
Compound (13) 4000 200 2000 100 3000 300 3100 400 
Compound (14) - - - - - - 20000 4000 
Compound (15) 6200 600 6000 500 - - - - 
Compound (16) 12000 3000 24000 7300 20000 4000 6000 600 
Compound (17) 21000 00 2000 3000 14000 2000 15000 3000 
Table ‎3.2: The Gʹ and Gʹʹ using pH switch method at pH 3, 4, 5, 6 for 2-napthol and 6-bromo-naphthol 
derivatives. (–) refers to dipeptides that did not form gels. G’ and G’’ were measured using frequency sweep at 
10 rad/s. 
 
Table 3.3 shows the results of the formation of the hydrogels using the solvent switch 
and GdL methods. It can be clearly seen that eleven dipeptides out of nineteen formed 
hydrogels using GdL method, while nine dipeptides formed hydrogels using the solvent 
switch method. In the GdL method, the pH was measured (before adding GdL) to be 
between 10 and 12 for the solution of dipeptide derivatives. After adding GdL and 
forming hydrogels, the pH was measured to be between 3 and 4. The pH drop allows the 
formation of gels19. Other research reported that hydrogels can be formed at high pH 
using a different method (adding calcium salts)21.  
Table 3.3 also shows that some dipeptides formed transparent gels and others formed 
turbid gels. The factors that cause the turbidity could be the molecular structure of the 
dipeptides. For example, dipeptides that formed turbid hydrogels have high molecular 
structure, while dipeptides that formed transparent gels have low molecular structure 
(Fig. 3.3). This may due to the aggregation of the peptides that have high molecular 
structure into larger structures, which lead to increase in light scattering, leading to 
form a turbid hydrogel. Also, the turbidity can be affected by the concentration of the 
dipeptide. We noted that when we decrease the concentration of the hydrogelators, the 
turbidity decreased, presumably due to a decrease in the aggregation of the fibres.  
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Figure ‎3.3: Examples of hydrogel images that formed a turbid and transparent gel. Compound 17 (Left) 
formed a turbid gel and compound 12 (Right) formed a transparent using the GdL method. It shows the effect 
of the molecular structure on the turbidity. 
 
Furthermore, it can be seen that any change in the peptide structure such as 
substitution position or order of amino acid sequence can affect and change the ability 
of the molecules to form a hydrogel. For instance, if we compare between dipeptides 
that have similar amino acids and different numbers or different substitution positions 
of a bromine atom, we note that they have different gelation results. For example, 
compound 14, 18 and 22, where compound 14 (bromine at position 6 on the 
naphthalene ring) did not form hydrogel, while compound 18 (where there are 
bromines at position 1 and 6) and 22 (the bromine at position 1) formed a turbid 
hydrogels using the solvent switch method. As a result, it can be clearly seen that a small 
change in the peptide structure can affect and change the formation of the hydrogel. 
Also, as described above, we noted that the hydrophobicity did not correlate to hydrogel 
formation. For instance, compound 12 formed a turbid hydrogel, whereas compound 20 
and 25 which are more hydrophobic than 12 did not form hydrogel using the solvent 
switch method. These results agreed with other examples that discussed in the previous 
research29. Furthermore, Chen’s group19 have prepared similar naphthalene dipeptide 
hydrogel with different amino acid sequence using the GdL method. For example, their 
results showed that 2-napFVOH and 6Br-napFVOH formed turbid hydrogels, which are 
Similar to our results that showed compounds 13 and 17 which they have similar 
structure and different amino acid sequence formed also turbid hydrogels. Also, 
precipitate was formed from compound 11, while a crystal was formed from Chen’s 
compound which has different amino acid sequence (2-napAV)19. 
Compound 
30 
Compound 
33 
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It is clear that all the dipeptides that form gels with the solvent switch method also form 
gels with the GdL method. However, dipeptides 15, 25 and 30 all only form gels with 
the GdL method. It is still not clear why some peptides formed gel using only the GdL 
method. However, we expect that the method of preparing the hydrogel can modify the 
properties of the hydrogel formed11. 
Dipeptide Gel formation 
DMSO: H2O 
Gel formation GdL Molecular 
weight   
LogP 
Compound 10 - Precipitate - Precipitate 400.36 1.390 
Compound 11 - Precipitate - Precipitate 372.31 0.619 
Compound 12 √ Turbid Gel √ Transparent Gel 358.46 0.832 
Compound 13 √ Turbid Gel √ Turbid Gel 448.45 2.080 
Compound 14 - Precipitate - Transparent Gel  479.36 2.140 
Compound 15 - Precipitate √ Turbid Gel 451.31 1.360 
Compound 16 √ Transparent Gel √ Transparent Gel 437.46 1.570 
Compound 17 √ Turbid Gel √ Turbid Gel 527.45 2.820 
Compound 18 √ Turbid Gel √ Turbid Gel 558.20 2.920 
Compound 19 √ Turbid Gel √ Turbid Gel 530.21 2.141 
Compound 20 - Precipitate like gel √ Turbid Gel 516.18 2.354 
Compound 21 √ Turbid Gel √ Turbid Gel 606.30 3.602 
Compound 22 √ Turbid Gel √ Turbid Gel 479.36 1.520 
Compound 23 √ Turbid Gel √ Turbid Gel 451.31 1.400 
Compound 24 √ Transparent Gel √ Transparent Gel 437.46 1.620 
Compound 25 - Precipitate √ Transparent Gel 527.45 2.870 
Compound 30 - Precipitate √ Turbid Gel 384.47 1.490 
Compound 31 - Precipitate - Precipitate 356.44 0.717 
Compound 32 √ Transparent Gel - Gel precipitate 342.39 0.932 
Compound 33 √ Turbid Gel √ Transparent Gel 432.51 2.178 
Table ‎3.3: Dipeptides that formed gels and did not form gels using GdL method and DMSO: water method. (–) 
means did not form gels, (√) means formed gels. This is a qualitative observation. 
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We have also studied the rheology of the gels that are formed using frequency sweeps 
and the strain sweeps to demonstrate the mechanical properties of the formation of the 
hydrogel at different conditions. Figure 3.4 (a, b) shows example data for 16. The 
hydrogels were prepared using the GdL method at concentration of 5 mg/mL of the 
dipeptide. Figure 3.4 (a) shows the strain sweep. The data shows that the gel still has 
solid-like properties until a strain of about 5% and the deformation of the gel starts 
after this point. Here, we can see a fast drop of G’ and this indicates that after this point, 
the hydrogel has more liquid-like properties than solid-like properties, indicating 
breakdown of the structure of the hydrogel. A crossover point at a strain of about 5% is 
typical for this kind of hydrogel23. Figure 3 (b) shows the frequency sweep of the same 
hydrogel. From Figure 3.4 (b), it can be seen that the hydrogel has strong solid-like 
properties, with a G’ of over 104 Pa.  G’’ was approximately 103 Pa. As expected for this 
kind of hydrogel18, 23, 27, 32, both G’ and G’’ were relatively independent of frequency. This 
data shows that compound 16 is a good hydrogelator. Furthermore, we noted that the 
G’ is different in the strain and frequency sweep, although the data for the same 
hydrogelator. These differences might be simply because we have prepared two 
different samples of the same hydrogelator, one to measure the strain sweep and the 
other to measure the frequency sweep. This may lead to errors in the preparation. 
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Figure ‎3.4: An example of studying the mechanical properties of compound 16. (a) strain sweep (b) 
Frequency sweep. 
 
 
 
(a) 
(b) 
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Table 3.4 shows the rheology studies for the dipeptides that formed hydrogels (Table 
3.4 reports the Gʹ and Gʹʹ values). Gʹ and Gʹʹ for compound 20 were low, although a gel 
was still formed.  
In some cases, the rheology was very different for the gels prepared by the different 
methods. For example, compound 17 formed a turbid gel with both methods, but has 
higher G’ when the gel is formed by the GdL method than by the solvent switch method 
(27 kPa and 14 kPa respectively). However, the Gʹ of the gel formed from 12 was 26 kPa 
using the GdL method and 25 kPa using the solvent switch method, showing that the 
GdL method does not always result in stronger gels. Figure 3.5 shows examples of some 
dipeptides that formed gels using the GdL method and the solvent switch method where 
transparent gels are formed. Transparency will be a key parameter for uses in energy 
transfer (see Chapter 4). 
Peptides GdL DMSO 
Gʹ (Pa) Gʹʹ (Pa) Gʹ (Pa) Gʹʹ (Pa) 
Compound 12 26000 6000 25000 6000 
Compound 13 6000 300 6000 1000 
Compound 16 23000 4000 16000 3000 
Compound 17 27000 3000 14000 2000 
Compound 18 4000 400 5000 4000 
Compound 19 6000 800 1400 200 
Compound 20 2000 300 20 15 
Compound 21 3000 400 92000 11000 
Compound 22 3000 200 8000 400 
Compound 23 300 40 1000 130 
Compound 24 7000 1000 12000 2000 
Compound 25 15000 3000 - - 
Compound 32 3000 300 1000 200 
Compound 33 60000 7000 5000 500 
Table ‎3.4: Gʹ and Gʹʹ of the dipeptides that have formed hydrogels using GdL and DMSO methods. 
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Figure ‎3.5: (left): Hydrogel image of compound 16 using the GdL method. (Right): hydrogel image 
of compound 32 using the solvent switch method.  
 
3.3.1.2- Hydrogelation of phenanthrol dipeptides: 
Hydrogels based on phenanthrol dipeptide derivatives were prepared using the 
different strategies as shown in Figure 3.6. Table 3.5 shows hydrogelation results of 
phenanthrol dipeptide derivatives. From the results, it can be seen that compound41 
formed a turbid gel using GdL method and a gel mixed with water was formed using 
DMSO: water method. Compound 42 formed turbid gels using both methods, whereas 
compound 40 formed transparent gels by both methods. These results agreed with the 
observations for the naphthalene dipeptides (above) that the more hydrophobic 
peptides may lead to more turbid hydrogel. Table 3.6 shows the rheology results (G’ and 
G’’) of phenanthrol hydrogels formed by both methods. From Table 6, we note that the 
strongest gel formed by both methods was compound 40. Also, we can see that 
compound 41 formed a hydrogel using the GdL method, whereas it did not form a 
hydrogel using the solvent switch method. This agreed with previous work which 
illustrated that the way of preparing gel is not correlated to the formation of the gel33. 
 
 
Figure ‎3.6: The general structure of phenanthrol dipeptides  
 
Compound 32 Compound 16 
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Dipeptide Gel formation DMSO: H2O Gel formation GdL 
Compound 40 Transparent Hydrogel Transparent Hydrogel 
Compound 41 Turbid hydrogel Mix gel with water 
Compound 42 Turbid hydrogel Turbid hydrogel 
Table ‎3.5: Phenanthrol hydrogel form in GdL and in DMSO: water. 
Dipeptide GdL DMSO 
Gʹ (Pa) Gʹʹ (Pa) Gʹ (Pa) Gʹʹ (Pa) 
Compound 40 24000 3000 2000 300 
Compound 41 700 60 – – 
Compound 42 2000 200 2000 90 
Table ‎3.6: G’ and G’’ of phenanthrol hydrogels in GdL and DMSO: Water method. (– ) means did not form 
hydrogel and the rheology did not measure. 
For all of these gels, the structure is thought to be a result of the formation of fibres by 
the self-assembly of the dipeptides. To show that this is also the case here, we examined 
the hydrogel of compound 40 using scanning electron microscopy (SEM) of the 
hydrogel of compound 40 (prepared using the GdL method at peptide concentration of 
5 mg/mL). We have chosen this hydrogel because the dipeptides hydrogels based 
phenanthrol ring has not been studied before and chosen compound 40 because we 
examined the other phenanthrol hydrogel and they did not form a good fibres 
comparing to compound 40. The hydrogel was allowed to stand on the silicon wafer 
while it was air-dried for 1 hour. Figure 3.7 shows an example SEM image indicating 
that this hydrogelator formed fibres. Further work might be concentrated on other 
conjugated dipeptide hydrogels and also may use Cryo-SEM for different conjugated 
dipeptide hydrogels to ensure that the samples are completely dried by using the 
freeze-dry treatment. 
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Figure ‎3.7: SEM image of compound 40 showing the fibre form after the gelation. Inset is the 
hydrogel image of the peptide in GdL at concentration of 5mg/ mL.  
 
3.3.1.3- Hydrogelation of anthraquinone dipeptides: 
Hydrogels were also formed from anthraquinone dipeptide derivatives with the same 
two methods. The general structure of the dipeptide is shown in Figure 3.8. Table 3.7 
shows the gel formation and the rheology results of compound 47. From the results, we 
note that G’ of the gel formed from compound 47 prepared using GdL was higher than 
the G’ of the gel formed by the solvent switch method. Overall, looking at the 
naphthalene and phenanthrol dipeptide hydrogel data, it appears that the GdL method 
can result in stronger gels than the solvent switch method. However, the hydrogels 
formed from 47 by both methods were not very strong, having a lower G’ and G’’ 
comparing to the other functionalised dipeptides above. 
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Figure ‎3.8: The chemical structure of compound 47.  
 
Dipeptide Gel formation GdL DMSO 
GdL DMSO Gʹ (Pa) Gʹʹ (Pa) Gʹ (Pa) Gʹʹ (Pa) 
Compound 47 Turbid 
Gel 
Turbid 
Gel 
6000 800 2000 100 
Table ‎3.7: Hydrogel formation and rheology results of compound 47. 
 
3.3.1.4- Hydrogelation of carbazole dipeptides: 
Hydrogels based on carbazole dipeptide derivatives were prepared using the two 
different strategies. The general structure of the dipeptides is shown in Figure 3.9. Table 
3.8 shows the hydrogel formation results of the carbazole derivatives and the G’ and G’’ 
for the resulting gels. From the results, we can see that none of the carbazole derivatives 
formed gels using the solvent switch method, except compound 55 which formed a 
turbid gel. Using the GdL method, all derivatives formed gels. Here, we noted that 
changing the method of preparing the hydrogel affected the formation of the hydrogel 
result. This result agreed with other research that reported changing the solvent and 
the way of preparing the hydrogel can lead to gel or non-gel formed and also can change 
their mechanical properties11. This might be due to changing the condition of the 
preparing the hydrogel and changing the kinetic of the hydrogel formation. Compounds 
51a and 53 formed transparent gels, whereas 54, 55 and 56 formed turbid gels. The 
turbidity was lower when we decreased the concentration from 5 mg/mL to 2 mg/mL 
(compound 54) and to 0.5 mg/mL (compound 55). The rheology results show that 
compound 53 formed the strongest gel (G’ of 44 kPa) while compound 51a formed the 
weakest gel (G’ of 6000 Pa). Also, it can be clearly seen that when we decreased the 
concentration, the strength of the hydrogel decreased. For example, the G’ of compound 
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54 that formed a turbid gel at 5 mg/mL was 4000 Pa, which decreased to 500 Pa when 
we decreased the concentration to 2 mg/mL to form a transparent gel. A dependence of 
G’ on the concentration is expected31. As the concentration is lowered, we would expect 
less fibres to be formed and so a weaker network. Similarly, the turbidity of the gel 
formed using compound 55 was decreased when we decreased the concentration from 
5 mg/mL to 0.5 mg/mL.  As a result, it can be seen that decreasing the concentration 
leads to the formation of a weaker, but more transparent hydrogel. Figure 3.10 shows 
an example of hydrogel formation using carbazole derivatives and both methods 
(compound 53 and 54 using the GdL method and the solvent switch method).  
 
 
Figure ‎3.9: The general structure of carbazole dipeptides.  
 
Dipeptide Gel formation 
DMSO: H2O 
Gel formation GdL G’(GdL) 
(Pa) 
G’’(GdL) 
(Pa) 
Compound 51a Mix gel with 
water 
Transparent Gel 6000 700 
 Compound 53 Mix gel with 
water 
Transparent Gel 44000 6000 
 Compound 54 Mix gel with 
water 
Turbid at 5mg/mL 3700 400 
Transparent at 2mg/mL 500 30 
Compound 55 Turbid Gel Turbid Gel at 5mg/mL 41000 6000 
Compound 56 Precipitate Turbid Gel 26000 4000 
Table ‎3.8: The hydrogel formation by GdL and by the solvent swtich method and the rheology results. 
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Figure ‎3.10: An example of hydrogel formation of carbazole derivatives in both methods.  
 
3.3.1.5- Hydrogelation of anthracene dipeptides: 
Hydrogels based on anthracene dipeptide derivatives (Fig. 3.11) were prepared using 
the two different strategies. Hence, we attempted to prepare 12 hydrogels from 6 
dipeptides functionalised with an anthracene ring. However, none of the anthracene 
derivatives were able to form a gel using either method. Instead, they formed 
precipitates or turbid solutions (i.e. a soft precipitate like powder that suspended in the 
solution). Figure 3.12 shows examples of attempting to prepare hydrogels using both 
methods at a dipeptide concentration of 5 mg/mL, that lead to precipitate or turbid 
solutions. Table 3.9 summarises the hydrogelation results of anthracene dipeptide 
derivatives. The reason for this lack of gelation may be the lack of flexibilty between the 
anthracene ring and the amino acid that prevent forming non-covalent interaction such 
as hydrogen bonding leading to non formation of fibres and non-hydrogel. Other work 
has synthesised dipeptide-based anthracenes9, but with a different linker between the 
anthracene ring and the amino acid sequences and this peptide formed a hydrogel (Fig. 
3.13). From Figures 3.11 and 3.13, we can see that dipeptides 66 and 75 have the same 
aromatic group and the same amino acid sequences, but different linker. As reported 
previously19, the linker can affect the formation of the hydrogel. We noted that 
compound 75 has OCH2 linker between the aromatic group and the amino acid 
sequence which leads to flexibility between  the aromatic group and the amino acid 
sequence, hence lead to the formation of the hydrogel. In contrast, compound 66 does 
not have linker, therefore it leads to non-gel formed due to the lack of of flexibility. 
DMSO: water GdL 
Compound 53 
 
GdL 
Compound 54 
DMSO: water 
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Figure ‎3.11: The general structure of anthracene dipeptides.  
 
 
Figure ‎3.12: Examples of non-hydrogel images of anthracene derivatives using the GdL and 
solvent switch methods. 
 
Figure ‎3.13: The general structure of anthracene dipeptide tha t formed hydrogel9. 
 
 
 
 
 
 
DMSO: water DMSO: water GdL GdL 
Compound 66 Compound 63 
GdL GdL DMSO: water DMSO: water  
Compound 67 Compound 64 
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Gel formation 
Water  : DMSO 
Gel formation 
GdL 
Dipeptide 
Precipitate Precipitate Compound 62 
Precipitate Precipitate Compound 63 
Turbid solution Turbid solution Compound 64 
Precipitate Precipitate Compound 65 
Turbid solution Turbid solution Compound 66 
Turbid solution Turbid solution Compound 67 
Table ‎3.9: hydrogelation results based on anthracene derivatives using the GdL and solvent switch methods. 
 
We hypothesised that the lack of gel formation might be due to either the final pH or the 
kinetics of gel formation. Hence, we have attempted to prepare hydrogels from the 
anthracene dipeptides by changing the concentration of the GdL. However, no gels were 
formed. For example, compound 66 formed turbid solutions and 63 formed precipitates 
at all GdL concentrations (Fig. 3.14).  
 
 
 
Figure ‎3.14: An example of precipitate solutions of compound 63 with different concentrations of 
GdL. 
 
We have tried to study the formation of crystals from the anthracene dipeptides because 
the crystal structure may provide insights of the stability of the interactions as the gel 
can form fibres20. We attempted to recrystallise anthracene dipeptides 63, 66, 64 and 
67 from different solvents such as methanol, ethyl acetate or diethyl ether in order to 
study the crystal structure. Unfortunately, no crystals were formed. Instead, they 
formed precipitates (for example, 63 or 64, Fig. 3.15).  
Compound 63 Compound 66 
1mg/ mL 5mg/ mL 1mg/ mL 5mg/ mL 
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Figure ‎3.15: Examples of recrystallisation images of anthracene derivatives with methanol.  
 
3.3.1.6- Hydrogelation of pyrene dipeptides: 
Hydrogels based on pyrene dipeptide derivatives were previously prepared using 
different approaches18. Zhang et al. 34 illustrated an increase of the mechanical 
properties of hydrogels that formed via self-assembly in water by using a method based 
on molecular recognition. A weak hydrogel (pyrene-D-Ala-D-Ala) was formed with a 
storage modulus (G’) of 120 Pa. The strength of pyrene hydrogel increased when 
vancomycin was added to a G’ of 160000 Pa. Furthermore, when the L-Ala-L-Ala was 
used, it formed hydrogel with ten times lower in G’ over the gelator alone. Here, we have 
prepared pyrene dipeptides with a different linker compared to Zhang et al. The general 
structure of compound 72 is shown in Figure 3.16. We prepared hydrogels from 
compound 72 with different concentration of dipeptides using the GdL method and the 
solvent switch method at different ratios of DMSO: water. This was to study the 
turbidity of the resulting gels, because one of the aims of this project was to study the 
fluorescence in order to study energy transfer between dipeptides linked to different 
aromatic groups which are discussed in Chapter 4. Compound 72 formed turbid gels at 
a concentration of 5 mg/mL. However, at lower concentrations, a transparent hydrogel 
was formed. Similarly, we attempted to change the ratio of DMSO to water for the same 
reason. Table 3.10 shows the results for the GdL with different concentrations of 
dipeptides (5 mg/ mL to 0.5 mg/ mL) and the solvent switch method at different ratio of 
DMSO: Water (0.1:1.9 to 0.05:1.95) with a constant concentration of dipeptide. From the 
results, we can see that the turbidity increases when we increase the concentration of 
Compound 66 Compound 63 
 
Compound 64 
 
Compound 67 
 
138 | P a g e  
 
dipeptide or when we increase the ratio of DMSO to water. Figure 3.17 (a) shows 
photographs of the hydrogel formed by compound 72 at different concentrations of 
dipeptide to study the turbidity. Figure 3.17 (b) shows the G’ of compound 72 at a 
concentration of 5 mg/mL and 0.5 mg/mL. It can be clearly seen that as expected the G’ 
of the gel formed at a concentration of 5 mg/mL is higher than that of the gel formed at 
a concentration of 0.5 mg/ mL. Table 3.11 shows the rheology results of compound 72 
using both methods and different concentrations of dipeptides in GdL (5 mg/mL to 0.5 
mg/mL) and different ratio of DMSO: Water (0.1:1.9 to 0.05:1.95). From the results, we 
can see here compound 72 formed stronger turbid hydrogel at high concentration of 
dipeptide using the GdL method (at 5 mg/mL, the G’ is 25000 Pa) than using the solvent 
switch method at high ratio of DMSO: Water (at a ratio of 0.1:1.9, the G’ is 14000 Pa). 
Also, by decreasing the concentration or the ratio of DMSO, the turbidity decreased and 
a weaker gel was formed.  
 
 
Figure ‎3.16: The chemical structure of compound 72.  
Compound 72 Gel formation 
DMSO: water (0.1:1.9) Turbid Gel 
DMSO: water (0.05:1.95) Transparent Gel 
DMSO: water (0.03:1.97) Transparent Gel 
GdL /5 mg/mL Turbid Gel 
GdL /2 mg/mL Turbid Gel 
GdL /1 mg/mL Turbid Gel 
GdL /0.5 mg/mL Transparent Gel 
Table ‎3.10: Hydrogel form of compound 72 using the GdL and solvent switch methods with different 
concentration. 
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Figure ‎3.17: (a) Hydrogel images of compound 72 from left to right using the solvent switch 
method (0.1:1.9), and using the GdL method with different concentrations of dipeptide (5 mg/ mL 
to 0.5 mg/ mL). (b) The rheological data for gels formed from compound 72 at concentration of 5 
mg/ mL and 0.5 mg/ mL. 
 
 
 
 
 
 
 
 
0.1: 1.9 0.5mg/mL 1mg/mL 2mg/mL 5mg/mL 
(a) 
(b) 
140 | P a g e  
 
Compound 72 G’ (Pa) G’’ (Pa) 
DMSO: water (0.1:1.9) 14000 2600 
DMSO: water (0.03: 1.97) 20 20 
DMSO: water (0.05: 1.95) 10 3 
GdL (5 mg/mL) 25000 5000 
GdL (2 mg/mL) 4000 600 
GdL (1 mg/mL) 600 60 
GdL (0.5 mg/mL) 200 20 
Table ‎3.11: The rheology results of compound 72 in both methods with different concentrations of dipeptides 
and different ratio of DMSO: water. 
 
In the cases of the other dipeptides examined, the gels were stable with time. However, 
we observed that the pyrene dipeptide gels were not stable. We have measured the 
rheology with time for compound 72 at a concentration of 5 mg/mL as shown in the 
Figure 3.18. The data shows that the hydrogelation process started after 45 minutes, 
where G’ starts to dominate over G’’. After 1 hour, the hydrogel has formed and there is 
a plateau in both the G’ and G’’.  However, it can be clearly seen that the hydrogel 
became instable after about 2 hours where we can see the instability of G’ and G’’ during 
the hydrogelation process. After about 8 hours, the deformation has occurred as a result 
of the instability of the hydrogel, leading to a decrease in the solid like properties and 
deformation of the hydrogel. As a result, this hydrogel has unusual mechanical 
properties for its hydrogelation process over the time, as it shows instability after a 
certain time. 
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Figure ‎3.18: Time sweep of compound 72 that shows the formation of the hydrogel with time. It 
can be seen that after about 1 hour  the hydrogel has formed because at this time the ratio 
between G’ and G’’ has increased, and this means that increasing the solid like properties leading 
to the formation of the hydrogel. Then, the hydrogel has deformed after about 8 hours.  
 
3.3.2-  pH and pKa measurements: 
For similar dipeptides, it has been reported that the hydrogels form when the pH 
decrease below the pKa12, 19, 23, 35. pKa is the acid dissociation constant also known as the 
acidity constant and is a quantitative measure of the strength of an acid in solutions. pKa 
is defined according to Henderson-Hasselbalch equation where: 
 
pH = pKa + log 
[ 𝑨− ]
[ 𝑯𝑨]
 
 
Previous research has shown that the pKa decreases with an increase in temperature for 
naphthalene dipeptides and it increases with an increase in hydrophobicity12, 19, 23, 35. 
We have utilized a measurement method of measuring the pKa via titration with 0.1 M 
HCl. Hydrochloric acid is used to decrease the pH from a high pH (approximately 10 – 
12) to low pH (about 3). Figures 3.19 and 3.20 show examples of titration results of 
compounds 17 and 22 to determine the pKa (chosen as examples of peptides with the 
same aromatic group, but with different number of substituents and different 
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hydrophobicity). From Figure 3.19 and 3.20, the apparent pKa of the material can be 
established. The data shows the initial pH after dissolution to be 11.2 and 11.6 
respectively for these two dipeptides. On addition of HCl, the pH drops rapidly to a 
plateau at pH 7.0 and 6.2 respectively. This is the buffering region, where the pKa of the 
dipeptide is reached. The pH is then shown to drop over time until pH 3, where 
equilibrium is reached. 
 
 
Figure ‎3.19: The titration of compound 17 to determine the pKa. 
 
 
 
Figure ‎3.20: The titration of compound 22 to determine the pK  a.
 
pKa  
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Not all cases showed a single pKa. For example, Figure 3.21 shows the pKa of compound 
14 again measured by adding 0.1 M HCl. The data show the initial pH after dissolution 
to be 12. After the first addition of HCl, the pH drops slowly to about 10.6 where a first 
plateau reached. This is the buffering region, where might be the pKa 1 of the dipeptide 
is reached. The pH then drops until pH 6.5, where is the second plateau reached (pKa 2). 
Then the pH continues dropping until pH 3.0, where equilibrium is reached. According 
to other work,12 two different pKa are possible. This is because there might be different 
structures formed as the pH decreases. Here, the data imply that there are two apparent 
pKas, pKa 1 at 10.6 and pKa 2 at 6.5, although it is not clear where is the exact pKa. 
Formally, the pKa should be the point where 50% of the molecules are deprotonated. 
From Figure 3.21, this is at pH 6.5, which is pKa 2. These two pKas might arise from the 
possibility of forming artefacts that resulting from the formation of a hydrogel during 
the titration process. 
 
 
  
Figure ‎3.21: The changes in the pH on adding HCl to measure the pKa of compound 14 . 
 
Another way of measuring the pKa is to add GdL to the solution. This should help 
minimise artefacts from gelation. Figure 3.22 shows decreasing the pH over time of 
compound 14 on adding GdL. Here, we note that the pH dropped quickly, with no sign of 
Table 4 
pKa 1 
pKa 2 
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a plateau at pH 10.6. However, it can be noted that there is correlation between Figure 
3.21 and 3.22. After adding the GdL, the pH buffers at approximately 6.5, very close to 
the value of pKa 2 in Figure 3.21. The lack of an observable pKa 1 may be due to fewer 
artefacts from the pH measurement or may be due to a slightly different process when 
the pH is changed with GdL instead of HCl. 
 
 
Figure ‎3.22: An example of pH measurement over the time for compound 14 for 24 hours where 
the pH is changed using GdL.  
 
Other research has determined that there is a correlation between the apparent pKa and 
the hydrophobicity of each dipeptide12, 19, 35. As an extension to these findings, it was 
interesting to discuss whether the conjugated dipeptides with different aromatic groups 
and different substituents formed here exhibit similar behaviour. Hence, the 
determination of the pKa of the other dipeptides was carried out and analysed in the 
same manner as dipeptiode 17, 22 and 14 (Figures 3.19, 3.20, and 3.21). Tables 3.12 
shows the pKa measured and logP that calculated mathematically36 for the dipeptides. 
We can see that the pKa increases with increasing of logP for almost dipeptides. 
 
 
 
pKa 
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Table ‎3.12: The pKa and logP measurements36 of dipeptides. 
 
Figure 3.23 shows that there is a general increase of the pKa with increasing of logP for 
the substituted naphthalene dipeptides, which have bromine substituent with different 
positions at the 1, 6 and 1,6- position and have different linker between the naphthalene 
ring and the amino acid sequence, –CH2, –OCH2. Figure 3.24 shows data for the other 
dipeptides conjugated to different aromatic rings such as carbazole, anthracene, 
anthraquinone, pyrene and phenanthrol that form hydrogels. This group of dipeptides 
covers a wide range of hydrophobicities and pKa. There is an apparent relationship 
between these two factors and this agrees with the results of Chen et al.19 However, 
there seems to be a critical value of logP. Above this value (about 2.5), there is no 
Peptide LogP pKa Peptide LogP pKa 
10 1.390 5.7 32 0.932 4.6 
11 0.619 5.0 33 2.178 5.8 
12 0.832 5.4 40 5.478 7.4 
13 2.080 5.5 41 6.842 7.3 
14 2.183 pKa 1 = 10.6 
pKa 2 = 6.5 
42 6.160 7.5 
15 1.404 5.7 47 1.474 6.6 
16 1.617 6.3 53 0.976 6.1 
17 2.865 7.0 54 3.119 5.6 
18 2.920 7.0 55 1.755 7.5 
19 2.141 7.4 56 2.437 7.7 
20 2.354 6.6 62 2.540 5.7 
21 3.602 6.6 63 1.974 5.0 
22 1.520 6.2 64 3.222 5.8 
23 0.741 6.0 65 0.981 5.6 
24 2.202 7.0 66 1.761 7.7 
25 0.955 6.3 67 2.614 5.7 
30 1.490 7.4 72 2.688 7.4 
31 0.717 4.8 
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further increase in the pKa. This shows that there are two values; one shows an increase 
in the pKa with the increase of logP, indicating to a linear relationship between the pKa 
and the logP, hence a correlation between the hydrophobicity and the pKa, agreeing 
with previous work19, where it is reported a linear relationship between pKa and logP19. 
Other value shows no more increase in the pKa above the value of about 2.5. This result 
above this value is shown for compound 20, 21, and 25. These compounds have 
different substituents (21, 25) and different amino acid sequences (20, 21, or 20, 25), 
although they have similar pKa and logP values. This shows that these conjugated 
dipeptides with different aromatic groups and different substituents formed here have 
similar behaviour. Also the data in Figure 3.24 show that changing the aromatic ring 
follow the same trend for the correlation between the pKa and logP. Furthermore, a 
linear regression to data for the dipeptides with r2 of 0.3661(Fig. 3.23) and 0.3086 (Fig. 
3.24) shows that it is not close to fit the data. As a result, this correlation between pKa 
and logP may give the choice of appropriate gelator, although it is still unclear whether 
it can form gel or not. 
It must first be noted that the pKa of the terminus of each dipeptide is a lot higher than 
what is expected for the amino acids. For example, the pKa for the –COOH of a glycine 
unit is agreed to be around 235. As shown in Table 3.12, compound 16, which has a 
glycine terminus, has an apparent pKa of 6.3. This observation can be explained by the 
hydrophobic interactions that come from the different amino acids used. The shift of the 
pKa observed in water arises from the competition for fully hydrated shells between 
polar groups and hydrophobic groups in close proximity, as postulated by Urry et al.35 It 
therefore makes sense in relation to these data that as hydrophobicity of the side chain 
increases, this competition increases, and hence a more positive shift in pKa is acquired. 
Elsewhere, the use of such hydrophobic groups is demonstrated by Tang et al. by 
creating an Fmoc diphenylalanine compound which gels water at physiological pH.37 
Increase the π-π stacking of the fluorenyl and phenylalanine side chains is the main 
contributor to hydrophobic interaction in this case, enabling favourable self-assembly at 
a pH of 7.  
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Figure ‎3.23  and logP for naphthalene dipeptides (data shown in Table 3.12).  : The pKa
 
 
Figure ‎3.24: The pK  and LogP of other conjugated dipeptides (carbazole, anthraquinone, a
phenanthrol, pyrene and anthracene) (data shown in Table 3.12).  
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3.3.3- FT-IR of Hydrogels: 
For most of this Chapter, we have been interested in whether gels are formed. However, 
an important question is how these gels are formed. Infra-Red spectroscopy (FT-IR) has 
been used to determine the secondary structure of peptides and proteins12, 19, 23, 38. The 
secondary structure of a peptide can be defined as the three-dimensional form it takes 
as a result of non-covalent interaction39. Both β-sheets and α-helices are examples of 
secondary structure. The conformations of peptides are largely decided by the degrees 
of freedom they enjoy around the C-NH and C-C=O bond40, 41.  
Here, we studied the FT-IR spectroscopy of dipeptide hydrogels to determine the 
functional groups (carboxylate and amide group) and to study the presence of β-sheet 
structure. β -sheet structure has been suggested before as one of the driving forces for 
self-assembly of this type of dipeptide, with previous work demonstrating the presence 
of antiparallel β-sheets13, 41. 
Samples were prepared for FT-IR by preparing a gel at a concentration of 5 mg/mL 
suspension in DMSO with D2O (the ratio between DMSO and D2O was 0.1: 1.9). 
Deuterated solvents were used to avoid the water absorption band combining with the 
amide I band.38 Samples were left overnight to complete hydrogelation. Figure 3.25 
shows the IR spectra of compounds 18, 40, and 72. The spectra show the assignment of 
peaks due to the self-assembly of three conjugated dipeptides that have the same amino 
acid sequence (valine amino acid) and different aromatic groups, naphthalene, 
phenanthrol and pyrene to study β-sheet structure. IR spectroscopy shows different 
peaks, the most significant peaks are between 1600 cm-1 to 1700 cm-1 where the C=C 
bonds, amide and carboxyl groups occur26. From the spectra we can see that the peaks 
between 1600cm-1 to 1650cm-1 are different. This is because the hydrogelators have 
different aromatic groups, where at these wavenumbers C=C stretch of aromatic groups 
occurs. This IR result illustrates that these peaks may indicate to the presence of 
antiparallel β sheets, hence it provided evidence to determine that the self-assembly of 
the peptides resulted in the formation of β sheets via the H-bonding interactions of the 
dipeptide backbones leading to the formation of the hydrogel as described elswhere12, 
13. 
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Figure ‎3.25: IR spectroscopy of three dipeptides conjugated to naphthalene (compound 18), 
pyrene (compound 72) and phenanthrol ring (compound 40). 
 
Samples of compound 51a were prepared for FT-IR at a concentration of 5 mg/mL in 
D2O or H2O at pH 11. Sufficient GdL was then added to ensure each hydrogel had an end 
pH point of between 3 and 3.3, and samples were left overnight to complete 
hydrogelation. IR was measured for these samples wet and also after drying the gel. The 
data were compared to the data from the as-synthesised peptide to study the presence 
of β-sheets. Figure 3.26 shows the IR spectroscopy results of compound 51a in D2O, H2O 
wet and dry gel and the powder of dipeptide. The Figure shows the peaks that occur 
between 1600 and 1700 cm-1. From the Figures we can see two peaks in D2O at 1640 
cm-1 and at 1656 cm-1 which one assigns to the amide groups. In contrast, these peaks 
cannot be seen in H2O because there is a broad peak of OH occurs at the same 
wavenumbers. Also, in the powder state there are no peaks between 1600 and 1700 cm-
1 because there is no self-assembly. This result may indicate the presence of antiparallel 
β-sheets, which implies to the packing arrangement on the assembly. 
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Figure ‎3.26: The IR spectroscopy of compound 51a in D2O (Red) and in H2O wet gel (green), dry 
gel (purple) and powder peptide (blue).  
 
3.4- Conclusion: 
Different functionalised dipeptides can be used as hydrogelators such as napthalene, 
phenanthrol, pyrene, carbazole and anthraquinone dipeptide derivatives. The 
mechanical properties of these hydrogels have been studied. It is still not clear why 
some peptides formed gel and others not. Although the method of preparing hydrogel is 
not correlated with the formation of the gel, changing the method can modify the 
properties of the hydrogel formed. In conclusion, the results showed that the small 
change in the structure of the hydrogelator can affect the formation of the hydrogel and 
the method of how to prepare hydrogel is not relevant with the formation of the 
hydrogel. Moreover, the results showed that there is a correlation between the pKa and 
the hydrophobicity of the peptides. Here we established that the hydrophobicity 
increases with the increase of the pKa. Although it is still not clear why some peptides 
can form hydrogel and others not, these kind of dipeptides conjugated to different 
aromatic groups have different properties and can be used for number of different 
applications such as energy transfer and drug delivery, as we will discuss in the next 
Chapters. 
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Figure 3.27a shows the data plotted the logP against the success of gelation. From the 
Figure, we noted that there is no correlation between the logP and the formation of the 
hydrogel, although perhaps there is a tendency for the molecules with a higher logP to 
form gels. Figure 3.27b shows the data plotted with molecular weight. From the Figure, 
it seems to be more strongly suggest that those molecules with a higher molecular 
weight tend to form gels. Since the higher molecular weight molecules tend to be those 
incorporating phenylalanine as one of the amino acids in the dipeptide sequence, we 
then studied this as a factor (Fig. 3.27c). When neither amino acid in the dipeptide is a 
phenylalanine, there is a 55% chance that the molecule will form a gel. However, when 
either of the amino acids is phenylalanine, there is a 91% chance that the molecule will 
form a gel. If we discount structures based on anthracene dipeptides which did not form 
gel, then 100 % of the molecules formed gels. This does take into account the purity, 
where this factor can affect the gelation results. Therefore, this results show that 
incorporating phenylalanine into the dipeptide is a good way of maximising the chance 
of forming a gel. However, even this should be treated as a rule of thumb as we note that 
there are related dipeptides such as Fmoc-GF that do not gel.42, 43 
 
 
Figure ‎3.27: Histogram showing the ability of a dipeptide to form a  gel or not based on (a) clogP 
or (b) molecular weight. (c) Shows the number of dipeptides that form gels or not that do not 
(left) or do (right) contain phenylalanine as one of the amino acids.  
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CHAPTER 4 
Fluorescence And Energy 
Transfer 
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4- Fluorescence and energy transfer: 
4.1- Introduction: 
Hydrogels have been used in different applications such as drug delivery1, cell 
culturing2 and energy transfer3-6. Suitably protected dipeptides such as naphthalene 
peptides can be used as a fluorescent hydrogelators3, 7. According to previous research, 
energy transfer between organised aromatic groups has been utilised in different 
applications such as light-harvesting4, 5, 8 and molecular electronics3, 8, 9. One of the main 
strategies of organising the chromophores is to use materials that self-assemble to give 
organogels (gels which contain organic solvent)6. When the fibre-forming molecules 
contain a suitable donor chromophore, these fibres can be used to transfer energy to 
acceptor chromophores10. For example, cationic glutamate derivatives have been 
assembled with anionic naphthalene and anthracene-based fluorophores and used to 
prepare light-harvesting hydrogels3, 11. In addition, it has been found there can be 
energy transfer between a naphthalene-based hydrogelators and a dansyl molecule3, 12. 
Chen et al. illustrated that when the acceptor chromophore was incorporated in the 
aromatic groups, efficient energy transfer occurred. For example, they showed that 
there is an increase in fluorescence on formation of β-sheets between the dipeptides, 
because the dye incorporates within these β-sheets. The same authors also used 
another system where both donor and acceptor were functionalised dipeptides 
conjugated to different aromatic groups (donor is naphthalene dipeptide derivative and 
the acceptor is anthracene dipeptide derivative3). They reported that energy transfer 
occurred between naphthalene-diphenylalanine and a dansyl derivative leading to 
emission at 485 nm. In addition, there was emission at 355 nm from naphthalene 
diphenylalanine alone. Also, a transparent self-supporting hydrogel at a concentration 
of 2.2 mM and at pH of 4 was formed from this naphthalene diphenylalanine and dansyl 
derivative (Fig. 4.1)3. They also reported that there is energy transfer between 
naphthalene and anthracene derivatives3, 11. Elsewhere, MacPhee et al. showed energy 
transfer between donor and acceptor chromophores conjugated to fibre-forming 
peptides13. 
 
Supratim et al. reported that pyrene conjugated to glutamate derivatives formed a gel in 
benzene and cyclohexane, whereas a porphyrin functionalised derivative did not form 
gel. They also reported that energy transfer from pyrene to porphyrin occurred when 
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the gel of the pyrene-glutamate containing the porphyrin was prepared14. Furthermore, 
efficient transfer of excitation energy during nano-structures has been evidenced in an 
anthracene light-harvesting matrix doped with less than 1 mol% of a tetracene energy 
trap by Alexandre et al.15 They have shown that anthracenes, tetracenes and pentacenes 
self-assemble into stable nano-structures due to a 2,3-bis-n-alkoxy substitution. The 
fibres forming these 3-D supramolecular networks could be aligned with intense 
magnetic fields or mechanically, creating these materials of interest for different 
applications15. Moreover, pyrene conjugated to oligopeptides has been reported to give 
rise to fluorescent hydrogels16. 
 
 
 
Figure ‎4.1: (a) Structure of naphthalene-diphenylalanine (I) and dansyl derivative (II). (b) I form 
a transparent self-supporting hydrogel at a concentration of 2.2 mM and at pH of 4 (left). A 
transparent self-supporting gel was also formed in the presence of II (0.084 mM). (c) Energy 
transfer occurs between I and II leading to emission at 485 nm in addition to emission at 355 nm 
from I alone. From Chen et al..3 
 
In this Chapter, we have used our functionalised dipeptides that were described in 
Chapters 2 and 3. The aromatic groups that we used to functionalise the dipeptides are 
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9-anthracene carboxylic acid, 2-anthraquinone carboxylic acid, 1-pyrene carboxylic 
acid, carbazole and 9-phenanthrol. We prepared dipeptides from these starting 
materials using the three different approaches as explained in Chapter 2. In this 
Chapter, we describe a fluorescence study of the functionalised dipeptides that formed 
transparent hydrogels, with the aim of studying energy transfer between two different 
aromatic pairs such as naphthalene and anthracene, naphthalene and pyrene, 
anthracene and carbazole, and naphthalene and anthraquinone. These pairs were 
chosen on the basis of their excitation and emission wavelengths. 
 
4.1.1- Mechanism of energy transfer: 
Energy transfer can happen via two mechanisms: 
 
4.1.1.1- Förster energy transfer: 
Förster energy transfer is a mechanism that describes transfer energy (not electron 
transfer) between two compounds, one called the donor and the other called the 
acceptor. Here, the donor is excited by a photon from its ground state (S0), which then 
relaxes to its excited singlet state (S1). Then, the energy is transferred to the acceptor, 
resulting in excitation of the acceptor17-19. The excited acceptor then emits a photon and 
returns to its ground state (Fig. 4.2). The main conditions required for energy transfer 
are: 1) the donor and the acceptor must be in close proximity (typically 1 – 10 nm) and 
2) the emission spectrum of the donor must overlap with the excitation spectrum of the 
acceptor (Fig. 4.3). 
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Figure ‎4.2: shows the Förster energy transfer mechanism19. 
 
 
 
 
Figure ‎4.3: shows the overlap between the donor and acceptor to transfer energy. 
 
4.1.1.2- Dexter energy transfer: 
Dexter energy transfer is also called short range or exchange energy transfer. Here, the 
electron in its excited state transfers from the donor to the acceptor via a non-radiative 
process (without emitting a photon)20. Here, the main condition for energy transfer is a 
wave function overlap.  
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The differences between Förster and Dexter energy transfer are the length scale and the 
underlying mechanism. In the Dexter mechanism, the energy transfer occurs between 
donor in its excited state (D*) and the acceptor in its ground state (A) by exchange of an 
electron between the donor and the acceptor without the emission of a photon (non-
radiative) resulting in return the donor to its ground state (D) and the excitation of the 
acceptor to its excited state (A*) (Fig. 4.4). In the Förster mechanism, the energy 
transfer between donor and acceptor occurs via the emission of a photon17. 
 
 
Figure ‎4.4: shows the Dexter energy transfer mechanism. 
 
4.2- Experimental section: 
4.2.1- Fluorescence studies:  
Fluorescence studies the emitted light from a material. Here, fluorescence spectroscopy 
was carried out using a Perkin Elmer luminescence spectrometer LS55. Gels were 
prepared by two methods. In the DMSO: Water method, 10 mg of the peptide was 
dissolved in 100 µL of DMSO and then 1.9 mL of deionised water was added to the 
mixture in 1.0 cm path-length cuvette made out of PMMA. The sample was left to form 
hydrogel at room temperature overnight. In the GdL method, an equimolar amount of 
0.1 M NaOH was added to a solution of a dipeptide (10 mg) in 2 mL water (at 
concentration of 5 mg/mL) and placed in the 1.0 cm path-length cuvette. For the 
peptides that formed a turbid hydrogel at the concentration of 5 mg/mL, we decreased 
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the peptide concentration to 2 mg/mL (e.g. compound 54) and to 0.5 mg/mL 
(compound 72). The initial pH in all cases was about 10 to 12. Measured quantities of 
GdL were then added to the solutions.  
Emission spectra were recorded for each gel at different excitation wavelengths 
(between 265 nm – 360 nm). We also studied the change in fluorescence of some 
peptide such as compound 72 with time using the GdL method. Here, emission spectra 
were recorded every 60 seconds for the first hour after GdL addition and then every 30 
minutes for 18 hours. The emission spectra were collected between 250–600 nm by 
excitation at 265 nm. The slit widths of the emission and excitation were between 5 
mm, and the scan speed used to collect the spectra was 100 nm/ min.  
 
4.2.2- Energy transfer in hydrogels and organogels: 
The transfer of energy from donor in its excited state to an acceptor is known as Förster 
resonance energy transfer (FRET)17. According to previous research, hydrogels based 
dipeptides conjugated to an aromatic group can transfer energy from donor to 
acceptors3. It has been reported that energy transfer occurs between naphthalene 
dipeptides and dansyl or anthracene dipeptide, where the naphthalene acts as a donor 
and the dansyl and anthracene as acceptors. Energy transfer occurs when dipeptides 
start to self-assemble. This happens when fibres form at low pH. Other research 
reported that chromophore-based organogels can be used as a scaffold for energy 
transfer and light harvesting systems8, 21. Following this research, we have been 
preparing hydrogels based on naphthalene, carbazole, anthraquinone, pyrene and 
phenanthrol dipeptides derivatives to study fluorescence and energy transfer. We 
report the fluorescence studies and the energy transfer between different aromatic 
groups functionalising the dipeptides by preparing hydrogels containing two different 
aromatic hydrogelators. For example, we have prepared hydrogels containing two 
hydrogelators functionalised with naphthalene and pyrene moiety, as naphthalene 
dipeptides can emit light at 355 nm and pyrene dipeptides are excited by light at 355 
nm. 
4.2.2.1- Mix two dipeptides: 
We have prepared stock solution of peptide 1 at different concentrations and then we 
added different amounts (10 µL–20 µL) of a stock solution of peptide 2 at different 
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concentrations to peptide 1 for total volume of 2 mL of the mixture. Then we added GdL 
(0.016g) to the mixture and leave it overnight to form gel (Table 4.1). 
 
 
Mix two 
dipeptides 
Peptide 1 
conc. of 
the stock 
solution 
(mM) 
Peptide 2 
conc. of the 
stock 
solution 
(mM) 
Amount of 
peptide 2 
added to the 
mixture. (µL) 
Total amount 
of the 
mixture. (mL) 
conc. of 
the 
mixture 
in the 
gel 
(mM) 
12 + 62 14 12, 5, 1 10 2 14 
25 +72 4, 2 1 10, 20 2 4, 2 
54 +62 4 12, 5, 1 10 2 4 
72 +62 1 12 10 2 1 
40 + 62 11 12, 5, 1 10 2 11 
Table ‎4.1: Shows the different concentrations and the amount added to prepare hydrogel 
containing two dipeptides.  
 
4.2.2.2- Mix dipeptide and dansyl: 
We have prepared stock solution of dipeptide derivative at different concentrations and 
then we added different amounts (10 µL–20 µL) of a stock solution of dansyl derivative 
at different concentrations to the dipeptide for total volume of 2mL of the mixture. Then 
we added GdL (0.016g) to the mixture and allowed it to stand overnight to form gel 
(Table 4.2). 
 
Dipeptide 
with dansyl 
Peptide 
conc. of the 
stock 
solution 
(mM) 
Dansyl 
conc. of 
the stock 
solution 
(mM) 
Amount of 
dansyl added 
to the 
mixture. (µL) 
Total 
amount of 
the 
mixture. 
(mL) 
 
Conc. of the 
mixture in 
the gel 
(mM) 
40 + dansyl 11 3.4 10 2 11 
54 + dansyl 4 10 20 2 4 
Table ‎4.2: Shows the different concentrations and the amount added to prepare hydrogel containing 
dipeptides and dansyl derivative. 
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4.3- Results and discussion: 
4.3.1- Fluorescence study: 
The fluorescence of dipeptide hydrogels such as Fmoc or naphthalene dipeptide 
hydrogels was previously studied3, 22, 23. Here, we have studied the fluorescence of each 
functionalised dipeptides before forming the hydrogel (i.e. in the solution state) and 
after gelation (the gel state) using both gelation methods (i.e. the GdL and the DMSO: 
Water methods). We measured the fluorescence at different excitation wavelengths 
(265, 285, 300, and 360 nm) and compared between different aromatic groups. The 
reason for this measurement is to know if the different aromatic groups can emit light at 
the same wavelength or not; to use them as a donors or acceptors depends on their 
excitation and emission, because to transfer energy between donor and acceptor, the 
emission of the donor should overlap the excitation of the acceptor (if not, there will be 
no energy transfer occur between them). We also studied the fluorescence of some 
peptides such as compound 72 and compound 16 (Fig. 4.5) with time before and after 
adding GdL as examples to study their fluorescence during the hydrogelation process.  
 
 
 
Figure ‎4.5: The chemical structure of compound 16 and 72.  
 
Fluorescence study of dipeptides hydrogels: 
We have studied the fluorescence using both methods (the GdL and DMSO: water 
methods) of the dipeptide hydrogel conjugated to phenanthrol only (38b, 40), because 
only these hydrogels formed transparent hydrogel using both methods. In order to 
study the fluorescence, the hydrogel should be transparent to allow the light to pass 
through the sample; where the aggregation of the peptides increases in the turbid gel 
leads to affect the fluorescence results. Other conjugated dipeptides that we have 
studied their fluorescence formed a transparent hydrogel just by using the GdL method. 
We have prepared hydrogels at concentrations of the dipeptides of 5 mg/mL. The 
chemical structure of compounds 38b, 40, and 62 are shown in Figure 4.6. Figure 4.7 
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shows the fluorescence spectra of compound 38b after forming hydrogels using both 
methods. From Figure 4.7, we can see that the hydrogel has a similar emission spectrum 
in both methods when excited at 265 nm. The intensity at the maximum emission 
wavelength of 380 nm was about 600 units. The fluorescence of a related peptide 
hydrogel, compound 40, was also similar when formed by both methods. The intensity 
at the maximum emission wavelength of 380 nm was 520 units when gelled by the 
DMSO: water method and 558 units when gelled by the GdL method (Fig. 4.8). These 
data indicates that the method of forming the gel does not significantly affect the 
fluorescence of the phenanthrol ring. Also, we can see that the data in Figure 4.8 is less 
noisy than that in Figure 4.7. This is due to using different scan speeds during the 
measurements. Although here, using different methods does not affect the fluorescence 
result of the hydrogel, it affects the results of their mechanical properties (see Chapter 
3), where it has been reported that changing the method can change the mechanical 
properties of the hydrogel formed7.  
 
 
 
 
Figure ‎4.6 The chemical structure of compounds 38b, 40, and 62.  : 
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Figure ‎4.7: The emission spectra of compound 38b after gelation using the DMSO: Water (red) and GdL 
method (black). The excitation wavelength was 265 nm. 
 
 
Figure ‎4.8: The emission spectra of compound 40 after gelation using the both methods, DMSO: Water (red) 
and GdL method (blue). The excitation wavelength was 265 nm. 
 
 
Change in fluorescence with the gelation: 
We studied the fluorescence of dipeptides functionalised with each aromatic group in 
solution and in the gel state. We followed the change of the fluorescence over time and 
after the self-assembly of the peptide. We have studied the emission of dipeptide 
conjugated to different aromatic groups before gelation (i.e. in the solution state) and 
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after forming a gel to compare between both states. The chemical structures of 
naphthalene and carbazole dipeptide derivatives are shown in the Figure 4.9. Figures 
4.10, 4.11 and 4.12 show the emission results for compounds 12, 72 and 56, 
respectively in the solution and gel states when excited at 265 nm. From the Figures, it 
can be clearly seen that the intensity in the solution state is higher than that after 
forming gel. For example, the intensities of compound 12 at the maximum wavelength 
(353 nm) in the solution state and the gel state are 880 and 732 units respectively (Fig. 
4.10). The decrease in the intensity after forming a hydrogel may due to the self-
quenching between the molecules due to an increase in the concentration of the 
dipeptide caused by the packing and stacking of the aromatic rings. This result is similar 
to that from other research on the fluorescence of Fmoc-dipeptides, where it has been 
shown that a red shift occurred and broad peak after gelation due to self-assembly and 
forming π-π stacking interactions between naphthalene rings24, 25. Zhang et al.25 also 
demonstrated that that the intensity decreased after gelation due to the quenching and 
this result agrees with our data. This self-quenching occurs when the naphthalene rings 
π-π stack. Similarly, we noted that the intensity of compound 72 before gelation at the 
maximum wavelength of 410 nm was more than 1000 units (unfortunately, the LS55 
has a maximum capacity of 1000 units), which decreased to 600 units after forming a 
hydrogel (Fig. 4.11).   
Figure 4.12 shows the fluorescence results of the carbazole derivative (56). The data 
show different emission results from other conjugated dipeptides. After forming a 
hydrogel, a blue shift (decrease in wavelength) occurred. This blue shift might be 
indicating the formation of parallel orientations of carbazole moieties to give H-type 
aggregates26, 27. This result has not been reported before for dipeptides hydrogels. Also, 
the emission spectrum show decrease in the intensity after gelation (947 units in 
solution state and 800 units in the gel state) at the emission maximum wavelength of 
365 nm. The decrease in the intensity after forming a hydrogel may again be due to self-
quenching. 
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Figure ‎4.9: The chemical structure of compounds 12, 53, 54, and 56.  
 
Figure ‎4.10: The emission spectra of compound 12 in solution (red) and the gel state (blue), showing a red 
shift after forming a gel, indicating to π-π stacking interactions. The excitation wavelength was 265 nm. 
 
 
Figure ‎4.11: The emission spectra of pyrene dipeptide derivative in solution (blue) and in the gel state (red). 
The excitation wavelength was 265 nm. 
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Figure ‎4.12: The emission spectrum of a carbazole dipeptide derivative in solution (red) and in the gel state 
(blue). The excitation wavelength was 265 nm. 
 
Figure 4.13 (a) shows the intensity at 350 nm that were collected for the compound 16 
that formed a transparent hydrogel using the GdL method at a concentration of 5 
mg/mL over time. From Figure 4.13(a), we note that the fluorescence increased very 
quickly at early times after adding the GdL. Moreover, we noted that two plateaus 
occurred during the pH decrease. This implies that the assembly of the molecules occurs 
by two stages. This result agreed with previous work, where it was reported that two 
plateau occurred during the hydrogelation process, indicating that the self-assembly 
occurs by two stages23. This was explained by the formation of fibres, followed by the 
aggregation of these fibres. Figure 4.13(b) shows the fluorescence emission spectra of 
the same hydrogel, 60 minutes after adding GdL, after 6 hours and after forming the 
hydrogel overnight. From Figure 4.13(b), we can see an increase of the intensity over 
the time. This is might be resulting from the differences in the environment at high and 
low pH; where the fibres have formed indicating the formation of the hydrogel, agreeing 
with previous research; where also has shown an increase of the fluorescence intensity 
when the pH decreased3. 
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Figure ‎4.13: (a) The emission intensity at 350 nm of compound 16 over time after adding GdL. (b) The 
emission spectra (after 60 minutes of adding GdL (red), 6 hours after adding GdL (green) and after forming 
the hydrogel (blue)). The excitation wavelength was 265 nm. 
Figure 4.14 shows the emission spectra of compound 72, which formed a transparent 
hydrogel using the GdL method at a concentration of 0.5 mg/mL. The compound 
emitted light at 450 nm when excited at 339 nm. The Figure 4.14 shows the spectra 
before adding GdL, 60 minutes after adding GdL and after 24 hours. We note that there 
was a decrease in the intensity after the addition of GdL, again probably due to self-
quenching. 
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Figure ‎4.14: The emission spectra of compound 72 at concentration of 0.5 mg/mL, before adding GdL (red), 
after 60 minutes of adding GdL (green) and after forming a hydrogel overnight (blue). The excitation 
wavelength was 339 nm. 
 
We also studied the emission of anthracene, phenanthrol and carbazole dipeptides at 
different excitation wavelengths (285 nm, 300 nm, and 360 nm) to understand their 
fluorescence properties and to know if they can be used for energy transfer. For 
instance, phenanthrol dipeptides (compound 40) can emit light at 370 nm when excited 
at 285 nm as shown in Figure 4.16, while the maximum emission of the carbazole 
derivative (compound 56) is 365 nm when excited at 285 nm as shown in Figure 4.17. 
Thus, energy transfer is unlikely to occur between naphthalene and carbazole 
derivatives, because they can emit light at the same excitation wavelength. Figures 4.16, 
4.17 and 4.18 show the fluorescence results of compound 40 (Fig. 4.6), 56 (Fig. 4.9) and 
75 (Fig. 4.15) respectively (all formed transparent hydrogels using the GdL method at 
concentrations of 5 mg/mL, 1 mg/mL and 5 mg/mL respectively), at different excitation 
wavelengths (285, 300, and 360 nm). From these data, we note that all the aromatic 
rings can emit light at the same excitation wavelength. For this reason, energy transfer 
might not occur between these aromatic groups. For example, Figure 4.16 shows the 
results of compound 40 when excited at different wavelengths. It can be seen that there 
are differences in the intensity at the maximum emission wavelength of 380 nm; the 
intensity increases as the excitation wavelength is increased. Also, from Figure 4.17 we 
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note that the intensity of compound 56 increased with increasing excitation 
wavelength. This increase of the intensity with an increase of the excitation wavelength 
is due to an increase of absorbing photons, because the molecule is excited by absorbing 
a photon from its ground state to its excited state, therefore at high excitation, the 
molecule absorbs more photons leading to increase the intensity. Also increasing the 
absorption of the photon could lead to shift of the peaks, therefore to the overlap of the 
peaks. 
 
 
Figure ‎4.15: The chemical structure of compound 75.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure ‎4.16: The emission spectra of compound 40 in the gel state at different excitation wavelengths (at 285 
nm (green), 300 nm (purple), and at 360 nm (blue). 
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Figure ‎4.17: The emission spectra of compound 56 in the gel state at different excitations wavelengths (at 
285 nm (green), 300 nm (purple), and at 360 nm (blue). 
 
Similarly, Figure 4.18 shows the emission results of compound 75 at excitations of 285 
nm, 300 nm and 360 nm; hence the carbazole can emit light at the excitation 
wavelength of phenanthrol and anthracene. We have studied the emission at different 
excitation wavelengths for different aromatic groups because we attempted to find 
which aromatic ring can be used as a donor and which one can be used as an acceptor in 
order to study the energy transfer. From the above results, we can see that phenanthrol, 
anthracene, and carbazole dipeptides hydrogel are unlikely to be good pairs for energy 
transfer as the emission of the donor does not overlap the excitation of the acceptor. 
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Figure ‎4.18: The emission spectra of compound 75 at pH 4 and at different excitation wavelengths (at 285 nm 
(green), 300 nm (purple), and at 360 nm (orange). 
 
We also compared the fluorescence spectra of peptides conjugated to carbazole, 
naphthalene, phenanthrol and pyrene at the same excitation wavelength (265 nm) (Fig. 
4.19). From this Figure, we can see that all the functionalised dipeptides emitted light 
when excited at 265 nm. Moreover, we have compared the emission spectra of different 
dipeptides conjugated to the same aromatic group, carbazole (compounds 53, 54, and 
56) (Fig. 4.20). It can be clearly seen that changing the amino acids does affect the 
fluorescence results, because the dipeptide sequences have changed the properties of 
the carbazole, where they have different intensity and different fluorescence spectra, 
although they can be emitted at the same excitation wavelength. As a result, we can see 
that any small change in the hydrogelator by modifying the aromatic group or amino 
acid sequence can affect its molecular packing, hence affect its fluorescence properties. 
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Figure ‎4.19: The emission spectra of dipeptides hydrogels based on different aromatic groups on excitation 
at 265 nm in the gel state;. The figure shows the fluorescence of compound 12 (red), compound 40 (purple), 
compound 56 (blue), and compound 72 (green). 
 
 
Figure ‎4.20: The emission spectra of carbazole hydrogels that have different amino acid sequence, compound 
53 (red), compound 54 (green), and compound 56 (blue) in the gel state. 
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4.3.2- Energy transfer in hydrogels and organogels: 
According to a previous research which illustrated that energy transfer occurred 
between naphthalene dipeptides and anthracene hydrogelators3, 15 or dansyl 
compounds3, we prepared hydrogels based on dipeptides conjugated to different 
aromatic rings to study fluorescence and energy transfer. We prepared hydrogels of two 
components of hydrogelators using the GdL method such as naphthalene and pyrene to 
study transfer energy from naphthalene (donor) to pyrene (acceptor) (as naphthalene 
can emit light at 355 nm and pyrene can be excited by light at 355 nm). However, the 
results showed no evidence of energy transfer (Fig. 4.22). We have tried with other 
aromatic groups such as phenanthrol and anthracene or naphthalene and carbazole 
(data are shown below in more detail, Figure 4.23 – 4.27), but there was no energy 
transfer, because for successful energy transfer between two aromatic groups, the 
emission of the donor must overlap the excitation of the acceptor. Also, the energy 
transfer depends on the distance between the donor and the acceptor. Here, from the 
results we attempted to find aromatic groups that can overlap each other, where one 
can be used as a donor and the other as an acceptor. 
 
 Mix two peptides: 
Previous research demonstrated that when two molecules are mixed to form a gel, these 
molecules may coassembly, self assemble randomly or self-sort28. In a self-sorting 
system, the molecules separate between self and non-self. This system requres specific 
interaction or choice of molecules. Mixing two dipeptides such as Fmoc-dipeptide 
hydrogel system was demonstrated before29. Other research has  been reported that the 
self-sorting system can be achieved thermally30 or by molecular trigger (where the 
order of the gelation can be controlled)31, 32. Thermal self-sorting has been achieved by 
heating the solution containing two hydrogelators above the temperature required to 
allow dissolution of the hydrogelators completely, and then cooling the solution, where 
one hydrogelator assembles at a higher temperature than the other; hence the 
hydrogelation results in a self-sorted network30. The molecular triggered self-sorting 
system has been demonstrated by chosing two hydrogelators that have different pKa  
and assembly carried out using the GdL method31, 32. The pKa of the dipeptides is 
correlated to the hydrophobicity of the molecule33. This can provide a molecular 
gelation trigger, where the assembly of the dipeptide start to occurs at the apparent pKa. 
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Morris et al. showed that self-sorting of two gelators that have different pKa can occur; 
where one gelator can assemble at higher pH than the other31. Here, mixing two 
dipeptides that have different pKa using the GdL method may also result in self-sorted 
hydrogel. For example, mixing two dipeptides, 72 and 25, which have different pKa of 
7.4 and 5.7 respectively (see Chapter 3) may lead to self-sorted system because 72 
could self-assemble at higher pH than 25. Similarly, the self-sorting system could occurs 
between 12 and 62 or 40 and 62, which also have different pKa of 7.4 (12, 40) and 5.7 
(62).  
We have studied the potential energy transfer between two peptides by preparing 
hydrogel containing two peptides such as naphthalene and anthracene, napthalene and 
pyrene, carbazole and anthracene, pyrene and anthracene or phenanthrol and 
anthracene, using the GdL method. Figures 4.22 and 4.23 show energy transfer studies 
between two dipeptides conjugated to different aromatic groups. Figure 4.22 shows the 
results of the attempted energy transfer between compound 25 (Fig. 4.21) and 
compound 72. Here, we added 0.01 mmol / 0.02 mmol of the pyrene dipeptide (72) to 4 
mmol / 8 mmol  naphthalene dipeptide. From Figure 4.22, we can see that there is no 
evidence for energy transfer occurring between naphthalene and pyrene because the 
data show just the emission peak of the naphthalene dipeptide when the system was 
excitated at 265 nm. On increasing the amount of pyrene and changing the 
concentration of naphthalene dipeptide, the results were similar. This absence of energy 
transfer here might be due to the very low amount of pyrene dipeptide added compared 
to the naphtahlene dipeptides. 
 
 
Figure ‎4.21: The chemical structure of compound 25.  
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Figure ‎4.22: The data show the emission spectra of the energy transfer study between naphthalene and 
pyrene derivative. 10µL of compound 72 (1 mM) was added to 4 mM of compound 25 (light blue), 20 µL to 4 
mM of compound 25 (green), 10µL to 2 mM of compound 25  (blue colour), and 20 µL to 2 mM of compound 
25  (purple). 
 
Figure 4.23 shows the energy transfer study between naphthalene and anthracene. We 
added 0.12 mmol / 0.05 mmol / 0.01 mmol of anthracene dipeptide (acceptor) to 28 
mmol of naphthalene dipeptide (donor) and left the solution overnight to form hydrogel 
after adding GdL. Then, we studied the energy transfer on excitation at 265 nm (Fig. 
4.23). The Figure shows the emission spectra of napthalene dipeptide alone and the 
emission spectrum of the mixture of napthalene and antharcene dipeptides at different 
concentrations of anthracene dipeptides to compare the emission spectrum between 
the napthalene dipeptide alone and the mixture. The Figure does not show the emission 
spectrum of anthracene dipeptide alone because the anthracene dipeptide derivatives 
that we have synthesised did not form gels, while the mixture of this dipeptide with 
naphthalene dipeptide formed gel. From the Figure 4.23, we noted that the fluorescence 
data shows two emission peaks at 410 nm and at  371 nm. This is might be indicating to 
the overlapped emission peaks of naphthalene dipeptide and anthracene dipeptide, 
because we can see that the emission peak of the naphthalene dipeptide alone occurs in 
the wavelength (356 nm) that close to the small peak ocurring in the emission spectrum 
of the mixture (at 371 nm) (with a small shift for the mixture that might be due to the 
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changing of the fluorescence properties after mixing two dipeptides). This may be 
implying that energy transfer occurred between these aromatic groups. 
 
 
Figure ‎4.23: Energy transfer study between naphthalene and anthracene dipeptide derivatives in the gel 
state. The Figure shows the emission spectrum of the mixture dipeptides of compound 12 at concentration of 
14 mM and different concentration of compound 62 (12 mM (light blue), 5 mM (red) and 1 mM (purple)) that 
was added to compound 12. Also it shows the emission spectrum of naphthalene dipeptide alone (blue) 
between its emission spectrum and the overlapped spectrum. 
 
Figure 4.24 shows the energy transfer study between carbazole dipeptide (donor) and 
anthracene dipeptide (acceptor). We added 0.12 mmol / 0.05 mmol of anthracene 
dipeptide to 8 mmol of carbazole dipeptide. Also the Figure shows the emission 
spectrum of carbazole dipeptide alone to compare between the fluorescence of 
dipeptide hydrogel alone and the mixture (the emission spectrum of anthracene 
dipeptide alone was not studied because anthracene dipeptide derivatives did not form 
gels). From the Figure 4.24, we can see that there are two small peaks occurred at 365 
nm and 387 nm. These two peaks might be arise from the overlapped emission peaks of 
carbazole dipeptide and anthracene dipeptide, because, it can be seen that the emission 
spectrum of the carbazole dipeptide alone showed one peak at the same wavelnegth of 
the small peak ocurring in the emission spectrum of the mixture at 365 nm. This may 
implying that energy transfer might be occurred between these aromatic groups, but 
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the figure does not show clear peaks due to adding low amount of anthracene compared 
to the amount of carbazole. 
 
 
Figure ‎4.24: Energy transfer study between carbazole and anthracene dipeptide derivative in the gel state. 
Compound 54 was used at a concentration of 4 mM and different concentration of compound 62 was added; 
12 mM (red) and 5mM (green). Also it shows the emission spectrum of carbazole dipeptide alone (blue) to 
compare between its emission spectrum and the overlapped spectrum 
We also compared the fluorescence behaviour of compounds 54, 72 and the mixed 
gelators on excitation of 265 nm (Fig. 4.25). From the Figure we can see that the 
emission spectrum of carbazole dipeptide alone occurs at different wavelength from 
pyrene dipeptide alone spectrum when they excited at the same wavelength (265 nm) 
and the emission spectrum of the mixture shows just one broad peak. This is indicating 
to that there is no energy transfer between the carbazole and pyrene dipeptides. 
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Figure ‎4.25: Emission spectra for compound 54 (red), compound 72 (blue), and the mixed of 54 and 72 
(green) in the gel state. 
Furthermore, energy transfer was studied between compound 72 (donor) and 
compound 62 (acceptor) at excitation of 265 nm (Fig. 4.26). We added 0.12 mmol of 
anthracene dipeptide to 2 mmol of pyrene dipeptide and left the solution overnight to 
form hydrogel after adding GdL. The Figure 4.26 also shows the emission spectrum of 
pyrene dipeptide alone to compare between its emission spectrum and the emission 
spectrum of the mixed dipeptides to illustrate whether energy transfer between pyrene 
and anthracene dipeptides occurs or not. From the Figure 4.26, we noted that there are 
two emission peaks resulting from mixing pyrene and anthracene dipeptides. One peak 
occurs at 410 nm, and the other peak at 522 nm. Also, the emission spectrum of the 
pyrene dipeptide alone shows one peak at the same wavelength (at 410 nm) of one peak 
for the emission spectrum of the mixture. The two overlapped peaks that result from 
the mixture might indicate to the occurrence of energy transfer between the pyrene 
dipeptide and anthracence dipeptide.  
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Figure ‎4.26: Energy transfer study between pyrene and anthracene dipeptide derivative (black) and 
emission spectrum of pyrene dipeptide alone (blue) in the gel state. 
 
Figure 4.27 shows the energy transfer study between compound 40 as a donor and 
compound 62 as an acceptor. We added 0.12 / 0.05 mmol of anthracene dipeptide to 22 
mmol of phenanthrole dipeptide and left the solution overnight to form hydrogel after 
adding GdL. It also shows the emission spectrum of phenanthrol dipeptide hydrogel 
alone (the emission spectrum of anthracene dipeptide did not study because the 
anthracene dipeptide derivative did not form hydrogel alone as we explained above). 
From the Figure 4.27, we can see that there are two peaks at about 370 nm and 398 nm 
resulting from the emission spectrum of the mixed dipeptide hydrogel. Also we noted 
that the emission spectrum of phenanthrol dipeptide alone occurs in the same 
wavelengths with two peaks at similar wavelengths (at 380 nm and 395 nm). Therefore, 
we demonstrated that the energy transfer might not be occurring between phenanthrol 
and anthracene because the amount of anthracene dipeptide that added was very low 
compared to the amount of the other dipeptide (phenanthrol dipeptide). 
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Figure ‎4.27: Energy transfer study between phenanthrol and anthracene dipeptide derivative in the gel state 
at different concentrations of anthracene (12 mM (red), 5 mM (green). The Figure also shows the emission 
spectrum of phenanthrol dipeptide alone (blue). 
 
 
 Mix peptide with dansyl: 
We also attempted to study energy transfer between dipeptide derivatives (donor) and 
dansyl derivative (acceptor) because the energy transfer between naphthalene 
dipeptides and dansyl derivative was successfully studied previously3. Here, we have 
tried with different functionalised dipeptide as a donor. 
 
Figure 4.29 shows energy transfer study between compound 40 as a donor and a dansyl 
derivative (Fig. 4.28) as an acceptor. Here, we added 0.034 mmol of dansyl derivative to 
22 mmol of phenanthrol dipeptide derivative. From the Figure 4.29, we note that there 
are two emission peaks, one between 350 nm and 450 nm (which is similar to the 
emission spectrum of compound 40 alone) and another broad peak between 470 nm 
and 600 nm, which is similar to the spectrum of dansyl derivative. This result indicates 
that the dansyl derivative has been incorporated into the gel fibres, hence the energy 
transfer occurred between the phenanthrol dipeptide and dansyl derivative.  
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Figure ‎4.28: The chemical structure of the dansyl derivative used here.  
 
 
Figure ‎4.29: Energy transfer study between phenanthrol and dansyl derivative at concentration of 3.4 mM in 
the gel state. The excitation wavelength was 265 nm. 
 
Furthermore, we studied the energy transfer between a carbazole derivative 
(compound 54 at concentration of 4 mM) and a dansyl derivative (at concentration of 
10 mM) using an excitation wavelength of 265nm over time with amounts of 20µL of 
the dansyl solution added to the carbazole solution (Fig. 4.30). We added 0.2 mmol of 
dansyl derivative to 8 mmol of carbazole dipeptide derivative and left the solution 
overnight to form hydrogel after adding equivalent amount of GdL. The Figure shows 
the emission spectrum results before adding GdL and at different times after adding 
GdL. From the Figure 4.30, it can be seen that energy transfer occurred between the 
carbazole dipeptide and dansyl derivative; two emission peaks were present. We also 
note that the intensity of emission spectrum was high before adding GdL and then 
decreased with time to reach the lowest intensity after forming gel (after 19 hours), 
again due to self-quenching. As a result, we note that although all functionalised 
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dipeptides can emit light on excitation at the same wavelength, energy transfer has 
occurred between some derivatives, pyrene and anthracene, phenanthrol and dansyl, 
and between carbazole and dansyl. Other mixture that showed no energy transfer 
occurred might result from the low amount of the acceptor that added compared to the 
amount of the donor. 
 
 
Figure ‎4.30: Energy transfer study between carbazole and dansyl derivatives (add 20µL of the concentration 
of 10mM), overnight (before adding GdL (red), after 60 minutes (light blue), after forming hydrogel (after 
19hours) (blue). 
 
Furthermore, the quantum yield (QY) of this system has not been measured (QY is the 
ratio between the number of photons emitted to the number of photons absorbed). For 
the clear occurrence of energy transfer, the QY of the donor must be high. Here, if we 
compare the known QY of one aromatic ring (donor) to other aromatic ring (acceptor), 
we might assume the efficiency of the QY on the energy transfer. For example, the QY of 
pyrene is (0.32) and the QY of anthracene is (0.3234) and so QY of the both rings is 
similar. This value of the QY is high and may be indicative that the loss of the energy in 
the gel state is very low; hence, the efficiency of the energy transfer might be affected35. 
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Moreover, according to our results, it can be seen that the efficiency of the energy 
transfer might be affected by the system of how the hydrogel formed, self-sorting or a 
random system formed (Fig. 4.31). Here, there are two different components to form 
hydrogel in order to study energy transfer, one containing dipeptide and dansyl and the 
other containing two functionalised dipeptides. In the system containing dansyl, the 
energy transfer is probably not affected by how the hydrogel formed, because the 
dansyl is hydrophobic molecule and it will ‘stick’ to the other hydrophobic environment 
and energy transfer then occurs between them. On the other hand, whether energy 
transfer between two dipeptides may depend on the type of the self-assembly system 
formed, i.e. if a self-sorting or a random system occurs. If a self-sorting results from the 
hydrogelation of two dipeptides, it is difficult to know if energy transfer can occur or 
not. The fibres resulted from the self-sorting might be close enough to each other to 
transfer energy between two aromatic units or they might not. In contrast, if the 
hydrogelation result in a random fibres formed, this may refer to the possibility of 
transfer energy between dipeptides because the efficiency of the energy transfer 
depends on the distance between the dipeptide fibres and from this we hypothesise that 
energy transfer will occur if two mixed components form a random fibre. It is still 
unclear whether the mixing of two peptides can be self-sorted or forms random fibres, 
and this may give expand to this project to be studied in more details. 
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Figure ‎4.31: Top: Schematic of possible assembly of two LMWG into fibres. (a) Self-sorting; (b) random co-
assembly. Bottom: Two hypothetical networks formed from a self-sorted system, where entanglement of the 
self-sorted fibres occurs (left) or an interpenetrated network forms (right)32. 
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4.4- Conclusion: 
In conclusion, we synthesised peptides conjugated to different aromatic group such as 
pyrene, carbazole, 2-anthraquinone and 9-anthracene as explained in Chapter 2. 
Hydrogels have been prepared from these dipeptides. In this Chapter, we carried out a 
fluorescence study of the dipeptides that formed transparent hydrogels in order to 
study potential energy transfer between two different aromatic groups. The 
fluorescence of naphthalene, pyrene, anthracene, phenanthrol and carbazole dipeptides 
was studied. The results showed that all dipeptides conjugated to different aromatic 
groups can emit light at the same excitation with different fluorescence properties. 
Previous research illustrated that energy transfer occurred between naphthalene 
dipeptides and anthracene hydrogelators or dansyl compounds3. We carried out similar 
work using different functionalised dipeptides hydrogels to study the energy transfer. 
As a result, energy transfer has occurred between some dipeptide derivatives (pyrene 
and anthracene dipeptides), and between dipeptide and dansyl derivative (phenanthrol 
and dansyl, and carbazole and dansyl). These results indicated that energy transfers can 
occur between two dipeptides hydrogel or between dipeptide and dansyl derivative. In 
other cases, no evidence for energy transfer was found. This may imply that the packing 
of the fibres is important for energy transfer and this should be the focus of future work. 
 
Table (4.3) shows the summary of the pairing that successfully transferred energy. The 
successful energy transfer occurred between pyrene and anthracene dipeptide 
derivatives, phenanthrol dipeptide and dansyl derivative, and carbazole dipeptide and 
dansyl derivative.  
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Table ‎4.3: The summary of the pairing that successfully transferred energy  
 
 
 
         
 
 
 
 
 
 
 
Donor  Acceptor  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
54 
Dansyl 
Dansyl 
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CHAPTER 5 
Controlled Release 
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5- The controlled release: 
5.1- Introduction: 
Hydrogels are a 3D dimensional network that can be prepared using different methods1-
12. Of relevance to this Thesis are hydrogels prepared using LMWG dipeptides13, 14. 
These hydrogels have been used in some biomedical applications such as cell 
culturing15, 16 and drug delivery17-19. Drug delivery systems such as injections, tablets or 
sprays must deliver the correct dose of the drug in an efficient manner. Often, a 
controlled release is needed so that the drug is effective for a reasonable period of time. 
In a drug delivery system, the concentration of the drug increases to reach the 
maximum peak and then it falls off so that another dose needs to maintain the effective 
of the drug. If the concentration of the drug increases above the maximum range, this 
may cause the toxicity. Also, if the concentration of the drug falls below the minimum 
level, the drug will be ineffective20. To control and maintain the effective level of drugs, 
we have to study new controlled release systems.  
 
Drug delivery in hydrogels has had great attention since the 1960s21. Although the first 
hydrogels that were prepared were not suitable for the purpose of controlled release 
because some of them were toxic, it is possible that the LWMG gels based on peptides 
may be appropriate to be used as a scaffold because they are easy to remove and release 
when no longer needed. Some examples of LMWG hydrogels based on amino acids and 
peptides have been used for controlled release, for example hydrogels based on FmocF 
and FmocY17. Other examples include hydrogels based on FmocFF12, 22, 23. The controlled 
release from a hybrid hydrogel based on FmocFF and konjac glucomannan (KGM) has 
been studied24. The hydrogel was prepared by the self-assembly of FmocFF in a solution 
of KGM. This study provides a new self-assembly of peptide-polysaccharide hybrid 
hydrogels and also provides a new sustained-release drug carrier. Docetaxel was used 
as a model of hydrophobic drugs and incorporated into hydrogel to study the release 
properties of the hydrogel. Different concentrations and molecular weights of KGM 
solutions were prepared for controlled release experiments. The results showed that 
the release rate increased with hydrogel prepared in KGM more than that without the 
KGM. Also the mechanical properties showed that the hybrid hydrogel (FmocFF 
conjugate to KGM) was higher (G’) than FmocFF hydrogel. This means that KGM 
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increases the mechanical properties of the hydrogel. In all these cases, the controlled 
release of a model dye from the hydrogel to a solution placed on the top of the hydrogel 
was studied14, 25 (Fig. 5.1).   
 
 
 
 
 
over time. 
 
 
 
Figure ‎5.1: the controlled release study of the dye from hydrogel. 
 
To measure the rates of release, the diffusion coefficient (D) of each (dye/gel) system 
can be calculated13, 26 using the non-steady-state diffusion model equation: 
 
Mt/M∞ = 4(Dt/πλ2)1/2 
 
Where Mt is the total amount of molecules released during the measurement, M∞ is the 
total amount of molecules that are loaded at the start, λ is the hydrogel thickness, t is the 
time of the measurement and D is the diffusion coefficient of the molecules24. If the 
results show a linear relationship between Mt/M∞ and the square root of time, this 
indicates that the release of dye from the hydrogel is under Fickian control27. 
 
To investigate dipeptide hydrogels for drug delivery, we have decided to study the 
controlled release of a model dyes from the hydrogel. To do this, we have to control 
factors that are important for controlled release such as the pH, the mesh size, the 
microstructure and the strength of the gel. We have used the solvent switch method, 
using DMSO and water, to control the microstructure because the hydrogel should be 
injectable14 (Fig. 5.2). Also, by using the solvent switch method, the hydrogel is formed 
in a few minutes compared to the GdL method, which takes overnight to fully form the 
gel. 
Dye diffuse 
Hydrogel 
Solution 
Dye 
Hydrogel  
Time 
Hydrogel  
+ Dye 
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Figure ‎5.2: an example of image of injectable hydrogel loaded dyes using DMSO: Water method. The gels were 
prepared in a syringe and then injected on to a microscope slide through a needle. 
 
Also, we studied the release of the hydrogel at different concentrations. We thought that 
this would allow us to control the mesh size28, which is important as the rate of the 
release increases with increase of the mesh size. Therefore, by studying the 
concentration of LMWG, we can find which the best concentration for controlling the 
rate of the release. Furthermore, we have studied the release of the hydrogels at 
different pHs. For drug delivery, we have to choose the dipeptide that can form a 
hydrogel at pH 7 (the pH of the body). Moreover, we have studied the rheology of the 
hydrogel loaded with dyes. We need to ensure that the hydrogel will remain stable as a 
scaffold while it delivers the drug. Therefore, to be a good gelator, a good peptide should 
form hydrogel at pH 7, at a concentration that forms strong gel using the solvent switch 
method, must be injectable and must allow us to control the rate of the release for drug 
delivery application. 
 
5.2- Experimental section: 
The hydrogels that were used to study controlled release were prepared using the 
solvent switch method described in Chapter 3, but we loaded dyes in the water. These 
dye solutions were added to solutions of the gelators in DMSO. The peptide that was 
used for controlled release was FmocFF (Fig. 5.3) and compound 42 (Fig. 5.4). We have 
chosen these dipeptides because the FmocFF was commonly used as a good 
hydrogelator and in controlled release. It has been used previously for controlled 
release by using different dyes and method of the release study17, therefore we used this 
gelator as a control. We have used other dyes here to probe the effect of dye solubility 
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and size. The other gelator, compound 42, was chosen because it is the only peptide 
prepared in this Thesis that forms hydrogel at pH 7. 
 
 
Figure ‎5.3: The chemical structure of FmocFF. 
 
 
Figure ‎5.4: The chemical structure of compound 42. 
 
 
Dyes used in this study were Direct Red 81 (DR), Rhodamine B (RB) and Sunset Yellow 
(SN). Figure 5.5 shows the chemical structures of the dyes. We have chosen these dyes 
because they have different structure, different molecular weight and different 
hydrophobicity, therefore we can study the release rate of each dye and compare the 
results between them and also to correlate between the release rate and the molecular 
weight, the structure and the hydrophobicity of the dye. All of these dyes were used at a 
concentration of 0.078 mg/mL. The concentration was chosen according to the 
calibration curves; where is the UV-vis data at this concentration showed a good peak 
and absorption of the dyes.  
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Figure ‎5.5: The chemical structure of Direct Red, Rhodamine B, and Sunset Yellow. 
 
 
We have prepared the hydrogels at different concentrations of peptides (10 mg/mL, 7 
mg/mL, 5 mg/mL and 2.5 mg/mL) and at different pH (pH 4, pH 5, pH 6 and pH 7) to 
compare the rate of the release under these different conditions.  
 
5.2.1-      Hydrogel loaded dyes preparation: 
5.2.1.1- Release from FmocFF gels: 
FmocFF was dissolved in 100 µL DMSO and then an acetate buffer solution at pH of 4, 5, 
or 6 loaded with dye of Direct Red (DR), Rhodamine B (RB) or Sunset Yellow (SN) at 
concentration of 0.078 mg/mL (1.9 mL) was added. The final FmocFF concentrations 
were 10, 7, 5 and 2.5 mg/mL). The samples were left to stand overnight before being 
tested. 
5.2.1.2- Release from gels formed from 42: 
Compound 42 was dissolved in 100 µL DMSO and then an acetate buffer solution at pH 
of 4, 5, or 6 loaded with dye of Direct Red (DR), Rhodamine B (RB) or Sunset Yellow 
(SN) at concentration of 0.078 mg/mL (1.9 mL) was added. The final FmocFF 
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concentrations were 10, 7, 5 and 2.5 mg/mL). The samples were left to stand overnight 
before being tested. 
 
5.2.2-      Release study: 
5.2.2.1- FmocFF and compound 42: 
After the formation of the hydrogel, we added a buffer solution to the top of the 
hydrogel. At specific times, the total buffer solution on top of the gel was carefully 
removed by pipette and the amount of dye measured using UV-Vis spectroscopy at 
different wavelengths depending on the dye (523 nm for DR, 556 nm for RB, and 481 
nm for SN). Then, we returned the buffer solution carefully to the top of the gel. This 
was repeated at regular times to follow the release. The release of dyes was studied at 
room temperature and the errors of the release study were calculated from the average 
of measuring three samples of the same hydrogel and the errors were +/- 0.005 for DR, 
0.0015 for RB, and 0.003 for SN. 
 
5.3- Result and discussion: 
 
5.3.1-      Calibration curves: 
Figures 5.6, 5.7, and 5.8 show the calibration curves for the DR, RB, and SN dyes. From 
the Figures, we can see a linear relationship between the concentration and the 
intensity providing an equation that we can use to calculate Mt/M∞ in order to calculate 
the diffusion coefficient of the release of dye from the hydrogel.  
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Figure ‎5.6: the calibration curve for DR. 
 
Figure ‎5.7: The calibration curve for RB. 
 
Figure ‎5.8: The calibration curve for SN. 
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We have also studied the confocal microscopy images of hydrogels loaded with dyes at 
concentration of the peptide at 5 mg/mL.  Figure 5.9 shows the confocal microscopy 
images of a FmocFF hydrogel loaded with RB (left) and a hydrogel loaded with SN 
(right). This data demonstrates the effect of the structure of the dye and the mesh size 
on the rate of the release. From the Figures, we can see that there is a differences of the 
confocal image of hydrogel loaded SN and RB. The confocal image of RB shows the fibres 
and dark areas which might indicate the presence of RB dye. Here, the dye might stick to 
the fibres and this may affect the rate of release, and so perhaps decrease the release of 
the dye from the hydrogel. This is probably because the RB is a hydrophobic dye (this is 
similar to dansyl that we studied its fluorescence and shows effect of its hydrophobicity 
on the fluorescence properties; where it sticks with the fibres (see Chapter 4). Also the 
charge on the RB dye may affect the interaction between the RB and the fibres. The RB 
contains positive charge which might interact strongly with the fibre networks, hence 
affect its release from the hydrogel29. In contrast, the confocal image of SN does not 
show clear fibres and this might be because it formed weak fibres and also has a 
negative charge, therefore the SN will not stick with the fibres and lead to release 
quicker. Furthermore, the release of the dye might be affected by other factors, such as 
the size of the dye, where large dye may diffuse less well through the network. 
Moreover, the mesh size can also affect the rate of the release, where changing the 
concentration of the peptide to form hydrogel can lead to change in the mesh size. Here, 
the confocal images show the hydrogels formed at concentration of 5 mg/mL, but if we 
decrease the concentration of the peptide from 5 mg/mL to 2.5 mg/mL, this may result 
in a decrease in the fibre structure and an increase in the mesh size, leading to increase 
the rate of the release.  
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Figure ‎5.9: an example of confocal microscopy image of hydrogel loaded dyes (Rhodamine B (RB) (left) and 
Sunset yellow (SN) (right)) showing the effect of the mesh size at concentration of peptide of 5mg/ mL. 
 
5.3.2-      FmocFF loaded dye hydrogel and release study: 
We have prepared hydrogels using FmocFF, loaded with the different dyes (DR, RB, and 
SN) at different concentrations of peptide and at different pHs. We have used the 
solvent switch method to prepare the hydrogels. The hydrogels formed after few 
minutes. Figure 5.10 shows the process of preparing hydrogels loaded with dyes for the 
controlled release study. Figure 5.10 (A) shows the solution of the FmocFF dipeptides 
immediately after adding the water, but before the gel has forming (the red sample is a 
solution of dipeptide with DR, the pink sample with RB and the yellow with SN). Figure 
5.10(B) shows the hydrogels that formed after few minutes of adding the buffer 
solution. We can see the change of the sample appearance before and after the gelation, 
especially for the hydrogel loaded with SN, as we can see the transparent hydrogel that 
formed after few minutes. Figure 5.10(C) shows the addition of the buffer to the top of 
the hydrogel in order to study the release of the dyes from the hydrogel to this added 
buffer. 
 
 
 
 
 
(SN) (RB) 
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                         (A)  Before gelation                             (B) Hydrogels after few min  
 
                                                     
                                                   (C)Buffer solution on the top 
 
Figure ‎5.10: The process of preparing samples for controlled release study. 
 
 
5.3.2.1- Release study at different pHs and dyes at the same concentration of the 
peptide (5 mg/mL): 
Here, we have changed the pH and the dyes while using the same concentration of 
FmocFF (5 mg/mL). The data is shown in Figures 5.11, 5.12 and 5.13. We found that the 
release increased at higher pH for DR and RB. At pH 5 and 6, we noted that the 
concentration of DR did not increase in the first day (Fig. 5.11). After about 23 hours, 
the concentration of the dye started to increase with time, indicating the release of the 
dye with the time. On the other hand at pH 4, the concentration of DR did not increase 
with the time over the three days, showing a strong pH effect on the release. At pH 5, the 
release of DR was quicker than that at pH 4 but it still takes a long time to release from 
the hydrogel. For RB, the release rates at different pH have similar results (Fig. 5.12). 
The rate of release was higher at pH 6 than at pH 4. However, we noted that SN release 
201 | P a g e  
 
results were very similar at all of the pH studied. Fig. 5.13 shows that there is an 
increase in the concentration after 30 minutes of adding the buffer on the top of the 
hydrogel, indicating that the SN is released quickly from the hydrogel. Therefore, we 
note that changing the pH can affect the rate of the release and also the structure of the 
dye can affect the rate of the release.  
 
 
 
              Figure ‎5.11: The release results of DR at different pH (pH 4, 5, and 6). 
 
 
Figure ‎5.12: The release results of RB at different pH (pH 4, 5, and 6). 
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Figure ‎5.13: The release results of SN at different pH (pH 4, 5, and 6). 
 
Also, we have studied the rheology of the hydrogel loaded with dyes at different pHs 
(Fig. 5.14). From the Figure, we noted that at all pHs a strong hydrogel was formed. 
Also, it can be seen that the hydrogel at pH 5 has the highest G’, indicating that at this pH 
the peptide formed a strong hydrogel. This agrees with previous work on the pH 
dependence of FmocFF hydrogels30. For this reason, we have studied further the release 
of the dyes at this pH at the concentration of 5 mg/mL (data shown in more details in 
Section 5.3.2.3). 
 
 
Figure ‎5.14: The rheology results of hydrogel at different pHs (pH 4, 5, and 6). 
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5.3.2.2- Release study at different concentration of the peptide and dyes at the 
same pH: 
Here, we have changed the concentration of peptide and dyes at the same pH (pH 5). We 
have prepared hydrogels of FmocFF at different concentration (2.5 mg/mL, 5 mg/mL, 
7.5 mg/mL, and 10 mg/mL) to study the effect of changing the concentration on the rate 
of the release, because the mesh size can affect the rate of the release of the dyes from 
the hydrogel. It is expected that increasing the concentration will lead to a decrease in 
the mesh size and this may lead to decrease the rate of the release. This expectation 
agreed with our results except at a concentration of 10 mg/mL. Figures 5.15, 5.16, and 
5.17 shows the release of DR, RB, and SN respectively at pH 5 from gels formed at 
different concentrations (2.5 mg/mL, 5 mg/mL, 7.5 mg/mL, and 10 mg/mL). From the 
Figures, for DR and RB, we can see that the release increases with decreasing FmocFF 
concentration except at concentration of 10 mg/mL. It is clearly seen that dyes release 
more quickly at concentrations of 2.5 mg/mL, then 5 mg/mL and the lowest release rate 
was at concentration of 7.5 mg/mL. This result agrees with the idea of decreasing the 
mesh size with increasing the dipeptide concentration. However, at a concentration of 
FmocFF of 10 mg/mL, the release was the highest. This is because at this concentration 
the hydrogel was unstable and shrunk after adding the buffer on the top, so the dyes can 
release quickly from the weak hydrogel; where the weak hydrogel has less fibre, hence 
this allows the dye to release quickly. For the release of SN, the rate is very similar from 
gels at all concentrations of FmocFF. 
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Figure ‎5.15: The release results of DR at different concentrations (10, 7.5, 5, and 2.5 mg/mL) at the same pH 
(pH 5). 
 
Figure ‎5.16: The release results of RB at different concentrations (10, 7.5, 5, and 2.5 mg/mL) at the same pH 
(pH 5). 
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Figure ‎5.17: The release results of SN at different concentrations (10, 7.5, 5, and 2.5 mg/mL) at the same pH 
(pH 5). 
 
Again, we studied the rheology of the hydrogel-loaded dyes at different concentrations 
(Fig. 5.18). From Figure 5.18, we noted that the strength of the gel increased with 
increase of the concentration over the time except at concentration of 10 mg/mL where 
the hydrogel was unstable, although there is not a significant difference between the G’ 
at all concentrations. In all cases, G’ is greater than G’’ by an order of magnitude. This 
shows that it is difficult to always understand all the properties of a hydrogel from a 
simple rheological measurement. We can see from the Figure 5.16 we did not study the 
release at concentration of 10 mg/mL on the third day because the hydrogel has shrunk 
and it mixed with the buffer due to its instability; where RB shows an increase in the 
concentration with the time in the first two days and then the hydrogel has shrunk, so 
the release did not study after this time. As a result, it is expected that the mesh size of 
the hydrogel will affect the rate of the release for the hydrogel-loaded dye. 
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Figure ‎5.18: The rheology results of the hydrogels at different concentrations (10, 7.5, 5, and 2.5 mg/mL). 
 
5.3.2.3- Compare the release study of different dyes at the same pH (pH5) and the 
same concentration (5 mg/mL): 
From the above results of different concentrations and pH, we have compared the 
release results of the three dyes at pH 5 and at the concentration of 5 mg/mL. Figure 
5.19 shows the release results of the dyes at pH 5 for three days. From the Figure, we 
noted that the concentration of (DR) and (RB) increased very slowly over the three 
days, indicating to that they released very slowly, while the concentration of Sunset 
Yellow (SN) increased with the time quickly. These differences between the dyes are 
might be due to the differences of the structure and the hydrophobicity. DR has the 
largest structure and molecular weight, so it is difficult to release from the hydrogel 
resulting in low concentration of the dye diffused from the hydrogel; and hence the slow 
release. Therefore, we noted that the size and the molecular weight of the dyes and the 
hydrophobicity may affect the rate of the release. This results agreed with other 
works31, where it is been reported that the release properties of the dye from the 
hydrogel can be affected by the molecular weight of the dye32, 33.   
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Figure ‎5.19: The comparison between the release results of different dyes (DR, RB, and SN) at the same 
concentration (5 mg/mL) and pH (pH 5). 
 
The size of the three dyes was estimated by Dan Holden (University of Liverpool) using 
Materials Studio 5.5. The three dimensions of the size of DR result are 25.39 Å, 8.43 Å 
and 6.30 Å (Fig. 5.20). These first were measured from the Na atom, across the dye, to 
the extreme oxygen atom. The second was from the Na atom to the hydroxyl hydrogen, 
and the third from the nitrogen to the extreme hydrogen atom. Atom van der Waals 
radii have not been taken into account here; this is from atom centre to atom centre. 
The three dimensions of the size of RB are 14.75 Å, 11.93 Å and 10.84 Å, and the two 
dimensions of the size of SN are 11.19 Å and 14.9 Å. These were measured from the Na 
atoms, across the dye, to the extreme hydrogen atom (Fig. 5.20). From the proximate 
calculations, we noted that the dyes showed different sizes; where DR has the largest 
size and the SN has the smallest size, therefore this result provided that the size of the 
molecules may affect their release from the hydrogel. However, all of these dyes are 
smaller than the expected mesh size34. 
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Figure ‎5.20: The molecular structure of the three dyes (DR, RB, and SN) with the calculation of their sizes. 
 
Also, we have estimated the hydrophobicity of the three dyes using logP that was 
calculated for the dyes35. From the calculations, we found that logP of DR, RB, and SN 
are 2.75, 2.74, and 0.27 respectively. From these results, we noted that DR and RB have 
similar hydrophobicity while the SN has a significantly lower hydrophobicity. Hence, SN 
is significantly more water-soluble and hence is released much more quickly from the 
gels. From the same calculation programme, we estimated the molecular volume of the 
three dyes (molecular volume is expected to determine the transport characteristics of 
molecules. Volume is therefore often used to model molecular properties and biological 
activity). From these calculations, we found the molecular volume of DR, RB, and SN is 
493.3, 424.7, and 299.9 Å3 respectively. Hence, DR has the large molecular volume and 
the SN has the smallest molecular volume which indicates that the molecular volume of 
the dye can also affect their rate of the release. From these data, SN has the smallest 
volume and the lowest logP. As expected therefore, this dye is released the most quickly 
from the gels. 
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5.3.2.4- Diffusion coefficient: 
The diffusion coefficient (D) of each model dye in the hydrogel was calculated using 
non-steady state diffusion model equation: 
 
Mt/M∞ = 4(Dt/πλ2)1/2 
 
where Mt is the total amount of molecules released during the measurement, M∞ is the 
total amount of molecules that are kept in the matrix, λ is the hydrogel thickness, t is the 
time of the measurement and D is the diffusion coefficient of the molecules24. 
 
The diffusion coefficient was calculated from the equation for the three dyes from the 
gels prepared at FmocFF concentration of 5 mg/mL and at pH 5. The diffusion 
coefficients over the time were between 3.77x10-10 and 7.72x10-11 m2/s for DR, between 
4.87x10-9 and 7.14x10-11 m2/s for RB, and between 1.05x10-7 and 3.98x10-10 m2/s for 
SN (Table 5.1, 5.2, and 5.3). The diffusion coefficient of the three dyes for the three days 
was different due to differences in the structure and the molecular weight of the dyes. 
The highest diffusion coefficient was for SN dye (3.98x10-10 m2/s). Also, from Table 1, 
we note that we were unable to calculate the diffusion coefficient of the release of DR 
dye in the first day, because its rate of the release was very slow at that time and after 
about 26 hours started to increase with the time. Moreover, when we plotted the square 
root of time against Mt/M∞, a good linear relationship was found, demonstrating that 
the release of dyes from the hydrogel is following Fickian diffusion control27 (Fig. 5.21, 
5.22, and 5.23).  As a result, we noted that there is a great influence of the dye size and 
their molecular weight on the rate of the release, hence on the diffusion coefficient as 
reported on other work31-33.  
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Direct Red 
Conc. Time Mt/M∞ D(m2/s) 
0 50 0 0 
0 80 0 0 
0 110 0 0 
0 300 0 0 
0 360 0 0 
0.000167 1440 0.0085 3.77x10-10 
0.000354 1560 0.019 5.21x10-10 
0.000416 1740 0.0213 4.94x10-10 
0.000436 3180 0.0223 2.77x10-10 
0.000478 3240 0.0245 2.84x10-10 
0.000602 7200 0.0309 1.42x10-10 
0.000623 7320 0.032 1.44x10-10 
0.00136 20160 0.07 7.72x10-11 
Table ‎5.1: The results of the release of DR that calculated from the diffusion coefficient equation.  
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Figure ‎5.21: Plot of released DR dye against the square root of time that calculated from the calibration curve 
of the dye. 
 
Rhodamin B 
Conc. Time Mt/M∞ D(m2/s) 
0.0000164 35 0.00084 4.87x10-9 
0.000154 85 0.0078 6.11x10-9 
0.000244 210 0.0125 3.13x10-9 
0.000527 1410 0.027 6.86x10-10 
0.000531 1440 0.027 6.71x10-10 
0.00099 5760 0.05 2.28x10-10 
0.00096 5880 0.05 2.24x10-10 
0.00108 7200 0.06 2.01x10-10 
0.0012 20160 0.06 7.14x10-11 
Table ‎5.2: The results of the release of RB that calculated from the diffusion coefficient equation. 
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Figure ‎5.22: Plot of released RB dye against the square root of time showing a linear relationship between 
them. 
 
Sunset Yellow: 
 
Conc. Time Mt/M∞ D(m2/s) 
0.0025 20 0.128 1.05x10-7 
0.0057 90 0.292 3.53x10-8 
0.0095 300 0.486 1.37x10-8 
0.0188 1440 0.965 4.01x10-9 
0.0196 1500 1.007 3.93x10-9 
0.0316 5760 1.62 1.30x10-9 
0.0322 5900 1.65 1.28x10-9 
0.0337 7200 1.73 1.07x10-9 
0.0363 20160 1.86 3.98x10-10 
Table ‎5.3: The results of the release of SN that calculated from the diffusion coefficient equation. 
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Figure ‎5.23: Plot of released SN dye against the square root of time showing the linear relationship between 
them. 
 
 
5.3.3- Compound 42 release study: 
Here hydrogels have been prepared from compound 42 at pH 5 and a concentration of 5 
mg/mL using different dyes (DR, RB, and SN) at concentrations of 0.078 mg/mL. After 
hydrogel had formed, we placed on each sample buffer of pH 5. Then we studied the 
release of the dye over time using the UV-vis spectroscopy at different wavelength for 
each dye (523 nm for DR, 556 nm for RB, and 481 nm for SN). Figure 5.24 shows the 
release results of the dyes at pH 5 for three days. From the Figure, we can see that RB is 
released slowly, while the SN is released quickly. From the Figure, it can be clearly seen 
that the DR was also released slowly. This result is similar to the release results of DR 
from the FmocFF hydrogel described above. This shows that DR release has similar 
behaviour despite the change of the hydrogelator. Similarly the SN released very quickly 
with only small differences of the release result compared to that from the FmocFF 
hydrogel. On the other hand, RB release from gel formed from 42 has a different 
behaviour compared to that from the FmocFF hydrogel. RB released very slowly. Also, 
we noted that after that time, the intensity of the UV data started to decrease. This is 
might be because the RB affected by the light and decomposed lead to an apparent 
decrease of its release36. These differences between the results are might be due to the 
differences of the structure and the hydrophobicity as described above. Therefore, we 
noted that the structure and the molecular weight of the dyes and the hydrophobicity 
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can affect the rate of the release. This results agreed with the above results and other 
research, where it is been reported that the release properties of the dye from the 
hydrogel can be affected by the molecular weight of the dye17. Hence, by studying these 
factors of control release we can choose the appropriate hydrogel that can be used for 
drug delivery applications.  
 
 
 
Figure ‎5.24: The release results of  different dyes (DR, RB, and SN) at pH 5 and  concentration of peptide of  5 
mg/mL.  
 
We have also studied the release of the dyes (DR, RB, and SN) from gels formed using 42 
at pH 7.4, because the eventual aim of this study is to study the release of dyes at pH 7 
(the pH of the body) in order to use it for drug delivery application. This peptide formed 
hydrogels at pH 7 using the PBS buffer solution. Figure 5.25 shows the release study of 
these dyes from the hydrogel at pH 7 over three days. From the Figure and comparing to 
previous data, we can see that the DR was released more quickly at pH 7 than that at pH 
5. In contrast, RB still has a low rate release at pH 7, which is the same as at pH 5.  
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Figure ‎5.25: the release results of different dyes (DR, RB, and SN) at pH7 and concentration of peptide of 5 
mg/mL. 
 
Diffusion coefficient: 
We have calculated the diffusion coefficients of the dyes from gels form from 42 at pH 7. 
The diffusion coefficients over the three days were between 8.07x10-08 and 2.52x10-09 
m2/s for DR, 5.45x10-09 and 5.38x10-11 m2/s for RB, and 9.07x10-08 and 2.56x10-09 m2/s 
for SN (Table 5.4, 5.5, and 5.6). We noted that the diffusion coefficients of the three dyes 
over the three days were different due to differences in the structure and the molecular 
weight of the dyes. From the results, we found that after three days of the release of 
dyes from the hydrogel, the diffusion coefficient for SN dye and DR dye was very similar. 
However, the diffusion coefficient of RB is significantly lower, agreeing with its release 
rate, which was low in the first day and increased slowly in the second day, and then it 
started decreasing in the third day. This might be because the RB affected by the light 
and decomposed lead to an apparent decrease of its release36.  Furthermore, when we 
plotted the square root of time against the Mt/M∞, a good linear relationship was found, 
indicating that the release of dyes from the hydrogel is following Fickian diffusion 
control27 (Fig. 5.26 and 5.28), except the RB which its release start to decrease in the 
third day due to its light effect (Fig. 5.27).  Again, we note that there is a great effect of 
the dye size and their molecular weight on the rate of the release, therefore the 
significant change in the diffusion coefficient with change the dye. 
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Direct Red: 
  
Conc. Time  Mt/M∞ D(m2/s) 
0.00147 20 0.0754 8.07 x10-08 
0.00607 110 0.31 2.89 x10-08 
0.00946 210 0.485 5.61 x10-08 
0.0116 285 0.595 4.13 x10-08 
0.0248 1440 1.272 4.61 x10-09 
0.0258 1500 1.323 4.51 x10-09 
0.0262 1540 1.344 4.42 x10-09 
0.0281 1740 1.441 4.06 x10-09 
0.0345 2865 1.769 2.73 x10-09 
0.0348 2940 1.785 2.67 x10-09 
0.0354 3015 1.815 2.63 x10-09 
0.0353 3140 1.81 2.52 x10-09 
Table ‎5.4: The results of the release of DR dye that calculated from the diffusion coefficient equation. 
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Figure ‎5.26: Plot of released DR dye againest the square root of time, showing a linear relationship between 
them. 
 
Rhodamine B: 
 
Conc. Time  Mt/M∞ D(m2/s) 
0 20 0 0 
0.000203 110 0.0104 5.45 x10-09 
0.000388 210 0.0198 3.94 x10-09 
0.000486 285 0.0249 3.25 x10-08 
0.000576 1440 0.0295 7.02 x10-10 
0.000561 1500 0.0287 6.64 x10-10 
0.000547 1540 0.0281 6.41 x10-10 
0.000437 1740 0.0224 5.06 x10-10 
0.0000144 2865 0.00073 5.38 x10-11 
Table ‎5.5: The results of the release of RB that calculated from the diffusion coefficient equation. 
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Figure ‎5.27: Plot of released RB dye againest the square root of time. 
Sunset Yellow: 
 
Conc. Time  Mt/M∞ D(m2/s) 
0.00184 20 0.0944 9.07 x10-08 
0.00632 110 0.324 3.05 x10-08 
0.01 210 0.513 2.01 x10-08 
0.0121 285 0.62 1.63 x10-08 
0.0251 1440 1.287 4.63 x10-09 
0.0253 1500 1.297 4.46 x10-09 
0.0261 1540 1.338 4.41 x10-09 
0.0274 1740 1.405 4.01 x10-09 
0.0334 2865 1.713 2.68 x10-09 
0.0337 2940 1.728 2.63 x10-09 
0.0338 3015 1.733 2.56 x10-09 
0.0342 3140 1.754 2.48 x10-09 
Table ‎5.6: the results of the release of SN that calculated from the diffusion coefficient equation at pH 7. 
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Figure ‎5.28: Plot of released SN dye against the square root of time, showing the linear relationship between 
them. 
 
5.4- Conclusion: 
Controlled release drug delivery systems can be used to deliver drug to the body over 
long periods of time. Here, hydrogels loaded dyes were formed by the self-assembly of 
peptides for controlled release. The release of the dye from the hydrogel can be 
controlled by many factors, including the pH, peptide concentration, the microstructure 
and the mesh size. Moreover, choosing the right method to prepare hydrogel allows us 
to control the microstructure for hydrogel to be injectable. We have also examined the 
effect of concentration on both the strength of the gel (by studying the rheology) and 
the mesh size, by studying the release of the dye using gels formed at different 
concentrations of the dipeptide. There is a correlation between the release results and 
the rheological data. Also, we found that changing the concentration, dyes size and 
molecular weight can affect the rate of the release, where the rate of the release 
decreases with increase of the concentration and decreasing the mesh size. Similarity, 
the large dye with high molecular weight was restricted in the rate of the release. 
Therefore, these results showed that the rate of the release can be affected by these 
factors and these gels may be useful for applications in drug delivery. 
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CHAPTER 6 
Conclusion 
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5.1- Conclusion: 
Dipeptides hydrogels are LMWG that have great potential. Previously, hydrogels based 
on functionalised dipeptides such as naphthalene dipeptides and Fmoc-dipeptides have 
been used in different applications, energy transfer, cell culture and controlled release. 
In this thesis, we have synthesised a large number of functionalised dipeptides to study 
their ability to form hydrogels and study some of their applications. 
 
In the second Chapter, we have synthesised a large number of functionalised dipeptide 
derivatives with different aromatic protecting groups such as naphthalene, anthracene, 
pyrene, phenanthrol, anthraquinone and carbazole in order to study their ability to 
form gel because it is still unclear why some peptides form gel and others not when a 
small change in the molecular structure is applied. We have synthesised 35 dipeptides 
conjugated to different aromatic groups. 
 
In the next chapter, hydrogels were formed from these dipeptides functionalised with 
naphthalene, phenanthrol, anthraquinone, pyrene and carbazole using one of two 
different methods, the solvent method (DMSO: Water) or the GdL method. We have also 
studied the mechanical properties of the hydrogels, as well as comparing pKa and pH 
measurements. From the results, it can be seen that there is a correlation between the 
pKa and the hydrophobicity of the peptides. We established that the hydrophobicity 
increases with the increase of the pKa. As with other similar LMWG, for our dipeptides, 
the properties of the hydrogel can be modified by changing the structure, amino acid 
order or by the method of preparing hydrogel, it is still not fully understood why some 
peptides formed gel and others not.  
 
In Chapter 4, we have studied the fluorescence and energy transfer between different 
aromatic groups. The fluorescence of naphthalene, pyrene, anthracene, phenanthrol and 
carbazole dipeptides was studied. The results showed that all dipeptides conjugated to 
different aromatic groups can emit light at the same excitation with different 
fluorescence properties. We also noted that energy transfer occurred between two 
dipeptides (pyrene and anthracene dipeptides), and between dipeptide and dansyl 
derivative (phenanthrol and dansyl, or carbazole and dansyl). These results showed 
that energy transfers can occur between two dipeptides hydrogel or between dipeptide 
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and dansyl derivative. In other cases, no evidence for energy transfer was found. This 
might indicate that the packing of the fibres is important for energy transfer and this 
should be the focus of future work. 
 
In Chapter 5, we demonstrate the controlled release between components in such gels 
using different dyes. We also studied controlled release of FmocFF hydrogel and 
another functionalised dipeptide hydrogel (chosen as it can be used to form a gel at pH 
7) at different concentrations and different pHs. The data shows that the release of the 
dye from the hydrogel can be controlled by different factors, including the pH, peptide 
concentration, the microstructure and the mesh size. Furthermore, choosing the right 
method to prepare hydrogel allows us to control the microstructure for hydrogel to be 
injectable. Therefore, by controlling these entire factors we can use these kinds of 
hydrogels for drug delivery applications. 
 
Further work will need to consider the following areas:  
 Focus on studying the self-sorting system because it is still unclear whether the 
mixing of two peptides can be self-sorted or forms random fibres, where the 
efficiency of the energy transfer might be affected by the system of how the 
hydrogel formed, self-sorting or a random system formed. This may give expand 
to this project to be studied in more details. 
 In this thesis, we have found one gelator that form hydrogel at pH 7.4 for 
studying the controlled release. Further work might be concentrated on finding 
the gelators that can form hydrogel at pH 7.4 in order to expand the work and 
study the similar effect on the controlled release and drug delivery application. 
 Further work might be concentrated on examining the SEM of other conjugated 
dipeptide hydrogels. 
 
 
 
 
 
 
 
